Top 10 selections for 2013 by NIMH director

15 12 2013

By Thomas Insel on December 13, 2013

It’s time again for the year’s ten best from NIMH. A year that included a 16-day government shutdown and a 5.2 percent sequester also saw some outstanding scientific breakthroughs and historic changes in policy. Befitting the complexity of the problems, many of the breakthroughs were not individually reported findings but the cumulative results of several groups contributing different pieces of the puzzle. And some of the most historic policy changes are just launching so their impact is unclear. Paring a lengthy list down to “ten best” is both difficult and unsatisfying, but here goes.

Illustration of neurotransmitters10. Nobel Prize—This year’s Nobel Prize in Physiology or Medicine (and Lasker Award) recognized NIMH grantee Thomas Südhof for his discoveries of how neurotransmitters are released from the pre-synaptic terminal. Südhof and his colleagues described the molecular machines that allow vesicles to empty their contents into the synapse and then re-form to collect more neurotransmitters. This process is critical for neurons to communicate efficiently. Recently, Südhof’s work on the post-synaptic compartment has revealed a new world of molecules important for translating these biochemical messages. The genes for many of these protein families (i.e., shanks, neuroligins, neurexins, etc.) are emerging as leading risk candidates for autism and schizophrenia, giving us a new vocabulary for the molecular basis of mental disorders.1

brain three-quarters view9. Beyond Magic Bullets—Several important new trends emerged this year in non-pharmacological treatments, sometimes from pharmaceutical companies. In April, a Nature commentary that included authors from the pharmaceutical giant GSK described “electroceuticals,” heralding a new era in treatment development focusing on devices to deliver electric signals rather than drugs to alter the activity of neurotransmitters in the brain. Neuromodulation, arguably a better term than electroceuticals, had already been gaining traction with treatment of depression using deep brain stimulation and direct current stimulation. This year neuromodulation was introduced for anorexia nervosa. But neuromodulation was also extended to include approaches beyond electrical stimulation. In September, the cover headline of Nature—“Game Changer”—referred to a study by Adam Gazzaley and colleagues on the impact of cognitive training with NeuroRacer, a video game for enhancement of cognitive control. Not only did older adults (60 – 85 years old) trained on this game surpass performance of untrained 20-year-olds, cognitive enhancement generalized to working memory and other forms of cognitive control, with improvements persisting 6 months later. Cognitive training changed local brain activity as well. The key concept: if mental disorders are brain circuit disorders, then successful treatments need to tune circuits with precision. Chemicals may be less precise than electrical or cognitive interventions that target specific circuits.2,3,4

8. Organoids—It’s been 6 years since the first report of induced pluripotent stem cells (iPSCs). These are cells derived from mature skin cells, induced to become undifferentiated stem cells in a dish, and then differentiated to form mature cells like neurons or heart muscle cells. It’s been a year since this work was awarded the 2012 Nobel Prize in Physiology or Medicine. The excitement of this new technique was the potential to take cells from an individual with a disorder and either regenerate new cells in vitro (imagine new dopamine cells for someone with Parkinson’s disease) or recapitulate the disorder in vitro to define its development and screen for new treatments. This year there were some remarkable reports of using iPSCs to explore the altered development of neurons in children with rare forms of autism. But if autism and mental illnesses are circuit disorders or “connectopathies,” how can individual cells teach us about the altered connections? Amazingly, according to a team from the Austrian Academy of Sciences in Vienna, when neurons are grown in a dish, they self-assemble into circuits that resemble the normal cortex. These “organoids” are not “mini-brains” capable of consciousness but they are functional enough to permit the study of connections. It now appears that iPSCs could be a powerful tool to study circuit disorders.5,6,7

7. DSM-5 and RDoC—For NIMH, probably the year’s most oft-quoted statement was my April blog post about transforming diagnosis. Referring to the pending release of the DSM-5, I said, “Patients with mental disorders deserve better.” To many, this was interpreted as a critique of mainstream psychiatry. In truth, I was complaining that we in the research community have failed to provide the objective measures for diagnosis present in every other area of medicine. The Research Domain Criteria (RDoC) project aims to do just that, by using biological, cognitive, and social information to build more precise classifiers for each patient. RDoC is not a diagnostic system. At this point it is simply a framework for organizing the data. But it is a promise from the NIMH to get beyond diagnostic categories based only on symptoms. Why is this important? For brain disorders, symptoms are generally a late manifestation of a years-long brain process. In medicine, early detection and early intervention have often been the best ways to improve outcomes. RDoC is a first step towards achieving these goals with mental disorders.8,9

6. EP3—A year that began with concerns about school shootings and mental illness saw more mass shootings, many of them connected to serious mental illness (SMI). For this unfortunate reason, there was more media attention on mental illness this year than any time in recent memory. The number of articles about “mental illness” in theNew York Times in 2013 were more than double the average of the previous five years. Among the many recurring themes—access to weapons, access to treatment, incarceration—one prominent one was the need for earlier detection and treatment for SMI. The Early Prediction and Prevention of Psychosis (EP3) program, launched this year at NIMH, is an example of efforts to answer that need. Building on the success of the Recovery After Initial Schizophrenia Episode (RAISE) project, which was implemented this year in New York and Maryland, EP3 will focus on tools for the prodrome, that period prior to psychosis when symptoms are just beginning to emerge and may be most treatable. New studies will build on results from the North American Prodrome Longitudinal Study (NAPLS), just completing 10 years of critical research to develop ways to identify individuals who are at risk for an initial psychotic episode. With a series of new funding announcements and with the success of RAISE and NAPLS, NIMH made EP3 its signature program this year.10,11

chromosones and double helix5. Psychiatric Genetics—In 2003,Science magazine named the identification of genes for mental illness as its #2 breakthrough of the year (just behind confirmation of the existence of dark energy in the cosmos). It has taken another decade to deliver results that are statistically significant and clearly reproducible. For schizophrenia there are now 128 genetic associations, all common variants found across the genome. None of these alone accounts for much of the risk, but groups of these “hits” point to specific biological pathways. For autism, there are many rare variants emerging, many of these “de novo” or spontaneous mutations not found in other family members. These mutations seem to be most common in children with both autism and intellectual disability. Studies that have looked across disorders find some common genomic associations, with some findings across childhood disorders and others across adult disorders, irrespective of diagnosis. Before concluding anything about the significance of these cross-disorder findings, it will be important to understand the actual variation (which gene is involved) and the functional role, if any, of the variant.12,13

4. Brain Exceptionalism—For me, 2013 will be the year when we began to realize how much the brain differs from other organs. We already knew that cells in the brain express (translate into protein) more of the genome and use more energy than any other organ. But two discoveries this year really made the case for the human brain as not only the most mysterious but the most exceptional of organs. Leveraging new tools for single cell biology, scientists working with Rusty Gage at the Salk Institute and Ira Hall at the University of Virginia reported that the brain has its own genome, with abundant and sometimes profound variation not found in other tissues. In human frontal cortex, they report as many as 41 percent of cells having at least one large mutation, with a million DNA bases either duplicated or deleted. These are mutations not seen in blood cells (which have been the basis for all psychiatric genetic studies) or in neurons elsewhere in the brain. Equally surprising, the brain epigenome also appears unique. The epigenome is a complex of molecules that coat the DNA helix, “silencing” parts of the genome to ensure that certain genes are not translated. The entire DNA strand consists of only four bases: cytosine, guanine, adenine, and thymine. Whereas in most cells in the body silencing occurs where cytosine and guanine are adjacent, brain cells follow a different set of rules with all the base pairs involved. This means that the mechanisms by which experience influence biology are completely different in brain cells compared to blood cells or liver cells. The lesson is that we cannot use peripheral cells to know what is happening in the brain.14,15

CLARITY 3D brain image3. CLARITY—It may be an inelegant acronym but the results are utterly beautiful. CLARITY = Clear Lipid-exchanged Anatomically Rigid Imaging/immunostaining-compatible Tissue hYdrogel. By replacing the brain’s fat with a clear gel, CLARITY turns the opaque and impermeable brain into a transparent and porous structure. Most important, the hydrogel holds the brain’s anatomy intact. And because the hydrogel is permeable, the brain can be stained to localize proteins, neurotransmitters, and genes at a high resolution. Unlike other recent breakthroughs in neuroanatomy, this one can be used in human brains. And unlike virtually all neuroanatomy of the past century, CLARITY is 3-dimensional. Flying through the tissue in 3-D allows the first comprehensive view of how cells and processes are arrayed across the entire brain. Karl Deisseroth earlier developed optogenetics as a revolutionary tool for studying brain circuits in behaving animals. This time his lab has revolutionized how we will look at the brain post-mortem.16

full color brain scan2. BRAIN—On April 2nd, President Obama in the East Room announced the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) initiative. The speech should be read by everyone with a stake in brain research or brain disorders. Calling BRAIN the “next great American project,” he challenged a broad scientific community to explore the brain as we had once explored space. BRAIN will involve several government research agencies as well as several private sector partners. And it complements a large brain project underway in the European Union and projects being developed in Israel, Japan, China, and elsewhere. This global interest in neuroscience reflects both the growing awareness of the cost of brain disorders and the growing recognition that success in the 21st century will depend on a “brain economy” rather than a “brawn economy.” The U.S. BRAIN initiative will launch in 2014 with $110M, of which $40M will be from NIH. Funding announcements for the first wave of NIH projects will be released this month.17

Woman at NIMH Clinic1. Parity—My guess is that in terms of mental health issues, history will remember 2013 not for a scientific finding but for a long overdue policy change: mental health parity. While the Mental Health Parity and Addiction Equity Act was signed into law in October 2008, the final rule providing the guidance to implement this law was only released in November 2013. Most important, the Affordable Care Act, signed into law in 2010, affirmed mental health care as an “essential benefit.” As a result, mental health care must be provided in all health care plans and the provision of care for mental disorders must be on a par with other medical disorders (i.e., same co-pays, deductibles, certification requirements). When you add to these changes the removal of exclusions for pre-existing conditions, the extension of coverage to offspring until age 26, and in some states the expansion of Medicaid, you can see that this is really the most far-reaching change in mental health care since the Community Mental Health Act 50 years ago. And this is coming at an important time. Over the summer, the Global Burden of Disease project reported out on 291 medical disorders, updating its 1990 report with 2010 data. The new report finds mental illness and substance abuse disorders to be the leading source of years lost to disability, with the burden of illness from this group of disorders increasing 37 percent since 1990. Depression and anxiety were the largest contributors among the 20 mental and substance abuse disorders, accounting for 55 percent of the DALYs (disability adjusted life years—a composite measure of disability and premature mortality).

There are many questions about how parity will reduce DALYs: Who will provide the care? What will it cost? Where will mental health care be delivered? What is the dose and duration of psychosocial treatments that will be covered? None of these questions will be answered in 2013, but going forward NIMH can ensure that the best science informs this historic change.18,19


1 Südhof TC. A molecular machine for neurotransmitter release: synaptotagmin and beyond. Nat Med. 2013 Oct; 19(10):1227-31. doi: 10.1038nm.3338.

2 Anguera JA et al. Video game training enhances cognitive control in older adults. Nature. 2013 Sep 5;501(7465):97-101. doi: 10.1038/nature12486.

3 Lipsman N et al. Subcallosal cingulate deep brain stimulation for treatment-refractory anorexia nervosa: a phase 1 pilot trial. Lancet. 2013 Apr 20;381(9875):1361-70. doi: 10.1016/S0140-6736(12)62188-6. Epub 2013 Mar 7.

4 Famm K et al. Drug discovery: a jump-start for electroceuticals. Nature. 2013 Apr 11;496(7444):159-61. doi: 10.1038/496159a.

5 Shcheglovitov A et al. SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients.Nature. 2013 Nov 14;503(7475):267-71. doi: 10.1038/nature12618. Epub 2013 Oct 16.

6 Krev JF et al. Timothy syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons.Nat Neurosci. 2013 Feb;16(2):201-9. doi: 10.1038/nn.3307. Epub 2013 Jan 13.

7 Lancaster et al. Cerebral organoids model human brain development and microcephaly. Nature. 2013 Sep 19;501(7467):373-9. doi: 10.1038/nature12517. Epub 2013 Aug 28.

8 Cuthbert BN, Insel TR. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med. 2013 May 14;11:126. doi: 10.1186/1741-7015-11-126.

9 Casey BJ et al. DSM-5 and RDoC: progress in psychiatry research?;
Nat Rev Neurosci. 2013 Oct 18;14(11):810-4. doi: 10.1038/nrn3621.

10 Fusar-Poli P et al. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry. 2013 Jan;70(1):107-20. doi: 10.1001/jamapsychiatry.2013.269.

11 Carrion RE et al. Prediction of functional outcome in individuals at clinical high risk for psychosis. JAMA Psychiatry. 2013 Nov 1;70(11):1133-42. doi: 10.1001/jamapsychiatry.2013.1909.

12 Cross-Disorder Group of the Psychiatric Genomics Consortium: Genetic Risk Outcome of Psychosis (GROUP) Consortium.Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet. 2013 Apr 20;381(9875):1371-9. doi: 10.1016/S0140-6736(12)62129-1. Epub 2013 Feb 28.

13 Ripke S et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia.Nat Genet. 2013 Oct;45(10):1150-9. doi: 10.1038/ng.2742. Epub 2013 Aug 25.

14 McConnell MJ et al. Mosaic copy number variation in human neurons. Science. 2013 Nov 1;342(6158):632-7. doi: 10.1126/science.1243472.

15 Lister R et al. Global epigenomic reconfiguration during mammalian brain development. Science. 2013 Aug 9;341(6146):1237905. doi: 10.1126/science.1237905. Epub 2013 Jul 4.

16 Chung K et al. Structural and molecular interrogation of intact biological systems. Nature. 2013 May 16;497(7449):332-7. doi: 10.1038/nature12107. Epub 2013 Apr 10.

17 Insel TR et al. Research priorities. The NIH BRAIN Initiative.Science. 2013 May 10;340(6133):687-8. doi: 10.1126/science.1239276.

18 US Burden of Disease Collaborators. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors.JAMA. 2013 Aug 14;310(6):591-608. doi: 10.1001/jama.2013.13805.

19 Whiteford HA et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013 Nov 9;382(9904):1575-86. doi: 10.1016/S0140-6736(13)61611-6. Epub 2013 Aug 29.

Neurogenesis or why don’t we remember almost anything from when we were babies?

20 08 2013

By Thomas Insel, NIMH Director:

My four-year-old grandson has a near photographic memory for outings we took a year ago, for people he met six months ago, and for books he has not seen in weeks.  Soon that will all disappear.  By the time he is eight, he will remember almost nothing of his first four years.  And by the time he is eighteen, he will remember details going back to age four and he will retain language and habits acquired before age four, but in terms of autobiographical or episodic memories, the earliest years will be almost a complete blank.  This normal loss of early memories is called infantile amnesia.

Freud, a source not cited often in this space, was one of the first to write about infantile amnesia.  He attributed the loss of early memories to repression, an active forgetting of early experiences because of their heavily charged psychosexual content.  Others have explained infantile amnesia as due to the absence of language, since words seem important for encoding certain kinds of memory.   Still others have cited the need for a sense of self to provide a reference for early memory.

The problem with these explanations is that other mammals, lacking language and presumably less burdened by psychosexual conflicts, show the same loss of early memories while having perfectly good long-term memory for later experiences.  If mice and rats and other mammals also have infantile amnesia, what is the mechanism?  It’s not simply an inability to learn early in life.  Very young mammals, like my grandson, are sponges for information.  The problem is that this information is either not accessible or not retained in later development.

Recent research on this problem by Paul Frankland, Sheena Josselyn, and their colleagues at the Hospital for Sick Children in Toronto suggest a surprising explanation.1,2 They suggest that infantile amnesia is due to the rapid birth of cells in the hippocampus during infancy.  The hippocampus has long been known to be associated with episodic memory, including autobiographical memory.  And many scientists over the past two decades have shown that brain cells in the hippocampus continue to be generated through adulthood.  This process, called neurogenesis, occurs in humans as well as mice.  Many studies have shown that exercise increases neurogenesis, while stress decreases it.  And several investigators have suggested that neurogenesis is important for learning.

Frankland, Josselyn, and colleagues are suggesting paradoxically that neurogenesis is important for forgetting.  Specifically, they hypothesize that the increased rate of neurogenesis during infancy leads to loss of the memories that would otherwise be stored long-term.  What’s the evidence?  When they experimentally increase neurogenesis in adult mice, they induce a change in memory that looks like infantile amnesia.  And when they experimentally decrease neurogenesis in infant mice, they reduce the amnesia.  They have also studied mammals that are born relatively mature, like guinea pigs and degus.  These species do not have the rapid neurogenesis of infancy and do not show infantile amnesia.

Why is this important?  Beyond the mystery of why we lose our earliest memories, understanding a natural process like infantile amnesia can help us discern the fundamental connections between brain and behavior.  Do traumatic events (which presumably influence neurogenesis) get encoded and stored differently during infancy?  What about attachments in the first three years?  Do individual differences in neurogenesis translate into differences in recall?  Would changes in neurogenesis lead to changes in memory in humans?  All of these issues remain to be explored.  At this point we can say that a mystery that was fundamental to Freud’s theory of sexuality may now be solved with the tools of modern neuroscience.


1 Frankland PW, Köhler S, Josselyn SA. Hippocampal neurogenesis and forgettingTrends Neurosci. 2013 Jun 12. pii: S0166-2236(13)00086-6. doi: 10.1016/j.tins.2013.05.002. [Epub ahead of print]

2 Josselyn SA, Frankland PW. Infantile amnesia: a neurogenic hypothesis. Learn. Mem. 2012 19:423-433. Doi:10.1101/lm.021311.110.

A New Job Board for Applicants with disabilities

10 07 2013

 Today I wish to briefly introduce a new Job board for applicants with disabilities. This unique job board was established by the Israel Ministry of Industry, Trade and Labor and is aimed to further enhance work inclusion of people with disabilities in Israel.  For more details (in Hebrew) see: or join the facebook page:

As part of this project, I had the privilege to write a guide for Job seekers with disabilities. In this guide, I sought to present relevant information about the job search process and to provide practical tools that will assist  job seekers in this complex journey. Furthermore, I discuss the disability disclosure issue, that is, whether, and when the person should disclose her/his disability (to read more on this issue see I will share this guide with you in the next few days. I will also share a review that I wrote about job boards to people with disabilities, worldwide.

A New State of Mind: Ending the Stigma of Mental Illness by Glenn Close

30 05 2013

Award-winning actress and mental health advocate Glenn Close will narrate “A New State of Mind: Ending the Stigma of Mental Illness” an inspiring documentary that tells the stories of everyday people to shatter myths about mental illness, highlighting the struggles faced by those with mental health challenges, and their hope, resilience and recovery.

Ms. Close is a dedicated mental health advocate, having founded a national anti-stigma campaign, Bring Change 2 Mind in partnership with The Balanced Mind Foundation, Fountain House, and Garen & Shari Staglin of the International Mental Health Research Organization (IMHRO). The idea for Bring Change 2 Mind was born when Ms. Close volunteered at Fountain House in order to learn more about mental illness, which both her sister, Jessie Close, and nephew, Calen Pick, live with.

“The toxic stigma around mental illness can be as painful as the illness itself,” said Ms. Close. “It’s crucial that these diverse and powerful stories are told and shared so that everyone realizes that mental illness touches us all. No one need struggle in isolation, silence and shame. Listening and having the courage to join the conversation will save lives.”

“A New State of Mind: Ending the Stigma of Mental Illness” is produced by KVIE, Sacramento’s PBS station, as part of a comprehensive statewide effort to increase the number of people who seek early help for mental challenges by reducing stigma and discrimination around mental illness. It is a Prevention and Early Intervention program of California Mental Health Services Authority (CalMHSA), an organization of county governments working together to improve mental health outcomes for individuals, families, and communities, and funded by the voter-approved CaliforniaMental Health Services Act (Prop. 63).

SOURCE California Mental Health Services Authority (CalMHSA)

Respond to Criticism of DSM-5 by NIMH Director

7 05 2013

Statement by David Kupfer, MD
Chair of DSM-5 Task Force Discusses Future of Mental Health Research

The promise of the science of mental disorders is great. In the future, we hope to be able to identify disorders using biological and genetic markers that provide precise diagnoses that can be delivered with complete reliability and validity. Yet this promise, which we have anticipated since the 1970s, remains disappointingly distant. We’ve been telling patients for several decades that we are waiting for biomarkers. We’re still waiting. In the absence of such major discoveries, it is clinical experience and evidence, as well as growing empirical research, that have advanced our understanding of disorders such as autism spectrum disorder, bipolar disorder, and schizophrenia.
This progress will soon be recognized in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). The new manual, due for release later this month, represents the strongest system currently available for classifying disorders. It reflects the progress that we have made in several important areas.
 A revised chapter organization signals how disorders may relate to each other based on underlying vulnerabilities or symptom characteristics.
 Disorders are framed in the context of age, gender, and cultural expectations, in addition to being organized along a valuable developmental lifespan within each chapter.
 Key disorders were combined or reorganized because the relationships among categories clearly placed them along a single continuum, such as substance use disorder and autism spectrum disorder.
 A new section introduces emerging measures, models and cultural guidance to assist clinicians in their evaluation of patients. For the first time, self-assessment tools are included to directly engage patients in their diagnosis and care.
DSM, at its core, is a guidebook to help clinicians describe and diagnose the behaviors and symptoms of their patients. It provides clinicians with a common language to deliver the best patient care possible. And through content such as the new Section III, the next manual also aims to encourage future directions in research.
Efforts like the National Institute of Mental Health’s Research Domain Criteria (RDoC) are vital to the continued progress of our collective understanding of mental disorders. But they cannot serve us in the here and now, and they cannot supplant DSM-5. RDoC is a complementary endeavor to move us forward, and its results may someday culminate in the genetic and neuroscience breakthroughs that will revolutionize our field. In the meantime, should we merely hand patients another promissory note that something may happen sometime? Every day, we are dealing with impairment or tangible suffering, and we must respond. Our patients deserve no less.
The American Psychiatric Association is a national medical specialty society whose physician members specialize in the diagnosis, treatment, prevention and research of mental illnesses, including substance use disorders. Visit the APA at

Changes in Prevalence of Parent-reported Autism Spectrum Disorder in School-aged U.S. Children: 2007 to 2011–2012

23 03 2013

The U.S. Centers for Disease Control and Prevention (CDC) and Health Resources and Services Administration released a report titled “Changes in Prevalence of Parent-reported Autism Spectrum Disorder in School-aged U.S. Children: 2007 to 2011–2012”. The report presents data on the prevalence of diagnosed autism spectrum disorder (ASD) as reported by parents of school-aged children ages 6–17 years in 2011–2012. Data was drawn from the 2007 and 2011–2012 National Survey of Children’s Health, which comprises independent, nationally representative telephone surveys of households with children.

Last year, the CDC’s Autism and Developmental Disabilities Monitoring Network estimated that 1 in 88 children had been identified with ASD. The CDC now estimates that in 2011–2012, about 1 in 50 school-aged children, or 2 percent of children ages 6–17 years have some form of the disorder. Since the average school bus holds 50–55 children, that means, statistically speaking, on average there is one child with parent-reported ASD on every school bus in America.

Click HERE for the full report.

Happy holidays!


News about the Convention on the Rights of Persons with Disabilities

1 03 2013

The United Nations Enable Newsletter is prepared by the Secretariat for the Convention on the Rights of Persons with Disabilities (DSPD/DESA) with input from UN offices, agencies, funds and programmes, as well as from civil society organizations, including organizations of persons with disabilities. I hope that you will find it interesting and helpful.

High-level Meeting on disability and development (23 September 2013)
The High-level meeting of the General Assembly on disability and development (HLMDD: is expected to take place at the level of the Heads of States on 23 September, this year. Prior to the meeting, a draft text of the outcome document will be produced by the President of the General Assembly in consultation with Member States, along with input from organizations of persons with disabilities and other relevant stakeholders, through online discussions and informal consultations. Toward this end, DESA, in partnership with UNICEF will conduct online consultations under the existing platform of the World We Want 2015 from 8-28 March. (

Commission for Social Development concludes its session
The 51st session of the Commission for Social Development (CSOCD) met in New York from 6 to 15 February under the theme: “Promoting empowerment of people in achieving poverty eradication, social integration and full employment and decent work for all”. Two reports were presented to the Commission at this sessions: “Report of the Secretary General on Mainstreaming Disability in the Development Agenda” (E/CN.5/2013/9) and “Report of the Special Rapporteur to the 51st Session of the Commission for Social Development: Monitoring of the implementation of the Standard Rules on the Equalization of Opportunities for Persons with Disabilities” (E/CN.5/2013/10). The Special Rapporteur on Disability, Shuaib Chalklen, also presented his statement to the Commission. (

Panel discussion on a post-2015 development framework
A panel discussion was organized by DESA in collaboration with the UN Regional Commissions on 12 February, as a side-event to the above session of the Commission. The event entitled: “Toward a disability-inclusive post-2015 development framework: Regional perspectives” was organized with a view to generate input to the outcome document for the High-level Meeting of the General Assembly on disability and development to be held on 23 September, this year. Focusing on the role of UN Regional Commissions, the discussion highlighted current efforts to integrate existing international instruments on disability in regional and national policies and frameworks on development. (

New Enable webpage on Indigenous persons with disabilities
DESA has prepared a new web page to draw attention to issues related to indigenous persons with disabilities. While no global data exists regarding indigenous persons with disabilities, available statistics show that indigenous peoples are disproportionately likely to experience disability in comparison to the general population. Indigenous persons with disabilities often experience multiple discrimination and face barriers based on their indigenous status, as well as their disability. The international community has also recognized that special measures are required to protect the rights of the world’s indigenous peoples. This web page will continue to develop as a hub of news, resources and links related to indigenous persons with disabilities. (

My World: The United Nations global survey
Make the voices of persons with disabilities heard… LOUD!
Vote for the changes that would make the most difference to your world! MY World is a United Nations global survey asking you to choose your priorities for a better world. There are 16 priority areas in the survey, plus one more for you to decide, which can be made disability-specific. For example: Freedom to make my own decisions; Being included in the community by removing architectural and attitudinal barriers; Including persons with disabilities in all development plans, programs and activities. You decide! Forward, translate and send this around the world!Results will be shared with world leaders in setting the next global development agenda. Tell them about the world you want, because your voice matters!
Vote at:

HRC – Work and employment of persons with disabilities
The fifth interactive debate of the Human Rights Council (HRC) on the rights of persons with disabilities will take place on Wednesday, 6 March 2013 in Geneva, focusing on the issue of work and employment of persons with disabilities. The debate will bring together experts in the field of promoting employment opportunities for persons with disabilities, including: representatives of a organization of persons with disabilities (DPO), the International Labour Organization (ILO), the private sector, the Committee on the Rights of Persons with Disabilities and a social entrepreneur. Presentations by panelists will be followed by an interactive discussion among Human Rights Council Member States and observers. The debate will seek to identify good practices in promoting employment opportunities for persons with disabilities in both public- and private-sector workplaces. It will also contribute to raising awareness of the challenges that persons with disabilities continue to face in employment, and to highlight the measures that States and employers can take with a view to ensuring that persons with disabilities enjoy access to, retention of and advancement in employment on an equal basis with others. The panel and its web cast will be made accessible to persons with disabilities through real time captioning and sign language interpretation. ( As requested by the HRC, OHCHR has also prepared a thematic study on the work and employment of persons with disabilities (A/HRC/22/25). (

HRC – Side-event on Inclusive Education
As a side-event to the 22nd session of the HRC, UNICEF and the Permanent Missions of Finland and Spain will co-organize a side-event titled: Inclusive Education for Children with Disabilities: Examples from Central and Eastern Europe and the CIS region, on 1 March, in Geneva, Switzerland. Speakers include: H. E. Mr. Zarko Obradovic, Minister of Education, Science and Technological Development of Serbia; H. E. Mr. Pance Kralev, Minister of Education and Science of the former Yugoslav Republic of Macedonia; H. E. Ms. Vesna Vucurovic, Deputy Minister of Education and Sports of Montenegro; Ms. Yoka Brandt, UNICEF Deputy Executive Director; and Mr. J Patrick Clarke, Chief Executive Officer of Down Syndrome Ireland, representing the International Disability Alliance.

OHCHR – General Discussion on women and girls with disabilities
The Committee on the Rights of Persons with Disabilities will hold a half Day of General Discussion on Women and Girls with Disabilities on Wednesday, 17 April 2013. Women and girls with disabilities experience multiple forms of discrimination, which hinder their meaningful participation on an equal basis with others in all spheres of life. The Committee has invited persons with disabilities and their representative organizations to submit their inputs to the Committee. (

WHO – JPMH Mental health and human rights: Call for papers
The Journal of Public Mental Health (JPMH) announces a call for papers for a special issue on mental health and human rights, to be published in 2013. Accepted contributions include original research papers, systematic reviews, policy analyses and case studies. In 2012, the World Health Organization (WHO) Department of Mental Health and Substance Abuse launched the QualityRights (QR) Project, which aims to improve the quality and human rights conditions in mental health and social care facilities and empower civil society organizations to advocate for the rights of people with mental and psychosocial disabilities. This call for papers aims to inform the core objectives of QualityRights. JPMH hopes to attract papers from academics, practitioners and activists in resource-scarce countries. Papers submitted for this special edition should be marked with “QualityRights” in the title. The manuscript selection process will follow the Journal’s peer-review procedures. Submit articles to before 1 June 2013.  Informal enquiries to: Information on WHO’s QualityRights Toolkit is available at:

World Bank – Disability & Development training course
The World Bank’s core course on Disability & Development aims to provide participants with an in-depth understanding of the conceptual and practical issues involved in the development and implementation of inclusive economic and social policies that are relevant for persons with disabilities. The course aims to help increase knowledge on disability, its social and economic relevance and development policies and programs responsive to the needs of persons with disabilities; increase understanding of the main issues involved in the process of including disability into development to ensure that persons with disabilities have equal access to all mainstream policies and services and to eliminate “disability disadvantage”. Deadline for registration: Friday, 1 March 2013. (

(Send us information on major international disability events for possible inclusion in the list below)

27 February to 1 March: Seminar on Indigenous peoples
The “International Expert Seminar on Access to Justice for Indigenous Peoples including Truth and Reconciliation processes” held at the Institute for the Study of Human Rights at Columbia University, New York, will contribute to the work of the United Nations Expert Mechanism on the Rights of Indigenous Peoples. Agenda Item 12 of the seminar covers: “Indigenous Women, Youth and Persons with Disabilities and Access to Justice”. (

11 March: ReelAbilities: NY Disabilities Film Festival at UN HQ
The Permanent Mission of Sweden will sponsor the screening of the film: “The Importance of Tying Your Own Shoes” at UN Headquarters in New York. Film synopsis: When Alex gets a job as the leader of a local theater group for persons with disabilities, his outlook on life begins to change. Through the theater group’s work, Alex comes to appreciate that every person has his or own talents, which can grow if given the opportunity and support. (Lena Koppel / 100 min.) The event is being organized by ReelAbilities: NY Disabilities Film Festival, the UN Department of Public Information (UNDPI) and DESA.  (

4 to 15 March: Commission on the Status of Women, 55th session
The fifty-seventh session of the Commission on the Status of Women will take place at UN Headquarters under the priority theme: “Elimination and prevention of all forms of violence against women and girls.” The review theme chosen is “the equal sharing of responsibilities between women and men, including caregiving in the context of HIV/AIDS (agreed conclusions from the fifty-third session). (

21 March: World Down Syndrome Day
In 2011, the General Assembly declared 21 March as World Down Syndrome Day (A/RES/66/149). This year at the United Nations the World Down Syndrome Conference 2013 will be organized at UN Headquarters in New York on 21 March, under the theme “The Right to Work”. This year’s Conference will focus on the rights of persons with Down syndrome to work in open, inclusive and accessible environments. It will help raise awareness on the importance of promoting early development and education, proper medical care, and providing for independent living in communities. The multi-stakeholder event will be organized in collaboration with Down Syndrome International, the Missions of Australia, Brazil, Poland, India, DESA and other partners. (;

2 April: World Autism Awareness Day
The United Nations General Assembly unanimously declared 2 April as World Autism Awareness Day (A/RES/62/139) to highlight the need to help improve the lives of children and adults who suffer from the disorder so they can lead full and meaningful lives. (

17 April: General Discussion on women and girls with disabilities
The Committee on the Rights of Persons with Disabilities will hold a half Day of General Discussion on Women and Girls with Disabilities. (see OHCHR above)

29 to 30 April: 29th Pacific Rim International Conference on Disability and Diversity
The theme for the 29th Pacific Rim International Conference on Disability and Diversity: “Being in Community”, embraces the ideals of all people living together harmoniously and happily in a barrier-free world without fear of exclusion from social, economic or political life. (

20 to 31 May: 12th session, Permanent Forum on Indigenous Issues
The session will be held at UN Headquarters, New York and include a review year of the Forum. (

6 to 7 June: M-Enabling Summit 2013
The second M-Enabling Summit 2013: Global Summit on Accessible Mobile Technology for Senior Citizens and Users of All Abilities is organized by the Global Initiative for Inclusive ICTs (G3ict) and E.J. Krause and Associates (EJK) in cooperation with the International Telecommunication Union (ITU) and the Federal Communications Commission (FCC), ensuring substantial participation for leading international mobile service providers, policy makers, apps developers and manufacturers. (

27 to 28 June: Symposium on Disability, Technology and Rehabilitation in Low and Middle Income Countries
The Symposium to be held at the University of Washington, Seattle, Washington, will focus on improving and increasing access to technology and rehabilitation products and services with the goal of ensuring full inclusion and participation for persons with disabilities in low-resourced communities in low and middle income countries.  The keynote speaker will be Chapal Khasnabis, Disability and Rehabilitation Team, World Health Organization. (

2 to 3 July: Include 2013: Global Challenges and Local Solutions in Inclusive Design
The event will be organised by the Helen Hamlyn Centre for Design, Hong Kong Design Centre and the School of Design at the Hong Kong Polytechnic University. (

2 to 13 September: 10th session of the Committee on the Rights of Persons with Disabilities
(Details forthcoming)

9 to 11 September: 6th International Urban Design Conference
The Conference will be held at the Novotel Sydney Olympic Park.  The conference “UrbanAgiNation” urbanisation | agitation | imagination will examine the future Density and Infrastructure requirements in cities. The call for abstracts is now open. (

23 September: High-level meeting on disability and development
(See item above).

16 to 18 October: 2nd International Conference of the WFD
The 2nd Conference of the World Federation of the Deaf (WFD) will be held in Sydney, Australia under the theme: “Equality for Deaf People”. (

3 December: International Day of Persons with Disabilities
The details and theme for 2013 are forthcoming.

(DISCLAIMER: The information below is provided by civil society organizations and others for informational purposes only. This does not constitute endorsement of, or an approval by, the United Nations of any of the products, services, or opinions of the organization or individual. The United Nations bears no responsibility for the accuracy, legality or content of their statements and opinions.)

New “COMPASS” on Human Rights Education
The Council of Europe’s Human Rights Education Manual “COMPASS”, a new, revised version now includes “Disability and Disablism” as a theme, as well as a 10-page background text on the topic produced through a multi-stakeholder partnership of the CoE, UN, European Disability Forum, IFHOHYP and other DPOs. COMPASS also includes training activities on disability and disability rights. (

Ibero-American Year for Workplace Inclusion of Persons with Disability
The XXII Ibero-American Summit of Heads of State and Governments held in Cadiz in November 2013 agreed to declare the year 2013 as the “Ibero-American Year for Workplace Inclusion of Persons with Disability”. This idea first came from an agreement initially signed by the Vice-presidency of Ecuador, the Employment Ministers Iberoamerica, the Ibero-American Secretariat (SEGIB) and the Ibero-American Social Security Organization (OISS). To support their proposal to the Ibero-American Summit, SEGIB and OISS presented the results of a study, which described the situation of persons with disability in Iberoamerica and the barriers they face to access the labour market (

Funding opportunities for disability policy scholars  
The Center for Studying Disability Policy (CSDP), through the Disability Research Consortium (DRC) and the Social Security Administration (SSA), is funding disability policy scholars.  Applications are being accepted for three grants that offer funding opportunities for graduate students and new researchers conducting disability policy research, under the Disability Policy Research Summer Scholars Program, the Disability Policy Research Dissertation Scholars Program, and the Disability Policy Research Emerging Investigator Award Program. Deadline: 8 March 2013. (

Inclusion International Launches Global Report on Article 19
Inclusion International launched a new global report entitled: “Inclusive Communities = Stronger Communities”. The report confirms that most adults with intellectual disabilities live at home and do not have the support they need to live and be included in their communities. It reveals that families are the major source of support. The report highlights that transforming communities to be inclusive and ensuring that people with disabilities are included in mainstream programmes are essential for securing the rights of people with intellectual disabilities. (

Strengthening the voices of the users and survivors of psychiatry
WNUSP, an international representative network of the voices of users and survivors of psychiatry, is working to ensure that the views and opinions of all users and survivors of psychiatry around the world are respected and upheld. Find out more about its new project “Strengthen Our Voices!” (

LCD New publication on inclusive education
Leonard Cheshire Disability (LCD) has recently published “Inclusive Education – An Introduction”. Every child in the world has a right to education. However, children with disabilities are still disproportionately excluded from school. In an inclusive school, disabled children do not study in separate classes; all children learn together in the same classroom using materials appropriate to their various needs. This publication explores LCD’s approach to inclusive education and highlights their projects in Africa and Asia that support children with disabilities to get the education that they, and all children, deserve. (

A Health Handbook for Women with Disabilities
Women with disabilities often discover that the social stigma of disability and inadequate care are greater barriers to health than the disability, itself. This Handbook, developed with the help and experience of women with disabilities in 42 countries, can help women with disabilities overcome barriers, improve their general health, self-esteem and ability to care for themselves, as well as increase their participation in their communities.

DPI convenes meeting on youth with disabilities in India
Disabled People’s International (DPI), India, organized a 2-day National Convention for Youth with Disabilities on 7 to 8 February in New Delhi. Around 50 young students with disabilities from the top colleges and universities, including engineering, medical, law, media and design institutes, participated in this first-ever initiative. The objective of the event was to reach out to young people with disabilities and inspire the next generation leaders of, not just the Indian disability sector, but also those who would be agents of change in other fields. The Convention was inaugurated by the Government Minister for Social Justice and Empowerment. DPI has also launched its new website. (


Secretariat for the Convention on the Rights of Persons with Disabilities
Division for Social Policy and Development (DSPD)
Department of Economic and Social Affairs (DESA)
S-2906, United Nations, New York, NY 10017, USA.

“With so many roads not yet taken, who would want to follow the herd?”

28 11 2012

Today I wish to present a new post of NIMH’s director Dr. Thomas Insel, that talks about the importance of research that explores the frontiers of science and funding efforts to encourage innovative research:

Julius Axelrod was one of NIMH’s greatest scientists and mentors for five decades until his death in 2004 at age 92. In addition to his many discoveries – which led to his 1970 Nobel Prize – Julie, as he was known, was famous for his aphorisms. One was his saying that “98 percent of the discoveries are made by 2 percent of the scientists.” While this might sound arrogant or elitist to some, data emerging over the past few years support the notion that much of our scientific endeavor involves following the herd and, importantly, that the herd grazes on not much more than 2 percent of the available land.

In a paper published last year in Nature entitled “Too many roads not taken,” Aled Edwards and his colleagues provide a nice example of this instinct.1 The class of enzymes called kinases are critical biological gatekeepers, and many are potentially involved in diseases of the brain. Although there are over 500 protein kinases known from the human genome, about 65 percent of the 20,000 kinase papers published in 2009 focused on the same 50 that were being studied in the early 1990’s. This narrow focus has persisted after many of the unexplored kinases showed up in unbiased genomic screens as potentially related to diseases.

The narrow focus of our science is even more conspicuous in this age of “-omics” – when we can study all of the genes, all of the transcripts, or all of the proteins without a hypothesis. Although we thought the fields of genomics, transcriptomics, and proteomics had defined the universe of roads not taken, recent publications from the ENCODE project reveal a dramatic expansion of this universe.2 ENCODE is a landmark effort that is mapping the working parts of the human genome and exposing just how limited our exploration has been to date. Researchers have focused mostly on the 2 percent of the genome that belongs to genes, but we now know that 80 percent of the genome is translated. In fact, the genome codes for a range of important biological signaling molecules, many of which are still being identified.

For the past 50 years, NIMH researchers have focused on a few pages of this vast text, assuming that dopamine and serotonin were most of what we needed to know about the biology of mental disorders. Where we have been is akin to colonial North America where the overwhelming majority of the population remained on a small fraction of the continent and the Midwest and West were frontiers explored by very few.

How do we encourage exploration of the vast frontiers of biology? How do we nudge the scientific field toward the unknown? In truth, much of what we currently do reinforces herd behavior. NIMH funding is guided largely by a system of peer review, and peer review tends to reward the familiar or, at best, small steps. But the problem is much more fundamental than this. Scientific training is based on an apprenticeship model, with the focus placed on following a mentor, not on breaking for a frontier. Furthermore, academic success requires publishing, which is most easily accomplished by remaining where the tools are good, the field is safe, and the territory is familiar. Not all kinases, for example, are equally easy to study. Successful scientists know to focus on problems that have a good chance of being solved. As the British biologist Sir Peter Medawar noted, “Science is the art of the soluble.” But the targets that are easiest to study are not always the most important. We have created a world of incentives for looking where the light is, even if that is not where the keys were lost.

This would not matter so much if our problems were not so important to solve. We simply cannot afford to have 98 percent of our scientists looking where the light is, staying within the safe zone. Given this, NIH has been working to build incentives to help attract the most intrepid scientists into the frontiers of science. NIH’s Pioneer Awards and New Innovator Awards are grants for innovative ideas that are opening new areas to research and creating new tools. Importantly, these awards are for the person, not the specific project, encouraging these scientists to pursue novel approaches to important problems. For example, a recent NIMH-supported Pioneer Award will allow Feng Zhang of MIT to develop a new approach to manipulating the genome and epigenome.3

NIMH is also trying to encourage innovation among young investigators through the BRAINS (Biobehavioral Research Awards for Innovative New Scientists) initiative. So far, we have awarded 28 early stage investigators with support to pursue an idea deemed high-risk but high-reward, helping to move them into areas not previously studied. Among the 28, Amit Etkin4 of Stanford is studying the neurobiology of psychotherapy, and Zhaolan Zhou5 of the University of Pennsylvania is defining the epigenetic signature of early life stress.

My own sense is that Julie Axelrod was partly right. There is a small group of scientific leaders who seek out new frontiers and set the pace for the vast majority of the field. But I am not convinced that tells the entire story. Each new breakthrough is based on a foundation laid by hundreds of scientists often working in distant fields. Today we find that discoveries are often the products of groups working together, rather than a lone investigator striving to be in the 2 percent club. At the same time, we do need to make more room for scientific pioneers – researchers who have completely new ideas and are willing to take risks to open up a new area of inquiry.

This need is important to consider during this period of austerity for NIMH funding. Tight budgets are not kind to risk takers. But, when budgets are tight, it is more important than ever to shore up support for the innovators who are not following familiar paths. At NIMH we are using the Pioneer and New Innovator initiatives, our own BRAINS awards program, and a policy of supporting grants that are trying new approaches even when the peer review scores are beyond our nominal payline. If there is any lesson to be learned from the many discoveries of this past year, it is that the continent we need to explore is both larger and more complex than we ever imagined. With so many roads not yet taken, who would want to follow the herd?


 1 Edwards AM, Isserlin R, Bader GD, Frye SV, Willson TM, Yu FH. Too many roads not taken. Nature. 2011 Feb 10;470(7333):163-5. PMID: 21307913

 2 The September 6, 2012 issue of Nature includes multiple articles pertaining to the ENCODE project. Information about the project and related publications are accessible via Nature’s ENCODE web pages:

 3 Additional information about this project may be accessed at:

 4 Additional information about this project may be accessed at:

 5 Additional information about this project may be accessed at:

Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain

18 11 2012

In light of the present [dire] situation in Israel I wish to share with you a great paper by Bruce S. McEwen (Alfred E. Mirsky Professor and Head, Harold and Margaret Milliken Hatch, Laboratory of Neuroendocrinology, The Rockefeller University, New York) about the impact of major stress and ways to reduce its negative consequences. This paper was published in 2007 at the Physiological Reviews journal.

For the sake of humanity I call for peace in our region and other conflicts areas around the world!
Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain


The brain is the key organ of the response to stress because it determines what is threatening and, therefore, potentially stressful, as well as the physiological and behavioral responses which can be either adaptive or damaging. Stress involves two-way communication between the brain and the cardiovascular, immune, and other systems via neural and endocrine mechanisms. Beyond the “flight-or-fight” response to acute stress, there are events in daily life that produce a type of chronic stress and lead over time to wear and tear on the body (“allostatic load”). Yet, hormones associated with stress protect the body in the short-run and promote adaptation (“allostasis”). The brain is a target of stress, and the hippocampus was the first brain region, besides the hypothalamus, to be recognized as a target of glucocorticoids. Stress and stress hormones produce both adaptive and maladaptive effects on this brain region throughout the life course. Early life events influence life-long patterns of emotionality and stress responsiveness and alter the rate of brain and body aging. The hippocampus, amygdala, and prefrontal cortex undergo stress-induced structural remodeling, which alters behavioral and physiological responses. As an adjunct to pharmaceutical therapy, social and behavioral interventions such as regular physical activity and social support reduce the chronic stress burden and benefit brain and body health and resilience.


Stress is a word used to describe experiences that are challenging emotionally and physiologically. “Good stress,” in popular jargon, generally refers to those experiences that are of limited duration and that a person can master and which leave a sense of exhilaration and accomplishment, whereas “bad stress” or “being stressed out,” in the vernacular, refers to experiences where a sense of control and mastery is lacking and which are often prolonged or recurrent, irritating, emotionally draining, and physically exhausting or dangerous. A hallmark of the stress response is the activation of the autonomic nervous system and hypothalamo-pituitary-adrenal (HPA) axis, and the “fight-or-flight” response is the classical way of envisioning the behavioral and physiological response to a threat from a dangerous situation, be it a predator, a mugger, an accident, or natural disaster. The organism needs the normal stress hormone response to survive such situations, and inadequate or excessive adrenocortical and autonomic function is deleterious for health and survival. Yet, unlike zebras, who don’t get ulcers because they do not worry, according to Robert Sapolsky’s bookWhy Zebras Don’t Get Ulcers (312), human beings are prone to prolonged periods of elevated activity of the same systems which help us survive more acute challenges. This prolonged elevation may be due to anxiety; to constant exposure to adverse environments involving such irritants as noise, pollution, and interpersonal conflict; and to changes in life-style and health-related behaviors that result from being under chronic stress.

The importance of acknowledging the protective, as well as the potentially damaging effects of the mediators of stress and adaptation, has led to the introduction of two terms: “allostasis,” meaning the process of maintaining stability (homeostasis) by active means, namely, by putting out stress hormones and other mediators; and “allostatic load or overload,” meaning the wear and tear on the body and brain caused by use of allostasis, particularly when the mediators are dysregulated, i.e., not turned off when stress is over or not turned on adequately when they are needed.

The brain is the organ of the body that interprets experiences as threatening or nonthreatening and which determines the behavioral and physiological responses to each situation. Besides the hypothalamus and brain stem, which are essential for autonomic and neuroendocrine responses to stressors, higher cognitive areas of the brain play a key role in memory, anxiety, and decision making. These brain areas are targets of stress and stress hormones, and the acute and chronic effects of stressful experiences influence how they respond. This is particularly evident over the life course, where early life experiences, combined with genetic factors, exert an important influence on adult stress responsiveness and the aging process.

This review summarizes a number of the major themes that have emerged with particular clarity over the past two decades since a previous review in this journal (214). Five themes are described that emphasize both the short-term and the long-term effects of the physiological mediators of the stress response and the central role of the brain as a target of stress and controller of the responses to stressors. The focus on the brain underlies all five themes of this review, including the types of behavioral and social interventions, besides pharmaceutical agents, that can reduce the chronic stress burden. The intent of this review is not only to summarize salient facts but also to provide a conceptual framework for future studies that will introduce more physiology and neuroscience into developing a better mechanistic understanding of vexing stress-related social and medical problems and their solution via biological, behavioral, and sociological means.


It is not uncommon to hear discussion about how hardships have “aged” a person, and indeed, the “weathering hypothesis” (117) proposed that stressful life experiences accelerate aging. Some of the ways that this can happen have become apparent with subsequent research on animal models (see below), as well as epidemiological studies in human populations (e.g., Ref. 188). The central focus of this review is the role of the brain, which is the key organ of the stress response because it determines what is threatening and, therefore, stressful and also controls the behavioral and physiological responses to potentially stressful experiences (Fig. 1).

FIG. 1.

FIG. 1. Central role of the brain in allostasis and the behavioral and physiological response to stressors. [From McEwen (211), copyright 1998 Massachusetts Medical Society.]

The involvement of my laboratory in this topic began with our finding in the late 1960s of receptors for adrenal steroids in the hippocampal formation (116217) (Fig. 2), a brain region that is important for spatial, episodic, and contextual memory formation (96336). This has led to a wide variety of studies of the functional consequences of adrenal steroid action over the life span.

FIG. 2.

FIG. 2.

Autoradiogram shows uptake and retention of [3H]corticosterone by principal neurons of Ammon’s horn and dentate gyrus of bilaterally adrenalectomized, adult rats. [Modified from Gerlach and McEwen (116).]

A. Stress, Aging, and the Hippocampus

In neuroscience and neuroendocrinology, the studies of Landfield (171) and Sapolsky (311) were among the first to call attention to how aging and adrenal stress hormones impact the hippocampus. The hippocampus also plays a role in shutting off the HPA stress response, and damage or atrophy of the hippocampus impairs the shut off and leads to a more prolonged HPA response to psychological stressors (134141). This led to the “glucocorticoid cascade hypothesis” of stress and aging (311). Longitudinal studies on aging human subjects support this model. For example, the work of Lupien et al. (186) revealed that progressive increases in salivary cortisol during a yearly exam over a 5-yr period predicted reduced hippocampal volume and reduced performance on hippocampal-dependent memory tasks.

While the initial view of aging in the hippocampus favored the notion of a loss of neurons, subsequent studies on animal models of aging have favored a loss of synaptic connectivity or impairment of synaptic function, although with some indication that the aging human hippocampus may lose neurons (115287289,377). As discussed later in this review, besides glucocorticoids, excitatory amino acids in the hippocampus play a prominent role in the aging process and the damage that can result from the severe stress of ischemia or seizures (310), as well as in the reversible stress-induced remodeling of neurons in the hippocampus. Before discussing these topics in section IV, there are other factors that contribute to hippocampal function and influence the aging process.

B. Role of 11-Hydroxysteroid Dehydrogenase Type 1 and Other Regulators of Glucocorticoid Availability

The glucocorticoid access to the brain and the metabolism of glucocorticoids in brain tissue both play important roles in determining the magnitude of glucocorticoid effects on the hippocampus (Fig. 3). Corticosteroid binding globulin (CBG) in blood determines the level of free corticosterone (or cortisol in human) that can gain access to the brain (325) and the multiple drug resistance P-glycoprotein (MDRpG) limits the access of synthetic glucocorticoids such as dexamethasone, as well as cortisol (not produced by the rat adrenal) to the rodent brain (147225). As a result of this protective barrier, low doses of dexamethasone, for example, can produce a hypocorticosteroid state by acting on the pituitary to shut off corticosterone production (146). Both corticosterone and 11-dehydrocorticosterone (11-DHC, the rat equivalent of cortisone in corticosterone secreting species) gain ready access to brain tissue, where 11-DHC (and cortisone in cortisol secreting species) can be reactivated by the enzyme 11-hydroxysteroid dehydrogenase type 1 (11-HSD1), which reactivates 11-dehydrocorticosterone to corticosterone and cortisone to cortisol. Mice with a genetic deletion of 11-HSD1 show a lesser age-related decline of cognitive function compared with wild-type mice (393). [It is noteworthy that mice with overexpression of 11-HSD1 in visceral fat develop visceral obesity and the metabolic syndrome (203).] The actions of 11-HSD1 in brain may have relevance for the age-related loss of cognitive function in humans described above, since even short-term treatment of people with metabolic syndrome and elevated cortisol levels with an inhibitor of 11-HSD1 has been reported to have beneficial effects on cognitive function (306) (Fig. 3).

FIG. 3.

FIG. 3.

Access of glucocorticoids to receptors in hippocampus and other brain regions is regulated by 3 factors: corticosteroid binding globulin (CBG), multiple drug resistance P-glycoprotein (MDRpG), and metabolism by 11-hydroxysteroid dehydrogenase type 1 (11 HSD-1). CBG in the blood binds natural glucocorticoids such as corticosterone, cortisol, and their 11-dehydro-metabolites, but not the synthetic glucocorticoid dexamethasone; only unbound steroid is able to enter the brain. However, MDRpG at the blood-brain barrier actively transports synthetic steroids (such as dexamethasone), and to some extent 17-hydroxylated natural steroids, such as cortisol, out of the brain so that they do not enter very readily and only at high doses. Thus MDRpG retards the entry of cortisol into the brain, especially in the rodent, but does not affect corticosterone, which enters readily. In brain tissue, the enzyme 11 HSD-1 converts 11-dehydro-metabolites of corticosterone and cortisol back to the parent steroid, thus “reactivating” these glucocorticoids. See text for details.

C. Metabolic Hormones Affect the Hippocampus

Besides glucocorticoids and excitatory amino acids, a number of protein hormones have been shown to affect the hippocampus (Fig. 4). The hippocampus has receptors for insulin-like growth factor I (IGF-I) and insulin (91), and it responds to circulating insulin to translocate glucose transporters to cell membranes (269). Circulating IGF-I is a key mediator of the ability of physical activity to increase neurogenesis in the dentate gyrus of the hippocampal formation (148). IGF-I is taken up into brain via a transport system different from that which transports insulin, although there is some overlap (280396). IGF-I is a member of the growth hormone family, and growth hormone is implicated in cognitive function and mood regulation (90248). Growth hormone is expressed in the hippocampus where it is upregulated by acute stress and also, in females, by estradiol (90). Interestingly, although growth hormone mRNA is expressed in hippocampus (89), growth hormone also enters the brain in small amounts from the circulation, although not by a specific transport system (256).

FIG. 4.

FIG. 4.

Four peptide/protein hormones, insulin-like growth factor I (IGF-I), insulin, ghrelin, and leptin, are able to enter the brain and affect structural remodeling or other functions in the hippocampus. A transport process is involved, and specific receptors are expressed in hippocampus as well as in other brain regions. See text for details. Molecular sizes are indicated for each hormone along with their molecular size in kiloDaltons (kDa): ghrelin, 3.5 kDa; leptin, 16 kDa; insulin, 5.8 kDa; IGF-I, 7.6 kDa.

Furthermore, circulating ghrelin, a proappetitive hormone, has been shown to increase synapse formation in hippocampal pyramidal neurons and to improve hippocampal-dependent memory (86). Ghrelin is transported into brain via a saturable system (20), and receptors for ghrelin are expressed in hippocampus, as well as in other regions of the brain (397).

Another metabolic hormone, leptin, has been found to exert antidepressant effects when infused directly into the hippocampus (184). Leptin is transported into the brain, and both glucose and insulin mediate the ability of fasting to increase leptin transport into the brain (151). Leptin receptors are found in hippocampus among other brain regions, and leptin has actions in hippocampus that reduce the probability of seizures and enhance aspects of cognitive function (131) (Fig. 4).

Thus far, there is little information that would indicate the cellular and molecular mechanisms by which these hormones produce their effects and whether they interact with some of the other factors that will be discussed below in connection with mechanisms of structural plasticity in the hippocampus. Nevertheless, it is clear that metabolic factors involving glucose regulation play a role in hippocampal volume change in the human hippocampus in mild cognitive impairment with aging (69). In rodents, fatty Zucker rats have poorer hippocampal-dependent memory than lean Zucker rats, as well as impaired translocation of an insulin-dependent glucose transporter to hippocampal membranes (381). Moreover, a diet rich in fat has been shown to impair hippocampal-dependent memory (380), and a combination of a high-fat diet and a 3-wk predator exposure causes retraction of dendrites in the CA3 hippocampus even though neither treatment alone had this effect (21). The topic of dendritic retraction and memory impairment by chronic stress will be revisited below in section IV.

D. Experiential Determinants of Brain and Body Aging

There are enormous individual differences in the response to stress, based on the experience of the individual early in life and in adult life, and some of the mediators described above may be involved. This section summarizes some of these early life experiences and the animal models that have been used to demonstrate them.

As for the role of experiences, positive or negative experiences in school, at work, or in romantic and family interpersonal relationships can bias an individual towards either a positive or negative response in a new situation. For example, someone who has been treated badly in a job by a domineering and abusive supervisor and/or has been fired will approach a new job situation quite differently than someone who has had positive experiences in employment.

Early life experiences perhaps carry an even greater weight in terms of how an individual reacts to new situations. Early life physical and sexual abuse carry with it a life-long burden of behavioral and pathophysiological problems (104132). Moreover, cold and uncaring families produce long-lasting emotional problems in children (291). Some of these effects are seen on brain structure and function and in the risk for later depression and posttraumatic stress disorder (152153360).

E. Animal Models of Early Life Experience

Animal models have been useful in providing insights into behavioral and physiological mechanisms (Table 1). Early life maternal care in rodents is a powerful determinant of life-long emotional reactivity and stress hormone reactivity, and increases in both are associated with earlier cognitive decline and a shorter life span (51107). Strong maternal behavior, involving licking and grooming of the offspring, produces a “neophilic” animal that is more exploratory of novel environments and less emotionally reactive and produces a lower and more contained glucocorticoid stress response in novel situations; poor maternal care leads to a “neophobic” phenotype with increased emotional and HPA reactivity and less exploration of a novel situation (223). Effects of early maternal care are transmitted across generations by the subsequent behavior of the female offspring as they become mothers, and methylation of DNA on key genes appears to play a role in this epigenetic transmission (107371).


Experiential influences on brain development in rodent models

The effects of maternal care explain at least part of the effects of “neonatal handling” that involved the short-term separation of pups from their mothers (178) (Table 1). The neonatal handling procedure overcomes the deleterious effects of prenatal stress to increase emotionality of offspring (366). Interestingly, more prolonged separation of pups from mothers increases emotionality and stress reactivity, in part by decreasing maternal care when pups are returned to their mothers (271), and an enriched environment during the peripubertal period ameliorates these deficits (108) (Table 1).

However, in rodents, abuse of the young, i.e., rough handling by the mother, is associated with an attachment to, rather than an avoidance of, the abusive mother, an effect that increases the chances that the infant can continue to obtain food and other support until weaning (346). One way to demonstrate the positive, rather than avoidance, effects of aversive stimuli in neonates is via shock-odor conditioning. In this paradigm, neonates become attracted to the odor, at least until they are almost 2 wk of age, when the presence of the mother during conditioning leads to an attraction to the odor paired with shock (seeTable 1). As for mechanism, the presence of the mother is able to suppress the pup’s corticosterone production, which otherwise would increase an aversive reaction. This has been demonstrated by overriding the maternal suppression of HPA activity rat pups by implanting corticosterone in the amygdala; this manipulation instates fear and fear conditioning and produces an aversive reaction (237).

Increased emotional reactivity and fear of novelty in young rats, whatever its cause, has consequences for longevity and for cognitive function. Male rats were screened at 43 days old for anxiety and divided into “high” and “low” anxiety groups and then subjected to 21 days of daily restraint stress when they were 72 days old; compared with the “low” anxiety” group given chronic stress and also compared with unstressed controls, the “high” anxiety rats showed impaired spatial memory in a subsequent test using the Y maze (27). In another study, the profiling of anxiety in even younger rats also has predictive power: male rats that were “neophobic” as pups continued this pattern into adult life and showed a significantly shorter life span by ∼200 days compared with young rats that were “neophilic,” that is, showed lower cortisol and emotional reactivity to novelty (51). However, the cause of death for the neophobic male rats was unclear. A subsequent study of female rats focused on tumors as the likely cause of death of neophobic females, which died 6 mo sooner than neophilic females. In contrast to the story for males, neophobic females had lower corticosterone levels than their neophilic counterparts, and they showed abnormal patterns of prolactin and estrogen secretion, pointing away from glucocorticoid dysregulation as the sole cause of pathophysiology (52). Yet, not all consequences of the neophilic state are necessarily beneficial. For example, in mice, neonatal handling, the procedure that induces the neophilic state, increases the damage associated with elevated corticosterone during ischemia, at least in part by increasing poststroke proinflammatory cytokine expression (74). The underlying mechanisms are as yet unexplored.

It is important to note that other conditions that affect the rearing process can also affect emotionality in offspring. For example, uncertainty in the food supply for rhesus monkey mothers leads to increased emotionality in offspring and possibly an earlier onset of obesity and diabetes (71). On a more positive side, the experience of novelty has beneficial effects for cognitive function and social interactions that go beyond the maternal influence (351) (Table 1). Exposure of pups to novelty away from the home environment in a carefully controlled paradigm that dissociates maternal individual differences from a direct stimulation effect on the offspring resulted in enhancement of spatial working memory, social competition, and corticosterone response to an unexpected stressor during adulthood compared with their home-staying siblings. These functional enhancements in novelty-exposed rats occurred despite evidence that maternal care was preferentially directed toward home-staying instead of novelty-exposed pups, indicating that a greater maternal care is neither necessary nor sufficient for these early stimulation-induced functional enhancements (351).

Early life experiences have effects on human physiology and behavior. Prenatal stress is believed to be a factor in causing preterm birth, as well as full-term birth with low birth weight (25364). Low birth weight is a risk factor for cardiovascular disease and high body mass (25274). Childhood experiences in emotionally cold families increase the likelihood of poor mental and physical health later in life (291), and abuse in childhood is a well-known risk factor for depression, posttraumatic stress disorder, idiopathic chronic pain disorders, substance abuse, antisocial behavior, as well as obesity, diabetes, and cardiovascular disease (14104132). Chaos in the home environment is a key determinant of poor self-regulatory behaviors, a sense of helplessness and psychological distress (102), as well as increased body mass and elevated blood pressure (101).

F. Genetic Factors

So far, this review has emphasized the important role of the environment and experiences of individuals in health outcomes, but clearly genetic differences also play an important role. This review will not attempt to summarize this growing area of investigation, but rather note some of the most prominent recent evidence showing that different alleles of commonly occurring genes determine how individuals will respond to stressful life experiences. For example, the short form of the serotonin transporter is associated with a number of conditions such as alcoholism (26133), and individuals who have this allele are more vulnerable to respond to stressful experiences by developing depressive illness (50). In childhood, individuals with an allele of the monoamine oxidase A gene are more vulnerable to abuse in childhood and more likely to themselves become abusers and to show antisocial behaviors compared with individuals with another commonly occurring allele (49). Yet another example is the consequence of having the Val66Met allele of the brain-derived neurotrophic factor (BDNF) gene on hippocampal volume, memory, and mood disorders (57, 130142265349). A mouse model of this genotype has revealed reduced dendritic branching in hippocampus, impaired contextual fear conditioning, and increased anxiety that is less sensitive to antidepressant treatment (56). Finally, alleles of the glucocorticoid receptor gene found in the normal population confers a higher sensitivity to glucocorticoids for both negative feedback and insulin reponsiveness (138) or glucocorticoid resistance (358), and there is evidence of increased likelihood of depression in several alleles and increased response to antidepressants in one of them. Therefore, the importance of continuing to identify candidate genes, as well as the subtlety of gene-environment interactions, should be clear from this brief overview.


A. Stress, Allostasis, and Allostatic Load

There are two key aspects of the stress response (211). On the one hand, the body responds to many experiences by releasing chemical mediators, for example, catecholamines that increase heart rate and blood pressure. These mediators promote adaptation to an acute stressor, as well as to simple acts like getting out of bed in the morning or climbing a flight of stairs. On the other hand, chronic elevation of these same mediators, e.g., chronically increased heart rate and blood pressure, can cause pathophysiological changes, for example, in the cardiovascular system that result, over time, in pathophysiological conditions like atherosclerosis, which can result in strokes and myocardial infarctions.

Because of the paradoxical actions of these mediators in both protection and damage, and also because the word stress has ambiguities and connotations that interfere with its precise use, the term allostasis was introduced by Sterling and Eyer (342) to refer to the active process by which the body responds to daily events and maintains homeostasis (allostasis literally means “achieving stability through change”). Because chronically increased allostasis can lead to pathophysiology, we introduced the term allostatic load or overload (see distinction below) to refer to the wear and tear that results from either too much stress or from inefficient management of allostasis, such as not turning off the response when it is no longer needed (211216218). Other forms of allostatic load/overload are summarized in Figure 5 and involve not shutting off the response efficiently, not turning on an adequate response in the first place, or not habituating to the recurrence of the same stressor and thus dampening the allostatic response.

FIG. 5.

FIG. 5.

Four types of allostatic load.Top panel: illustrates the normal allostatic response, in which a response is initiated by a stressor, sustained for an appropriate interval, and then turned off. The remaining panels illustrate four conditions that lead to allostatic load: top left, repeated “hits” from multiple stressors; top right, lack of adaptation; bottom left, prolonged response due to delayed shut down; bottom right, inadequate response that leads to compensatory hyperactivity of other mediators (e.g., inadequate secretion of glucocorticoid, resulting in increased levels of cytokines that are normally counterregulated by glucocorticoids). [From McEwen (211), copyright 1998 Massachusetts Medical Society.]

B. Protection and Damage: The Two Sides of the Response to Stressors

Thus protection and damage are the two contrasting sides of the physiology involved in defending the body against the challenges of daily life, whether or not we call them “stressors.” Besides epinephrine and norepinephrine, there are many mediators that participate in allostasis, and they are linked together in a network of regulation that is nonlinear, meaning that each mediator has the ability to regulate the activity of the other mediators, sometimes in a biphasic manner. For example, glucocorticoids produced by the adrenal cortex in response to ACTH from the pituitary gland is the other major “stress hormone.” Yet, pro- and anti-inflammatory cytokines are produced by many cells in the body, and they regulate each other and are, in turn, regulated by glucocorticoids and catecholamines; that is, whereas catecholamines can increase proinflammatory cytokine production (32), glucocorticoids are known to inhibit this production (313). And yet, there are exceptions, e.g., proinflammatory effects of glucocorticoids that depend on dose and cell or tissue type (88190). The parasympathetic nervous system also plays an important regulatory role in this nonlinear network of allostasis, since it generally opposes the sympathetic nervous system and, for example, slows the heart, and it also has anti-inflammatory effects (35355).

What this nonlinearity means is that when any one mediator is increased or decreased, there are compensatory changes in the other mediators that depend on time course and level of change of each of the mediators. Unfortunately, biomedical technology cannot yet measure all components of this system simultaneously and must rely on measurements of only a few of them in any one study. Yet the nonlinearity must be kept in mind in interpreting the results.

C. Stress in the Natural World

The operation of allostasis in the natural world provides some insight into how animals use this response to their own benefit or for the benefit of the species. As an example of allostasis, in springtime, a sudden snowstorm causes stress to birds and disrupts mating, and stress hormones are pivotal in directing the birds to suspend reproduction, to find a source of food, and to relocate to a better mating site or at least to delay reproduction until the weather improves (379). As an example of allostatic load, bears preparing to hibernate for the winter eat large quantities of food and put on body fat to act as an energy source during the winter (244). This accumulation of fat is used, then, to survive the winter and provide food for gestation of young; in contrast, the fat accumulation occurs in bears that are captive in zoos and eating too much, partially out of boredom, while not exercising (218). The accumulation of fat under these latter conditions can be called “allostatic overload” referring to a more extreme condition that is associated with pathophysiology. Yet, allostatic overload can also have a useful purpose for the preservation of the species, such as in migrating salmon or the marsupial mouse, that die of excessive stress after mating. The stress and allostatic load are caused for salmon, in part, by the migration up the rapidly flowing rivers but also because of physiological changes that represent accelerated aging and include suppression of the immune system (103120205). One beneficial result of eliminating the adult salmon is freeing up food and other resources for the next generation. In the case of the marsupial mouse, it is only the males that die after mating, and the hypothesized mechanism is a response to mating that reduces the binding protein CBG for glucocorticoids and renders them much more active throughout the body, including likely suppressive actions on the immune defense system (62).

D. Being “Stressed Out”: Example of Sleep Deprivation and Its Consequences

The common experience of being “stressed out” has as its core the elevation of some of the key systems that lead to allostatic overload: cortisol, sympathetic activity, and proinflammatory cytokines, with a decline in parasympathetic activity. Nowhere is this better illustrated than for poor or inadequate sleep, which is a frequent result of being “stressed out.” Sleep deprivation produces an allostatic overload that can have deleterious consequences.

Because the brain is the master regulator of the neuroendocrine, autonomic, and immune systems, as well as behavior (211) (Fig. 1), alterations in brain function by chronic stress can, therefore, have direct and indirect effects on the cumulative allostatic overload. Reduced sleep duration has been reported to be associated with increased body mass and obesity in the NHANES study (113). Sleep restriction to 4 h of sleep per night increases blood pressure, decreases parasympathetic tone, increases evening cortisol and insulin levels, and promotes increased appetite, possibly through the elevation of ghrelin, a proappetitive hormone, along with decreased levels of leptin (174334335). Moreover, proinflammatory cytokine levels are increased with sleep deprivation, along with decreased performance in tests of psychomotor vigilance, and this has been reported to result from a modest sleep restriction to 6 h/night (361).

Allostatic overload resulting from chronic stress in animal models causes atrophy of neurons in the hippocampus and prefrontal cortex, brain regions involved in memory, selective attention, and executive function, and causes hypertrophy of neurons in the amygdala, a brain region involved in fear and anxiety as well as aggression (213) (see sect. IV). Thus the ability to learn and remember and make decisions may be compromised by chronic stress and may be accompanied by increased levels of anxiety and aggression.

Sleep deprivation causes cognitive impairment. Sleep deprivation in rats using a treadmill for 96 h has been reported to decrease proliferation of cells in the dentate gyrus of the hippocampal formation by as much as 50% (126). A similar effect has also been reported by keeping rats in a slowly rotating drum, but here again, there is a question of how much physical activity and physical stress may have contributed to the suppression of cell proliferation (296). Nevertheless, sleep restriction by novelty exposure, a more subtle method, prevented the increased survival of new dentate gyrus neurons promoted by spatial training in a Morris water maze (128).

Indeed, with respect to memory and cognitive performance, there are numerous reports of impairments following sleep deprivation in animal models. For example, sleep deprivation by the platform (or flower pot) method resulted in impaired retention of passive avoidance memory, a context-dependent fear memory task (326), as well as impaired performance of spatial memory in the Morris water maze (395) and a reduction in long-term potentiation in the CA1 region of the hippocampus (159).

Sleep deprivation by gentle stimulation or novelty in the aftermath of contextual fear conditioning has been reported to impair memory consolidation (123). Moreover, a 6-h period of total sleep deprivation by novelty exposure impaired acquisition of a spatial task in the Morris water maze (125). Furthermore, a 4-h period of sleep deprivation by gentle stimulation impaired the late-phase long-term potentiation (LTP) in the dentate gyrus 48 h later but had the opposite effect to enhance late-phase LTP in the prefrontal cortex (297). Sleep fragmentation, produced by movement on a treadmill every 2 min, resulted in a complete suppression of LTP in the CA1 region of the hippocampus as well as impairing the acquisition of spatial learning, although long-term depression (LTD) and paired pulse facilitation were unaffected (353).

There is evidence not only for cognitive impairment resulting from sleep restriction, but also for altered neural levels of cytokines, oxidative stress markers, and brain glycogen levels, that may contribute to the impairment of function. With respect to proinflammatory cytokines, IL-1β mRNA levels in brain are reported to increase following sleep deprivation by gentle handling and to be higher in daytime (during the normal sleep period in rodents) than in darkness (during the normal activity time for rodents) (350). Closely related to inflammatory processes through the actions of NADPH oxidase (58352) is oxidative stress involving the generation of free radicals. Sleep deprivation in mice for 72 h by the “flower pot” or platform method has been reported to increase oxidative stress in hippocampus as measured by increased lipid peroxidation and increased ratios of oxidized to reduced glutathione (326).

Another noteworthy effect of sleep deprivation is to regulate the level of glycogen, found predominantly in white matter, that is reported to decrease by as much as 40% in rats deprived of sleep for 24 h by novelty and gentle handling and reversed by recovery sleep (40164). It is noteworthy that glycogen in astrocytes is able to sustain axon function during glucose deprivation in CNS white matter (374).

Sleep deprivation has also been associated with increases in fighting behavior after deprivation of rapid-eye-movement (REM) sleep (81); there is also a report of increased aggression in the form of muricide, i.e., killing by rats of mice, after phencyclidine administration following sleep deprivation (241). These findings may be related to the finding of increased aggression among cage mates in rats subjected to 21 days of 6 h/day of chronic restraint stress during the resting period when some sleep deprivation may occur (385). Interestingly, however, there are also anxiety-reducing effects of certain types of sleep deprivation. For example, a 12-h sleep deprivation that is applied by using a slowly rotating drum that minimizes physical stress, but does produce locomotor activity, reversed the decreased open field behavior induced by a single social defeat (224), and another study has shown that total sleep deprivation reduces immobility in a Porsolt swim test, which is regarded as a sign of behavioral depression (182). These interesting findings are perhaps related to the reported acute antidepressant effects of sleep deprivation in humans (261).



The brain is a target of stress and stress hormones, and the processes of allostasis and allostatic load are exemplified by how different brain regions respond to acute and chronic stressors. Because the hippocampus was the first higher brain center that was recognized as a target of stress hormones, it has figured prominently in our understanding of how stress impacts brain structure and behavior. The following discussion builds on the earlier discussion of the role of the hippocampus in HPA regulation and the aging process, and it considers both the positive and negative effects of stress on memory, as well as the gradual changes in hippocampal structure and function associated with prolonged or repeated stress. Effects of stress on the amygdala and prefrontal cortex will then be summarized.

A. The Hippocampus: Stress-Induced Excitability Enhancement Versus Suppression

The hippocampus expresses both type I (mineralocorticoid, MR) and type II (glucocorticoid, GR) receptors, and these receptors mediate a biphasic response to adrenal steroids in the CA1 region, although not in the dentate gyrus (143), which, nevertheless, shows a diminished excitability in the absence of adrenal steroids (200). Other brain regions, such as the paraventricular nucleus, lacking in MR but having GR, show a monophasic response (143) (Fig. 6). Adrenal steroids exert biphasic effects on excitability of hippocampal neurons in terms of long-term potentiation and primed burst potentiation (85257259) and show parallel biphasic effects upon memory (279).

FIG. 6.

FIG. 6.

Dose-response relationships of the cellular effects of corticosterone in the brain. Dose-response relationships are shown for the CA1 hippocampal area (A), the dentate gyrus (B), the PVN of the hypothalamus (C), and the dorsal raphe nucleus (D). Graphs show hormone responses expressed as a percentage of the maximal response in these brain regions. The concentration of corticosterone is an approximate estimate of the local concentration based on the solutions perfused on in vitro preparations or derived from the plasma concentration when fluctuations in hormone levels were accomplished in vivo. A: in the CA1 area, both the amplitude of depolarization-induced calcium currents (white squares) and the hyperpolarization caused by serotonin 1A receptor activation (black circles) display a U-shaped dose dependency. The descending limb is linked to the activation of mineralocorticoid receptors (MRs), whereas the ascending limb is associated with gradual glucocorticoid receptor (GR) activation in addition to already activated MRs, as occurs after stress. B: dentate gyrus granule neurons show a clear MR-dependent effect on the field potential (black squares) and the single-cell response (black triangles) caused by activation of glutamate AMPA receptors. Although these cells also abundantly express GRs, high doses of corticosterone do not cause additional changes in the signal, except when tested in chronically stressed rats (white triangles). C: neurons in the PVN (C) and the raphe nucleus (D) express GRs primarily. In these cells, a linear dose dependency is seen for the frequency of spontaneous γ-aminobutyric acid (GABA)A-receptor-mediated synaptic events (gray squares) and the inhibition caused by serotonin 1A receptor activation (gray circles). [From Joels (143), with permission from Elsevier.]

1. Role of genomic and nongenomic mechanisms

In considering possible mechanisms for the biphasic responses, the coexpression of MR and GR in the same neurons could give rise to heterodimer formation and a different genomic activation from that produced by either MR or GR homodimers (143). In addition, deletion of the type I (MR) receptor by genetic means has revealed that MR are required for nongenomic regulation of glutamatergic transmission by glucocorticoids (148), a phenomenon that involved glucocorticoid enhancement of extracellular levels of glutamate (359) that plays an important role in both modulatory and excitotoxic effects of glucocorticoids (see sect. IVB4). Although beyond the scope of this review, the subject of nongenomic actions of adrenal steroids has taken on increasing importance in view of the discovery of adrenal steroid receptors that are G protein coupled in the amphibian brain (252), as well as glucocorticoid receptor immunoreactivity in postsynaptic and other nonnuclear regions of neurons in the rodent brain (145,179) and a large number of reported rapid, nongenomic actions of adrenal steroids (36197). Hence, it is perhaps not surprising that there are conditions involving neural transmission that favor either rapid positive or negative actions of adrenal steroids on processes such as learning and memory.

Although much of the work on MR and GR has been done on rat and mouse brains, it is important to note that the rhesus monkey hippocampus has a predominance of MR and relatively less GR compared with rodent species (305). This finding may have important implications for the effects of adrenal steroids on learning and vulnerability to stress and excitotoxicity, as well as age-related changes discussed earlier.

2. The conditional nature of adrenal steroid actions on memory

Emotional arousal for a rodent by being placed in a novel environment is required for adrenal steroids to enhance object recognition memory, that involves the hippocampus; the effects of adrenal steroids on this memory show an inverted U-shaped dose response (250). Moreover, spatial memory in a Morris water maze, a stressful behavioral task, is facilitated by adrenal steroids in wild-type mice, but this facilitation is lacking in mice with a dimerization-deficient GR (249). In the study involving novelty-induced emotional arousal, the dose range of corticosterone is such that both GR and MR occupancy are involved (250). Yet, prior habituation to the novel environment, thus removing the emotional arouse of novelty, abolishes the facilitation (250). Moreover, corticosterone doses that facilitate memory at 24 h posttraining inhibit memory retention at 1 h posttraining (250). The inhibition of memory retrieval by acute corticosteroid administration is a phenomenon that has also been reported (82246247301), and biphasic effects of corticosteroids on working memory have been described (187).

In providing a framework for understanding these phenomena, Joels et al. (144) propose a very plausible unifying theory, which states that “…stress will only facilitate learning and memory processes: 1) when stress is experienced in the context and around the time of the event that needs to be remembered, and 2) when the hormones and transmitters released in response to stress exert their actions on the same circuits as those activated by the situation, that is, when convergence in time and space takes place” (see Fig. 7). According to their view, “the mechanism of action of stress hormones, particularly corticosteroids, can explain how stress within the context of a learning experience induces focused attention and improves memory of relevant information.”

FIG. 7.

FIG. 7.

Opposing effects of stress on learning depend on the timing of the events. A: stress within the context of a learning situation leads to the release of norepinephrine (NA), corticotropin releasing hormone (CRH), and cortisol (CORT), all of which are active in the brain at the time that the initial phases of learning take place. At this stage, the neurotransmitters and hormones facilitate the ongoing process. Corticosterone, however, also initiates a gene-mediated pathway, which will elevate the threshold for input unrelated to the initial event and restore neuronal activity (normalization), with a delay of more than an hour. B: if an organism has been exposed to a stressor some time before the learning process takes place, the gene-mediated suppression of activity will have developed by the time that acquisition occurs. Under these conditions corticosterone will impair learning processes. [From Joels et al. (144), with permission from Elsevier.]

B. The Hippocampus: Structural Remodeling

Another way that stress hormones modulate function within the brain is by changing the structure of neurons. As already noted, the hippocampus is one of the most sensitive and malleable regions of the brain. Within the hippocampus, the input from the entorhinal cortex to the dentate gyrus is ramified by the connections between the dentate gyrus and the CA3 pyramidal neurons. One granule neuron innervates, on the average, 12 CA3 neurons, and each CA3 neuron innervates, on the average, 50 other CA3 neurons via axon collaterals, as well as 25 inhibitory cells via other axon collaterals. The net result is a 600-fold amplification of excitation, as well as a 300-fold amplification of inhibition, that provides some degree of control of the system (212).

As to why this type of circuitry exists, the dentate gyrus-CA3 system is believed to play a role in the memory of sequences of events, although long-term storage of memory occurs in other brain regions (180). But, because the dentate gyrus (DG)-CA3 system is so delicately balanced in its function and vulnerability to damage, there is also adaptive structural plasticity, in that new neurons continue to be produced in the dentate gyrus throughout adult life, and CA3 pyramidal cells undergo a reversible remodeling of their dendrites in conditions such as hibernation and chronic stress, including a combination of food restriction and increased physical activity (170194212272273). The role of this plasticity may be to protect against permanent damage, or it may enhance vulnerability to damage, a topic that is discussed below. Whatever the physiological significance of these changes, the hippocampus undergoes a number of adaptive changes in response to acute and chronic stress.

1. Replacement of neurons in dentate gyrus

One type of change involves replacement of neurons. The subgranular layer of the dentate gyrus contains cells that have some properties of astrocytes (e.g., expression of glial fibrillary acidic protein) and that give rise to granule neurons (155320). After bromodeoxyuridine (BrdU) administration to label DNA of dividing cells, these newly born cells appear as clusters in the inner part of the granule cell layer, where a substantial number of them will go on to differentiate into granule neurons within as little as 7 days. In the adult rat, 9,000 new neurons are born per day and survive with a half-life of 28 days (46). There are many hormonal, neurochemical, and behavioral modulators of neurogenesis and cell survival in the dentate gyrus, including estradiol, IGF-I, antidepressants, voluntary exercise, and hippocampal-dependent learning (176356). Neurochemical systems that regulate neurogenesis are summarized in Figure 8and Table 2 and include excitatory amino acids, serotonin, norepinephrine, benzodiazepines, endogenous opioids, BDNF, and IGF-I, as well as glucocorticoids. With respect to stress, certain types of acute stress and many chronic stressors suppress neurogenesis or cell survival in the dentate gyrus, and the mediators of these inhibitory effects include excitatory amino acids acting via NMDA receptors and endogenous opioids (121). The topic of the regulation of neurogenesis is revisited in section VI.

FIG. 8.

FIG. 8.

Structural plasticity in hippocampus involving synaptogenesis (S), neurogenesis (N), and dendritic remodeling (D) involves multiple neurochemical systems, evidence for which is summarized below and in the text. Table 2 summarizes interactions of adrenal steroids with key neurochemical systems involved in structural remodeling. 1) Glutamate release and reuptake: S, N, D, see text; 2) NMDA receptor activation, blockade: S, N, D, see text; 3) circulating glucocorticoids involving both mineralocorticoid (MR) and glucocorticoid (GR) receptors: S, N, D, see text; 4) serotonin: N (136);5) norepinephrine: N (294); 6) endogenous opioids: N (97); 7) benzodiazepines: N, D (163192); 8) brain-derived neurotrophic factor (BDNF): N, D, see text; 9) IGF-I, insulin, ghrelin, and leptin: S, N, see text.

2. Remodeling of dendrites and synapses

Another form of structural plasticity is the remodeling of dendrites in the hippocampus, amydala, and prefrontal cortex. In hippocampus, chronic restraint stress (CRS; daily for 21 days) causes retraction and simplification of dendrites in the CA3 region of the hippocampus (212332). Such dendritic reorganization is found in both dominant and subordinate rats undergoing adaptation to psychosocial stress in the visible burrow system, and it is independent of adrenal size (219). It also occurs in psychosocial stress in intruder tree shrews in a resident-intruder paradigm, with a time course of 28 days (193), a procedure that, it should be noted, does not cause a loss of pyramidal neurons in the hippocampus (362). The mossy fiber input to the CA3 region at the stratum lucidum appears to drive the dendritic remodeling, since it is the apical dendrites above this input that retract (212).

Moreover, the thorny excrescences (giant spines) upon which the mossy fiber terminals form their synapses show stress-induced modifications (343). CRS caused retraction of thorny excrescence that was reversed after water maze training. In restrained rats that were water maze trained, postsynaptic density (PSD) volume and surface area increased significantly, and the proportion of perforated PSDs almost doubled after water maze training and restraint stress. Moreover, the numbers of endosome-like structures in thorny excrescences decreased after restraint stress and increased after water maze training (343). The number of active synaptic zones between thorny excrescences and mossy fiber terminals is rapidly modulated during hibernation and recovery from the hibernating state (194). The thorny excrescences are not the only spines affected by CRS. Dendritic spines also show remodeling, with increased spine density reported after chronic restraint stress on apical dendrites of CA3 neurons (347) (Fig. 8).

3. Puberty as a key stage of brain maturation and stress sensitivity

Puberty is a developmental period of great change in brain and body, and peripubertal male and female rats show a prolonged HPA response to acute stressors compared with adults (299300). While this prolonged response is not altered by the presence or absence of gonadal hormones (299300), 7 days of repeated restraint stress in male rats causes the HPA response to shut off more efficiently in the peripubertal rats and more slowly in the adult rats (298). Moreover, as noted earlier in this review, prepubertal rats that show higher anxiety respond to repeated stress as adults with a greater impairment of spatial memory in a Y maze and also show higher basal levels of corticosterone 1 mo after the end of chronic stress (27).

Although 3–4 wk of chronic stress in adult rats causes a reversible reduction in remodeling of dendrites and suppression of neurogenesis, prepubertal rats do show a delayed and prolonged effect of chronic stress on hippocampal development. A chronic variable stress regimen for 4 wk starting at postnatal day 28, prior to the onset of puberty, resulted in a stunting of growth of the CA1 pyramidal cell layer and in the dentate gyrus-granular cell layer, as well as the CA3 pyramidal cells, and yet there was no reduction of neuron number (140). The reduced volume was evident at 3 wk but not at 24 h after chronic stress and was accompanied by impairments in Morris water-maze performance and sustained downregulation in the basal hippocampal GR gene expression, and deficits in the shut-off of acute stress-induced corticosterone secretion (140).

Although the mechanism for the developmental effects of repeated stress are not known, data summarized at the beginning of this section suggest that the HPA axis is likely to play some role, as it does in stress effects on the adult hippocampus (see sect. V). Indeed, daily corticosterone treatment from 0–30 days resulted in a reduction of both volume and neuron number in both CA3 and dentate gyrus, whereas treatment of rats with daily corticosterone injections for 30–90 days starting in adult life produced no reductions of neuron number but did reduce volume of CA3 and dentate gyrus (333). Other differences between the effects of chronic corticosterone treatment and chronic stress will be discussed again below.

4. Mechanisms of structural remodeling

Exploration of the underlying mechanism for this remodeling of dendrites and synapses reveals that it is not adrenal size or presumed amount of physiological stress per se that determines dendritic remodeling, but a complex set of other factors that modulate neuronal structure (212) (Fig. 8 and Table 2). Indeed, in species of mammals that hibernate, dendritic remodeling is a reversible process and occurs within hours of the onset of hibernation in European hamsters and ground squirrels, and it is also reversible within hours of wakening of the animals from torpor (17194272273). This implies that reorganization of the cytoskeleton is taking place rapidly and reversibly and that changes in dendrite length and branching are not “damage” but a form of structural plasticity.

Regarding the cellular and molecular mechanisms underlying structural remodeling, adrenal steroids are important mediators of remodeling of hippocampal neurons during repeated stress, and exogenous adrenal steroids can also cause remodeling in the absence of an external stressor (192332). The role of adrenal steroids involves many interactions with neurochemical systems in the hippocampus, including serotonin, endogenous opioids, calcium currents, GABA-benzodiazepine receptors, and excitatory amino acids (212), as summarized inFigure 8 and Table 2 (213). Central to all of these interactions is the role of excitatory amino acids, such as glutamate. Excitatory amino acids released by the mossy fiber pathway play a key role in the remodeling of the CA3 region of the hippocampus, and regulation of glutamate release by adrenal steroids may play an important role (212). The role of factors in regulating dendritic remodeling and synaptogenesis is summarized in Figure 8 and Table 2.

Among the consequences of restraint stress is the elevation of extracellular glutamate levels, leading to induction of glial glutamate transporters, as well as increased activation of the nuclear transcription factor phosphoCREB (384). Moreover, 21 days of CRS leads to depletion of clear vesicles from mossy fiber terminals and increased expression of presynaptic proteins involved in vesicle release (124196). Taken together with the fact that vesicles which remain in the mossy fiber terminal are near active synaptic zones and that there are more mitochondria in the terminals of stressed rats, this suggests that CRS increases the release of glutamate (196).

Extracellular molecules play a role in remodeling. Neural cell adhesion molecule (NCAM) and its polysialated-NCAM (PSA-NCAM), as well as L1 are expressed in the dentate gyrus and CA3 region and the expression of both NCAM, L1, and PSA-NCAM are regulated by 21 days of CRS (307). Tissue plasminogen activator (tPA) is an extracellular protease and signaling molecule that is released with neural activity and is required for chronic stress-induced loss of spines and NMDA receptor subunits on CA1 neurons (260).

Within the neuronal cytoskeleton, the remodeling of hippocampal neurons by CRS and hibernation alters the acetylation of microtubule subunits that is consistent with a more stable cytoskeleton (31) and alters microtubule-associated proteins, including the phosphorylation of a soluble form of tau, that is increased in hibernation and reversed when hibernation is terminated (17). Another cytoskeletal molecule is called M6a, a transmembrane glycoprotein belonging to the PLP family (11). Although the PLP family is the most abundant protein of central nervous system myelin, M6a is a neuronal protein, and its knock-down by siRNA results in decreased filopodial number and decreased synaptophysin expression, whereas overexpression of M6a has the opposite effect (11). Repeated stress in both rodents and tree shrews decreases M6a expression, an effect that is prevented by treatment with an antidepressant, tianeptine, that prevents stress-induced remodeling of dendrites in the CA3 region of the hippocampus (12). Chronic psychosocial stress in the tree shrew also downregulated a number of other gene transcripts associated with neurotrophic effects and cytoskeletal plasticity, including nerve growth factor (NGF) (13).

Neurotrophic factors also play a role in dendritic branching and length. For example, BDNF +/− mice show a less branched dendritic tree and do not show a further reduction of CA3 dendrite length with chronic stress, whereas wild-type mice show reduced dendritic branching after chronic stress (A.-M. Magarinos, B. McEwen, unpublished observations). At the same time, overexpression of BDNF prevents stress-induced reductions of dendritic branching in the CA3 hippocampus and results in antidepressant-like effects in a Porsolt forced-swim task (122). However, there is contradictory information thus far concerning whether CRS reduces BDNF mRNA levels in hippocampus, with some reporting a decrease (330) and other studies reporting no change (140169). This may reflect the balance of two opposing forces, namely, that stress triggers increased BDNF synthesis to replace depletion of BDNF caused by stress (202). BDNF and corticosteroids appear to oppose each other, with BDNF reversing reduced excitability in hippocampal neurons induced by stress levels of corticosterone (129).

Corticotrophin releasing factor (CRF) is a key mediator of many aspects related to stress (165). CRF in the paraventricular nucleus regulates ACTH release from the anterior pituitary gland, whereas CRF in the central amygdala is involved in control of behavioral and autonomic responses to stress, including the release to tPA that is an essential part of stress-induced anxiety and structural plasticity in the medial amygdala (204). CRF in the hippocampus is expressed in a subset of GABA neurons (Cajal-Retzius cells) in the developing hippocampus, and early life stress produces a delayed effect that reduces cognitive function and the number of CA3 neurons, as well as decreased branching of hippocampal pyramidal neurons (4344). Indeed, CRF inhibits dendritic branching in hippocampal cultures in vitro (55) (105).

5. Functional consequences of structural remodeling in hippocampus

CRS for 21 days causes impairments in memory in a radial arm maze and in a Y maze that can be prevented by agents such as Dilantin and the antidepressant tianeptine, which prevent stress-induced remodeling of CA3 dendrites (65185,391). In another study using a 1-mo chronic variable stress paradigm, stressed rats took longer to train in the initial Morris water maze trial the day after the last stress session, and they also were impaired in learning a new platform location in a probe trial (332). The effects of chronic stress on both morphology and learning disappeared within 1–2 wk after cessation of the daily stress regimen (68332), suggesting that it serves an adaptive function and does not constitute “damage.” This notion, discussed above in relation to the dendritic remodeling during hibernation, is supported by the fact that dominant rats in a social hierarchy have somewhat larger reductions of CA3 dendritic length and branching compared with subordinate rats in the hierarchy, with both groups showing shorter dendrites than rats housed in groups in ordinary cages; adrenal size was larger in the subordinate rats (219).

Thus it is attractive to suppose that remodeling of dendrites in hippocampus is not only an adaptation to a behavioral situation but also possibly a protective strategy to reduce excitatory input and prevent permanent damage (212). Yet, there is evidence for enhancement of ibotenic acid-induced excitotoxic damage in the CA3 region in rats given 21 days of chronic restraint compared with unstressed rats (67). Interestingly, ibotenic acid damage to CA1 is not enhanced by chronic stress, and female rats do not show the stress-induced sensitization of damage in either CA3 or CA1 (67), nor do female rats show stress-induced remodeling of CA3 dendrites (112). Thus it is tempting to conclude that the remodeling of dendrites enhances excitotoxicity (64), but the only way to test that is to prevent remodeling and determine whether this makes damage less or worse. It is conceivable that damage would be much worse if dendritic remodeling were prevented, due to increased sensitivity to glucocorticoids (see below) along with undiminished excitatory input.

In spite of the focus on dendritic remodeling after repeated stress, it is apparent that chronic stress causes other changes in the brain besides dendritic remodeling in CA3, including effects on dentate gyrus neurogenesis (267), dentate gyrus dendritic remodeling (332), and dentate gyrus LTP (258). Moreover, 21 days of chronic restraint alters the ability of acute stress to affect hippocampal functions such as spatial memory, and here a change in sensitivity to glucocorticoids is involved (64). Using metyrapone to acutely reduce corticosterone levels in rats given 21 days of CRS resulted in prevention of the impairment of spatial memory seen in chronically stressed animals (392). And, yet, corticosterone levels in chronically stressed rats were only marginally higher during spatial maze training than in control rats during the maze training, indicating that there had been either a shift in sensitivity of the hippocampus to corticosterone or a qualitative change towards inhibition of the spatial task (392). Whatever the mechanism, these results also highlight the fact that stress-induced dendritic retraction, which was unlikely to have reversed itself in a matter of several hours during Y-maze training and metyrapone treatment, is not a sufficient condition for impairment of hippocampal dependent spatial memory (64). Rather, increased sensitivity to glucocorticoids is also a factor.

C. Variable Glucocorticoid Involvement in Structural Plasticity

There are a number of examples of altered responses to glucocorticoids in relation to structural plasticity. For neurogenesis in dentate gyrus, elevated glucocorticoid levels in an enriched environment or during physical activity are associated with increased neurogenesis and/or cell survival, even though there are other conditions in which glucocorticoids suppress neurogenesis (231). Chronicity of glucocorticoid elevation may play a role, with acute glucocorticoid elevation suppressing cell proliferation and prolonged glucocorticoid exposure ceasing to have this effect (231). Chronic restraint stress is known to reduce dentate gyrus proliferation, whereas acute restraint does not have any measurable effect (266). In contrast, the ability of physical activity to elevate neurogenesis depends on the social housing environment, that is, individual housing of rats that results in elevated corticosterone levels prevented running from acutely increasing neurogenesis. Yet, reducing corticosterone levels by adrenalectomy and supplementation with corticosterone in the drinking water reinstated the positive effect of exercise on neurogenesis (345).

This implies a shift in glucocorticoid sensitivity, and a possible factor may be excitatory neurotransmission. NMDA receptors play a role in regulation of neurogenesis, having both positive and negative effects in different experimental settings (242), and blocking NMDA receptors prevents acute glucocorticoid effects on neurogenesis (47), indicating that the role of excitatory amino acids is a primary one. In this connection, it is important to recall the different effects of stress on memory that depend on the state of arousal and the timing with the learning situation (144) (see Fig. 7). Moreover, the possible involvement of nongenomic effects of adrenal steroids must be considered (see above).

1. Effects of chronic glucocorticoid administration on morphology and memory

Chronic corticosterone treatment by injection or by passive administration in the drinking water are both able to cause dendrites to retract in CA3 hippocampus (192332389). Moreover, the effects of injected corticosterone are known to be blocked by Dilantin, an inhibitor of ion channels that has antiepileptic effects, a result that is consistent with the evidence that glutamate is involved in remodeling (370). Yet, there is an important difference between the effects of repeated stress and chronic glucocorticoid exposure, in that chronic corticosterone treatment was reported to reduce the volume fraction occupied by mitochondria in the CA3 region (61) while, as noted earlier, 21 days of CRS increases mitochondrial profiles in mossy fiber terminals (196). This suggests that somewhat different mechanisms may be involved in effects of CRS and corticosterone in hippocampus, a possibility that is supported by the finding that, while both corticosterone treatment in the drinking water and 21 days of CRS both caused CA3 remodeling when given alone, the combination of CRS plus corticosterone treatment abolished the morphological change (195). These mechanistic differences remain to be determined.

In spite of the possible differences in mechanism, chronic corticosterone treatment and chronic restraint or immobilization stress both cause impairment of hippocampal-dependent memory tasks, although there are differences in magnitude of effect that appear to be dependent on dose of corticosterone, duration of treatment, age of rat being treated, and whether or not the cognitive task is a demanding one (15232434607799221). These studies indicate that only more prolonged treatment by higher glucocorticoid doses are able to impair performance on more demanding tasks involving hippocampal function and that they do so under conditions in which there is no neuronal loss but there are reductions in volume of hippocampal neuropil that may be due to loss of glia cells or reduction of dendritic length and branching. Given these results with rodents, it is not so surprising that a relatively modest regimen of cortisol treatment for 12 mo did not cause outright neuronal loss in the pigtail macaque hippocampus (177).

D. Prefrontal Cortex and Amygdala

Acute and repeated stress (21 days of CRS) also cause functional and structural changes in other brain regions such as the prefrontal cortex and amygdala. CRS and chronic immobilization caused dendritic shortening in medial prefrontal cortex (4170168282284332363373) but produced dendritic growth in neurons in amygdala (363), as well as in orbitofrontal cortex (181). These actions of stress are reminiscent of recent work on experimenter versus self-administered morphine and amphetamine, in which different, and sometimes opposite, effects were seen on dendritic spine density in orbitofrontal cortex, medial prefrontal cortex, and hippocampus CA1 (295). For example, amphetamine self-administration increased spine density on pyramidal neurons in the medial prefrontal cortex and decreases spine density on orbitofrontal cortex pyramidal neurons (75).

Along with many other brain regions, the amygdala and prefrontal cortex also contain adrenal steroid receptors (68); however, the role of adrenal steroids, excitatory amino acids, and other mediators has not yet been studied in detail in these brain regions, in contrast to the hippocampus. Nevertheless, glucocorticoids do appear to play a role, since 3 wk of chronic corticosterone treatment was shown to produce retraction of dendrites in medial prefrontal cortex (373), although with subtle differences in the qualitative nature of the effect from what has been described after chronic restraint stress (283). Another study determined the effect of adrenalectomy or either chronic treatment for 4 wk with corticosterone or dexamethasone on volume and neuron number in the prefrontal cortex (53). Dexamethasone treatment at a dose that may have been high enough to enter the brain (although this was not directly measured) caused a loss of neurons in layer II of the infralimbic, prelimbic, and cingulate cortex, whereas corticosterone treatment reduced the volume but not the neuron number of these cortical regions (53). The dexamethasone treatment was particularly effective in impairing working memory and cognitive flexibility using working memory task in a Morris water maze (53). Effects of chronic stress were not investigated in this study. These data notwithstanding, the cautions expressed above concerning differences between chronic stress and chronic glucocorticoid treatment must be kept in mind for the prefrontal cortex, as well as the amygdala, that has not been studied yet in this regard.

Behavioral correlates of CRS-induced remodeling in the prefrontal cortex include impairment in attention set shifting, possibly reflecting structural remodeling in the medial prefrontal cortex (181). Attention set shifting is a task in which a rat first learns that either odor or the digging medium in a pair of bowls predicts where food reward is to be found, then new cues are introduced and the rat needs to learn which ones predict the location of food (33). There is also a report that chronic restraint stress impairs extinction of a fear conditioning task (230). This is an important lead since the prefrontal cortex is involved in extinction, a type of learning (309), but much more research is needed to explore the complex relationship between stress, fear conditioning, extinction, and possible morphological remodeling that may well accompany each of these experiences.

Regarding the amygdala, chronic stress for 21 days or longer not only impairs hippocampal-dependent cognitive function (212) but it also enhances amygdala-dependent unlearned fear and fear conditioning (68), which are consistent with the opposite effects of stress on hippocampal and amygdala structure. Chronic stress also increases aggression between animals living in the same cage, and this is likely to reflect another aspect of hyperactivity of the amygdala (385). Moreover, chronic corticosterone treatment in the drinking water produces an anxiogenic effect in mice (16), an effect that could be due to the glucocorticoid enhancement of CRF activity in the amygdala (72198).

As for mechanism of remodeling, besides the possible role of glucocorticoids and excitatory amino acids, tPA is required for acute stress to activate not only indices of structural plasticity but also to enhance anxiety (227). These effects occur in the medial and central amygdala and not in basolateral amygdala, and the release of CRF acting via CRF-1 receptors appears to be responsible (204). Nothing is yet known about the role of tPA, if any, in the prefrontal cortex, although tPA does appear to play a role in stress-induced reductions of spine synapse number in the CA1 region of the mouse hippocampus (260), as noted earlier.

BDNF may also play a role in amygdala, since overexpression of BDNF, without any applied stressor, enhances anxiety in an elevated plus maze and increases spine density on basolateral amygdala neurons, and this occludes the effect of immobilization stress on both anxiety and spine density (122). As noted above for hippocampus, BDNF overexpressing mice also show reduced behavioral depression in the Porsolt forced-swim task and show protection against stress-induced shortening of dendrites in the CA3 region (122).

E. Interactions Between Amygdala, Prefrontal Cortex, and Hippocampus

The prefrontal cortex, amygdala, and hippocampus are interconnected and influence each other via direct and indirect neural activity (9118208209264). For example, inactivation of the amygdala blocks stress-induced impairment of hippocampal LTP and spatial memory (160), and stimulation of basolateral amygdala enhances dentate gyrus field potentials (139) while stimulation of medial prefrontal cortex decreases responsiveness of central amygdala output neurons (281). The processing of emotional memories with contextual information requires amygdala-hippocampal interactions (268293), whereas the prefrontal cortex, with its powerful influence on amygdala activity (281), plays an important role in fear extinction (229236). Because of these interactions, future studies need to address their possible role in the morphological and functional changes produced by single and repeated stress.

F. Sex Differences in Stress Effects

There are sex differences in the effects of stress on the hippocampus and amygdala, whereas nothing is yet known about the prefrontal cortex in this regard. Chronic foot shock stress for 3 wk caused a decrease in proliferation in dentate gyrus in singly housed male rats but caused an increase in proliferation in female rats, and both effects were prevented by group housing (375). CRS-induced retraction of dendrites in the CA3 region of hippocampus is found in males but not in females unless the females are ovariectomized (112; G. Wood and B. McEwen, unpublished observations). Chronic restraint stress for 21 days has been reported to either enhance or have no effect on performance of female rats in a spatial learning task, while having an inhibitory effect in males (3738,66185220). Interestingly, as noted above, females did not show the chronic stress-induced enhancement of ibotenic acid-induced damage in the CA3 region, in contrast to chronically stressed male rats (67). In basolateral amygdala, chronic restraint stress increased dendritic length in males and in estradiol-treated females, but not in ovariectomized females (Wood and McEwen, unpublished observations). Furthermore, as another example of a sex difference, acute tail shock restraint stress produces opposite effects on classical eye blink conditioning, enhancing performance in males and reducing it in females (383), and both developmental and adult activation effects of gonadal hormones are involved (324). Further discussion of sex differences is beyond the scope of this article, and the reader is referred to reviews on why sex differences are important for the study of brain function (45161215).


Translation of the already vast amount of information on stress effects on the brain and body from animal models to the human organism, and vice versa, is an enormous challenge, yet there has already been considerable progress, some of which has already been noted throughout this review. This section addresses three topics with a distinct human flavor: 1) evidence for stress and glucocorticoid effects on human brain structure and activity in mood and anxiety disorders, chronic pain states, and in relation to gastrointestinal activity and food intake control; 2) new insights into brain-body interactions associated with “positive health” and low self-esteem; and 3) current understanding as to how socioeconomic status affects brain and body health. Indeed, the translation is not one-way, and a significant part of the information on brain-body interactions and health implications has come from studies on human populations and individuals. The discussion in this section of the review will pave the way for the next section, namely, a discussion of brain-centered interventions for our own species that will reduce stress and the negative consequences of allostatic overload.

A. Brain Structure and Function

Much of the impetus for studying the effects of stress on the structure of the human brain has come from the animal studies summarized thus far. Although there is very little evidence regarding the effects of ordinary life stressors on brain structure, there are indications from functional imaging of individuals undergoing ordinary stressors, such as counting backwards, that there are lasting changes in neural activity that coincide with the elevation of cortisol levels (368). Moreover, the study of depressive illness and anxiety disorders has also provided some insights. Life events are known to precipitate depressive illness in individuals with certain genetic predispositions (50156158). Moreover, brain regions such as the hippocampus, amygdala, and prefrontal cortex show altered patterns of activity in PET and fMRI and also demonstrate changes in volume of these structures with recurrent depression, namely, decreased volume of hippocampus and prefrontal cortex and amygdala (92321323). Yet, amygdala volume has been reported to increase in the first episode of depression, whereas hippocampal volume is not decreased (111191).

Studies of autopsy tissue from individuals suffering from long-term major depression have provided some insights into what may be going on. They have revealed loss of glial cells and not neurons in hippocampus (344), which is consistent with, but not proof of, a retraction of dendrites in this brain region. The amygdala and prefrontal cortex of chronically depressed individuals also show evidence of glial cell loss (286322).

Although there is dysregulation of cortisol secretion in many people with depressive illness (394), it is not clear so far whether the elevation or dysregulation of cortisol plays a direct role in changes in brain structure and function. However, Cushing’s disease provides some clues of what cortisol can do. In Cushing’s disease, there are depressive symptoms that can be relieved by surgical correction of the hypercortisolemia (240338). Both major depression and Cushing’s disease are associated with chronic elevation of cortisol that results in gradual loss of minerals from bone and abdominal obesity. In major depressive illness, as well as in Cushing’s disease, the duration of the illness and not the age of the subjects predicts a progressive reduction in volume of the hippocampus, determined by structural MRI (323337).

Moreover, there are a variety of other anxiety-related disorders, such as posttraumatic stress disorder (PTSD) (39) (270) and borderline personality disorder (94), in which atrophy of the hippocampus has been reported, suggesting that this is a common process reflecting chronic imbalance in the activity of adaptive systems, such as the HPA axis, but also including endogenous neurotransmitters, such as glutamate.

More generally, it has been known for some time that stress hormones, such as cortisol, are involved in psychopathology, reflecting emotional arousal and psychic disorganization rather than the specific disorder per se (303). Thus the dysregulation of cortisol and other mediators that form the network of allostasis, as summarized earlier in this review, is likely to play a role in many psychiatric disorders as well as systemic disorders such as diabetes in which there are often psychiatric manifestations (288). Indeed, another important factor in hippocampal volume and function is glucose regulation, as noted above in section II. Poor glucose regulation is associated with smaller hippocampal volume and poorer memory function in individuals in their 60s and 70s who have “mild cognitive impairment” (MCI)(69), and both MCI and type 2, as well as type 1, diabetes are recognized as risk factors for dementia (80127255).

Not all the effects of elevated HPA activity are bad in terms of brain function, and in the case of PTSD, there is evidence that inadequate cortisol responses to traumatic events make an individual more vulnerable to developing PTSD (316318). A recent animal stress study using the Lewis rat, which produces low levels of glucocorticoid in response to stress, provides supporting information, in that corticosterone administration before exposure to predator stress in the form of well-soiled cat litter reduced the poststress anxiety (63).

B. Stress, Fatigue, and Idiopathic Pain Disorders

There are a number of syndromes that have overlapping occurrence with PTSD and with each other. Chronic fatigue syndrome (CFS) and idiopathic chronic pain conditions, such as fibromyalgia and irritable bowel syndrome (IBS), appear to reflect an imbalance in mediators of allostasis, as depicted in Figure 5D (84110,206). These conditions are also associated with symptoms of PTSD (110). Multiple mediators of allostasis and end points of allostatic load are reported to be altered, for example, in CFS, accompanied by low aldosterone, low urinary cortisol, and elevated waist-hip ratio, as well as increased bodily pain and poor physical functioning (119199). Lower than normal cortisol and aldosterone are associated with higher than normal levels of proinflammatory cytokines in CFS (110233). However, a specific and uniform dysfunction of the HPA axis is unlikely to be a key feature of CFS; rather, imbalances in other hormones such as dehydroepiandrosterone (DHEA) and abnormal serotonergic function are also implicated, along with the above-mentioned elevations in cytokines, pointing to a broader disruption of the network of allostasis (59). Yet, certain alleles of the glucocorticoid receptor have been associated with CFS (285).

There is also an overlap of these symptoms with those of “burnout,” a condition associated with emotional exhaustion, depersonalization, lack of satisfaction with personal accomplishment, and low self-esteem (114137277). Although lower than normal cortisol has been reported in burnout along with higher than normal sensitivity to dexamethasone suppression of the HPA axis, this is not always reported, and the underlying physiology is undoubtedly more complex, as it appears also to be for CFS and idiopathic chronic pain disorders (234235,331). Increased risk for type 2 diabetes has been reported in chronic burnout in otherwise healthy individuals (226).

Psychological distress and strong emotions play an important role in promoting the symptoms of idiopathic pain disorders such as IBS, fibromyalgia, and temperomandibular joint disorder (87135292). In IBS, as also in other chronic pain conditions, there are alterations in activation of brain regions associated with central arousal, pain, and strong emotions, including brain stem, the insula, amygdala, hippocampus, and cingulate cortex among other brain regions (19,172207243388). Reduction in dopaminergic activity in the nucleus accumbens may play a key role along with elevated NMDA receptor-mediated activity in brain regions, including the hippocampus (386387). Elevated CRF is associated with sensory and emotionally driven pain symptoms, although not with CFS (222). One of the unanswered questions is whether there is structural remodeling of brain areas involved in these processes, which, along with chemical imbalances in 5-HT-, CRF-, dopamine-, and NMDA-mediated neural activity, would help explain the apparent sensitization of the brain to pain stimuli. When considering pain and brain activation associated with pain, it is important to recognize the role of brain mechanisms in the placebo effect, in which perceptions of pain can be manipulated by expectations (28365). This further emphasizes the importance of cognitive processes in top-down regulation of the body.

C. Stress and Cognitive Control of Food Intake

Along with sleep deprivation (sect. III), stress often triggers eating of comfort foods (78). Besides the hypothalamus (98), the hippocampus has also been linked to disturbances of food intake and body weight regulation, primarily for its ability to limit unrestricted food intake. Lesions of the hippocampus lead to increased body mass due to increased food intake (79). Obese and recovered obese subjects differ from lean individuals in showing lesser activation of posterior hippocampus after consuming a satiating meal; the persistence of activity in never-obese lean individuals is consistent with other findings that the hippocampus actively contributes to control of food intake (7983). This conclusion is further supported by a study of electrical stimulation-induced vagus nerve activity leading to gastric distension as a satiety inducer, in which the right hippocampus showed increased activation that was associated with scores on an “emotional eating” measure (367). Besides hippocampus, gastric distension increased activity in right anterior cerebellum, orbitofrontal cortex, and striatum, regions previously shown to be involved in drug craving, suggesting a broader role of these brain structures in regulating the craving for rewarding stimuli (367).

D. New Insights Into Positive Health and Self-Esteem as Brain-Body Interactions

“Positive health” and self-esteem are two uniquely human-oriented concepts that, nevertheless, have been recently subject to illumination based on the concepts and findings discussed in this review. Having a positive outlook on life and good self-esteem appear to have long-lasting positive health consequences (275), and good social support has a positive influence to reduce the measures of allostatic overload (319). Positive affect, assessed by aggregating momentary experiences throughout a working or leisure day, was found to be associated with lower cortisol production and higher heart rate variability (showing higher parasympathetic activity, a sign of cardiac health), as well as a lower fibrinogen response to a mental stress test (341).

On the other hand, poor self-esteem has been shown to cause recurrent increases in cortisol levels during a repetition of a public speaking challenge in which those individuals with good self-esteem are able to habituate, i.e., attenuate their cortisol response after the first speech (162). Furthermore, poor self-esteem and low internal locus of control have been related to 12–13% smaller volume of the hippocampus, as well as higher cortisol levels during a mental arithmetic stressor (276278). As noted above in section II, the elevated cortisol may be both a cause and a result of the smaller hippocampus, which is consistent with the glucocorticoid cascade hypothesis of Sapolsky (311).

Related to both positive affect and self-esteem is the role of friends and social interactions in maintaining a healthy outlook on life. Loneliness, often found in people with low self-esteem, has been associated with larger cortisol responses to wakening in the morning and higher fibrinogen and natural killer cell responses to a mental stress test, as well as sleep problems (340). On the other hand, having three or more regular social contacts, as opposed to zero to two such contacts, is associated with lower allostatic load scores (319).

E. Socioeconomic Status and Health

Differences in income and education, collectively referred to as “socioeconomic status” (SES) have significant effects on mortality and morbidity for a number of diseases, with low SES faring worse than middle SES and much worse than high SES individuals in industrialized western societies (45). The SES differences are also evident, in a linear fashion from low to high SES, for predisease conditions such as obesity and metabolic syndrome (42) and fibrinogen (201378), as well as substance abuse and anxiety and mood disorders (210). Subjective SES, that is, where people rate themselves on a scale of income and education, is also an effective predictor of health status (329390). Possible mediators of the subjective SES-health link include negative affect over such issues as economic insecurity associated with low SES and sense of control related to socioeconomic position (329), as well as low self-esteem.


A. Brain-Centered Interventions

Because the brain is the central organ of the stress response, it is a primary target for interventions intended to reduce the burden of chronic stress, as defined by the concept of allostatic load and overload. In general, brain-centered interventions are very familiar in everyday life. They involve changing behavior and life-style, for example, by improving sleep quality and quantity, improving social support, and cultivating a positive outlook on life, along with maintaining a healthy diet, avoiding smoking, and engaging in regular, moderate physical activity.

These types of changes are usually more easily said than done. Yet, policies of government and the private sector can play a major role in promoting this, as they have done for smoking cessation and wearing of seat belts in automobiles, by creating incentives at home and in work situations and also by building community services and opportunities that encourage the development of beneficial individual life-styles.

The intention of this section of the review is not to exhaustively review this area; that is the subject of textbooks of health psychology and the target of policy discussions at all levels of government and in the private sector. Rather, this portion of the review will discuss physiologically relevant aspects of an area that is now called “social neuroscience” ( that is beginning to address the effects of the social environment on the brain and the physiology that it regulates. We shall make note of some of the recent work on effects and mechanisms of two types of interventions for stress and allostatic load, namely, exercise and social support, and the combination of the two, after first acknowledging the important role of pharmaceutical agents along with their limitations.

B. Pharmaceutical Agents

It is important to note that there are many useful pharmaceutical agents, such as sleep medications, anxiolytics, beta blockers, and antidepressants, that counteract some of the problems associated with being stressed out. Likewise, drugs that reduce oxidative stress or inflammation, block cholesterol synthesis or absorption, and treat insulin resistance or chronic pain can help deal with the metabolic and neurological consequences of being “stressed out.” All of these medications are valuable to some degree, yet each one has its side effects and limitations, as illustrated by recent problems with the cyclooxygenase-2 inhibitors for chronic inflammatory pain (308).

Because of the nonlinearity of the systems of allostasis, the consequences of any drug treatment may be either to inhibit the beneficial effects of the systems in question or to perturb other systems that interact with it in a direction that promotes an unwanted side effect. An example is the use of anti-inflammatory agents to treat fever associated with an infection (245). Because the fever is a sign of the body’s attempt to fight the infection, it is unwise to suppress the fever completely. On the other hand, septic shock represents the excessive, unregulated response of the defense system to an infection that can be lethal (35,245). Thus some means of containing such responses are needed, and both glucocorticoids and activation of parasympathetic responses are helpful (35,239). In addition to pharmaceuticals, there are two behavioral interventions, namely, physical activity and social support, where there has been some progress in understanding how they may benefit brain and body functions associated with allostasis and allostatic load.

C. Physical Activity

A sedentary life-style is a major risk factor for many of the diseases of modern life including obesity, diabetes, cardiovascular disease, depression, and dementia, and recent studies have shown that moderate physical activity can be beneficial for the brain and cardiovascular and metabolic systems (2229167263302). Voluntary physical activity has been shown to increase neurotrophin expression in cortex and hippocampal regions of the brain (73), as well as to increase neurogenesis in the dentate gyrus of young as well as aging animals (357). One mechanism for these effects involves the actions of circulating IGF-I, which is taken up by the brain and acts via receptors found in the hippocampus, as summarized early in this article. Moreover, increased neurogenesis in dentate gyrus has been linked to the actions of antidepressant drugs, providing a potential parallel with the antidepressant actions of physical activity (95251). Increased neurogenesis improves memory (382), and new neurons are believed to participate in learning of hippocampal-dependent tasks (176). Although the role of neurogenesis in dentate gyrus is still controversial, new neurons appear to be more excitable and may contribute to greater cognitive flexibility (150382). Related to effects of exercise on neurogenesis is the effect of dietary restriction, which also increases neurogenesis and elevates the level of BDNF in hippocampus (173). BDNF is an important factor in current thinking about the actions of antidepressant treatments (369), including the consequences for hippocampal volume, memory, and mood disorders of having the Val66Met allele of the BDNF gene (130142265349).

D. Social Support

Another behavioral intervention that has begun to be investigated in terms of brain and body health is “social support.” Social support “is composed of emotional and instrumental support. It is an advocative interpersonal process characterized by reciprocal exchange of information; it is context specific and it results in improved mental health” (106). Social support in the form of having regular social contacts with supportive friends or family or health professionals, who provide emotional support and provided useful information, has been shown to reduce the allostatic load score, which measures key physiological markers related to chronic stress and a potentially health-damaging life-style (319). Social support also ameliorates the type of chronic stress in caregivers that has been associated with reduced length of telomeres in white blood cells (100). So far nothing is known about how social support may benefit brain circuits that are affected by chronic stress and allostatic load, although it is clear that social support has beneficial effects on mood and overall mental health (3175315,327).

Beyond the question of how emotional and instrumental support benefit the individual, a somewhat broader review of social support is how the policies of government and employers act to encourage creation of a compatible social environment for adopting health-promoting behaviors. The Acheson Report (2) from the United Kingdom in 1998 recognized that no public policy of virtually any kind should be enacted without considering the implications for health of all citizens. Thus basic education, housing, taxation, setting of a minimum wage, and addressing occupational health and safety and environmental pollution regulations are all likely to affect health via a myriad of mechanisms. At the same time, providing higher quality food and making it affordable and accessible in poor, as well as affluent neighborhoods, is necessary for people to eat better, providing they also learn what types of food to eat (93). Likewise, making neighborhoods safer and more congenial and supportive (154304) can improve opportunities for positive social interactions and increased recreational physical activity. However, governmental policies are not the only way to reduce allostatic load. For example, businesses that encourage healthy life-style practices among their employees are likely to gain reduced health insurance costs and possibly a more loyal workforce (10262376).

Finally, there are programs in existence that combine some of the key elements just described, namely, physical activity and social support, along with one other ingredient that is hard to quantify, namely, finding meaning and purpose in life. One such program is the Experience Corps that takes elderly volunteers and trains them as teachers’ assistants for younger children in the neighborhood schools (109). Not only does this program improve the education of the children, it also benefits the elderly volunteers and improves their physical and mental health and slows age-related decline of function (314). It will be important to see how this program may more directly benefit the function of the brain circuits that are responsive to chronic stress and allostatic load. This program has now been adopted as a key part of a successful political campaign for the governorship of the state of Maryland (Abbruzzese, R. O’Malley and Brown Release Detailed Plan to Support Maryland’s Aging Population. Press Release, Jan. 24, 2006), illustrating that politicians and policy makers do sometimes make use of what physiology and neuroscience are learning.


The intent of this review has been not only to summarize salient facts pertaining to the central role of the brain in the effects of stress on brain-body interactions over the life course, and the protective and damaging paradox of these interactions, but also to provide a conceptual framework for future studies that will infuse physiology and neuroscience into the better mechanistic understanding of complex stress-related social problems and their solution by every means available: biological, behavioral, sociological, and political.

As the interpreter of and responder to what is stressful, the adult brain is a malleable organ and adapts structurally and functionally to experiences including those which are stressful and potentially deleterious. These changes do not necessarily constitute “damage” but may, nevertheless, be long lasting, and it is their spontaneous reversal or reversal by behavioral and pharmaceutical means that may be the key to treatment of anxiety, mood, and other stress-related behavioral disorders.

Events early in life affect how the brain responds to stressors throughout adult life and influences the aging process as well as susceptibility to the diseases of modern life, such as cardiovascular disease, diabetes, and depression. This connection occurs in part because the nervous system regulates and responds to systemic processes via the neuroendocrine, autonomic, and immune systems. Social factors, along with physical activity, have a powerful impact on brain development, structure, and function throughout the life course and thereby affect the health of the body as well. Therefore, manipulations of the social environment via policies of government and the private sector, along with promoting increased physical activity, health life-style, and social support at an individual level, can help encourage individual behavior change, that, in turn, is an effective way of counteracting the deleterious effects of chronic stress as an adjunct and, in some cases, alternative to pharmaceutical therapy.


Address for reprint requests and other correspondence: B. S. McEwen, Alfred E. Mirsky Professor and Head, Harold and Margaret Milliken Hatch, Laboratory of Neuroendocrinology, The Rockefeller University, New York, New York 10021 (e-mail:


  1. 1.
    Aberg MA, Aberg ND, Hedbacker H, Oscarsson J, Eriksson PS.Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus. J Neurosci 20: 2896–2903, 2000.
  2. 2.
    Acheson SD. Independent Inquiry into Inequalities in Health Report.London: The Stationary Office, 1998.
  3. 3.
    Adams RE, Boscarino JA. Predictors of PTSD and delayed PTSD after disaster: the impact of exposure and psychosocial resources. J Nerv Ment Dis194: 485–493, 2006.
  4. 4.
    Adler NE, Boyce TW, Chesney MA, Folkman S, Syme L.Socioeconomic inequalities in health. JAMA 269: 3140–3145, 1993.
  5. 5.
    Adler NE, Marmot M, McEwen BS, Stewart JE. Socioeconomic Status and Health in Industrial Nations: Social, Psychological, Biological Pathways. New York: NY Acad. Sci., 1999.
  6. 6.
    Ahima R, Krozowski Z, Harlan R. Type I corticosteroid receptor-like immunoreactivity in the rat CNS: distribution and regulation by corticosteroids. J Comp Neurol 313: 522–538, 1991.
  7. 7.
    Ahima RS, Garcia MM, Harlan RE. Glucocorticoid regulation of preproenkephalin gene expression in the rat forebrain. Mol Brain Res 16: 119–127, 1992.
  8. 8.
    Ahima RS, Harlan RE. Charting of type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system. Neuroscience 39: 579–604,1990.
  9. 9.
    Akirav I, Richter-Levin G. Biphasic modulation of hippocampal plasticity by behavioral stress and basolateral amygdala stimulation in the rat. J Neurosci19: 10530–10535, 1999.
  10. 10.
    Aldana SG. Financial impact of health promotion programs: a comprehensive review of the literature. Am J Health Promotion 15: 296–320,2001.
  11. 11.
    Alfonso J, Fernandez ME, Cooper B, Flugge G, Frasch AC. The stress-regulated protein M6a is a key modulator for neurite outgrowth and filopodium/spine formation. Proc Natl Acad Sci USA 102: 17196–17201, 2005.
  12. 12.
    Alfonso J, Frasch AC, Flugge G. Chronic stress, depression and antidepressants: effects on gene transcription in the hippocampus. Rev Neurosci16: 43–56, 2005.
  13. 13.
    Alfonso J, Pollevick GD, van der Hart MG, Flugge G, Fuchs E, Frasch ACC. Identification of genes regulated by chronic psychosocial stress and antidepressant treatment in the hippocampus. Eur J Neurosci 19: 659–666,2004.
  14. 14.
    Anda RF, Felitti VJ, Bremner JD, Walker JD, Whitfield C, Perry BD, Dube SR, Giles WH. The enduring effects of abuse and related adverse experiences in childhood. Eur Arch Psychiat Clin Neurosci 256: 174–186, 2006.
  15. 15.
    Arbel I, Kadar T, Silbermann M, Levy A. The effects of long-term corticosterone administration on hippocampal morphology and cognitive performance of middle-age rats. Brain Res 657: 227–235, 1994.
  16. 16.
    Ardayfio P, Kim KS. Anxiogenic-like effect of chronic corticosterone in the light-dark emergency task in mice. Behav Neurosci 120: 249–256, 2006.
  17. 17.
    Arendt T, Stieler J, Strijkstra AM, Hut RA, Rudiger J, Van der Zee EA, Harkany T, Holzer M, Hartig W. Reversible paired helical filament-like phosphorylation of tau is an adaptive process associated with neuronal plasticity in hibernating animals. J Neurosci 23: 6972–6981, 2003.
  18. 18.
    Azmitia E, McEwen BS. Adrenocortical influence on rat brain tryptophan hydroxylase activity. Brain Res 78: 291–302, 1974.
  19. 19.
    Baliki MN, Chialvo DR, Geha PY, Levy RM, Harden RN, Parrish TB, Apkarian AV. Chronic pain and the emotional brain: specific brain activity associated with spontaneous fluctuations of intensity of chronic back pain. J Neurosci 26: 12165–12173, 2006.
  20. 20.
    Banks WA, Tschop M, Robinson SM, Heiman ML. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther 302: 822–827, 2002.
  21. 21.
    Baran SE, Campbell AM, Kleen JK, Foltz CH, Wright RL, Diamond DM, Conrad CD. Combination of high fat diet and chronic stress retracts hippocampal dendrites. Neuroreport 16: 39–43, 2005.
  22. 22.
    Barbour KA, Blumenthal JA. Exercise training and depression in older adults. Neurobiol Aging 26S: S119–S123, 2005.
  23. 23.
    Bardgett ME, Newcomer JW, Taylor GT. The effects of chronic corticosterone on memory performance in the platform maze task. Physiol Behav59: 1111–1115, 1996.
  24. 24.
    Bardgett ME, Taylor GT, Csernansky JG, Newcomer JW, Nock B.Chronic corticosterone treatment impairs spontaneous alternation behavior in rats. Behav Neural Biol 61: 186–190, 1994.
  25. 25.
    Barker DJP. The fetal origins of coronary heart disease. Acta Paediatr Suppl 422: 78–82, 1997.
  26. 26.
    Barr CS, Newman TK, Lindell S, Shannon C, Champoux M, Lesch KP, Suomi SJ, Goldman D, Higley JD. Interaction between serotonin transporter gene variation and rearing condition in alcohol preference and consumption in female primates. Arch Gen Psychiat 61: 1146–1152, 2004.
  27. 27.
    Bellani R, Luecken LJ, Conrad CD. Peripubertal anxiety profile can predict predisposition to spatial memory impairments following chronic stress.Behav Brain Res 166: 263–270, 2006.
  28. 28.
    Benedetti F, Mayberg HS, Wager TD, Stohler CS, Zubieta JK.Neurobiological mechanisms of the placebo effect. J Neurosci 25: 10390–10402,2005.
  29. 29.
    Bernadet P. Benefits of physical activity in the prevention of cardiovascular disease. J Cardiovasc Pharmacol 25: S3–S8, 1995.
  30. 30.
    Bhargava A, Meijer OC, Dallman MF, Pearce D. Plasma membrane calcium pump isoform 1 gene expression is repressed by corticosterone and stress in rat hippocampus. J Neurosci 20: 3129–3138, 2000.
  31. 31.
    Bianchi M, Heidbreder C, Crespi F. Cytoskeletal changes in the hippocampus following restraint stress: role of serotonin and microtubules.Synapse 49: 188–194, 2003.
  32. 32.
    Bierhaus A, Wolf J, Andrassy M, Rohleder N, Humpert PM, Petrov D, Ferst R, von Eynatten M, Wendt T, Rudofsky G, Joswig M, Morcos M, Schwaninger M, McEwen B, Kirschbaum C, Nawroth PP. A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci USA 100: 1920–1925, 2003.
  33. 33.
    Birrell JM, Brown VJ. Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci 20: 4320–4324, 2000.
  34. 34.
    Bodnoff SR, Humphreys AG, Lehman JC, Diamond DM, Rose GM, Meaney MJ. Enduring effects of chronic corticosterone treatment on spatial learning, synaptic plasticity, hippocampal neuropathology in young and mid-aged rats. J Neurosci 15: 61–69, 1995.
  35. 35.
    Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature405: 458–462, 2000.
  36. 36.
    Borski RJ. Nongenomic membrane actions of glucocorticoids in vertebrates. TEM 11: 427–436, 2000.
  37. 37.
    Bowman RE, Beck KD, Luine VN. Chronic stress effects on memory: sex differences in performance and monoaminergic activity. Horm Behav 43: 48–59, 2003.
  38. 38.
    Bowman RE, Zrull MC, Luine VN. Chronic restraint stress enhances radial arm maze performance in female rats. Brain Res 904: 279–289, 2001.
  39. 39.
    Bremner JD. Neuroimaging studies in post-traumatic stress disorder.Curr Psychiat Reports 4: 254–263, 2002.
  40. 40.
    Brown AM. Brain glycogen re-awakened. J Neurochem 89: 537–552,2004.
  41. 41.
    Brown SM, Henning S, Wellman CL. Mild, short-term stress alters dendritic morphology in rat medial prefrontal cortex. Cerebral Cortex 30: 1–9,2005.
  42. 42.
    Brunner EJ, Marmot MG, Nanchahal K, Shipley MJ, Stansfeld SA, Juneja M, Alberti KGMM. Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II study. Diabetologia 40:1341–1349, 1997.
  43. 43.
    Brunson KL, Eghbal-Ahmadi M, Bender R, Chen Y, Baram TZ. Long-term, progressive hippocampal cell loss and dysfunction induced by early-life administration of corticotropin-releasing hormone reproduce the effects of early-life stress. Proc Natl Acad Sci USA 98: 8856–8861, 2001.
  44. 44.
    Brunson KL, Kramar E, Lin B, Chen Y, Colgin LL, Yanagihara TK, Lynch G, Baram TZ. Mechanisms of late-onset cognitive decline after early-life stress. J Neurosci 25: 9328–9338, 2005.
  45. 45.
    Cahill L. Why sex matters for neuroscience. Nat Rev Neurosci 7: 477–484,2006.
  46. 46.
    Cameron HA, McKay RDG. Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus. J Comp Neurol 435: 406–417, 2001.
  47. 47.
    Cameron HA, Tanapat P, Gould E. Adrenal steroids and N-methyl-D-aspartate receptor activation regulate neurogenesis in the dentate gyrus of adult rats through a common pathway. Neuroscience 82: 349–354, 1998.
  48. 48.
    Carro E, Nunez A, Busiguina S, Torres-Aleman I. Circulating insulin-like growth factor I mediates effects of exercise on the brain. J Neurosci20: 2926–2933, 2000.
  49. 49.
    Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW, Taylor A, Poulton R. Role of genotype in the cycle of violence in maltreated children.Science 297: 851–854, 2002.
  50. 50.
    Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386–389, 2003.
  51. 51.
    Cavigelli SA, McClintock MK. Fear of novelty in infant rats predicts adult corticosterone dynamics and an early death. Proc Natl Acad Sci USA 100:16131–16136, 2003.
  52. 52.
    Cavigelli SA, Yee JR, McClintock MK. Infant temperament predicts life span in female rats that develop spontaneous tumors. Horm Behav 50: 454–462,2006.
  53. 53.
    Cerqueira JJ, Pego JM, Taipa R, Bessa JM, Almeida OFX, Sousa N.Morphological correlates of corticosteroid-induced changes in prefrontal cortex-dependent behaviors. J Neurosci 25: 7792–7800, 2005.
  54. 54.
    Chalmers DT, Kwak SP, Mansour A, Akil H, Watson SJ. Corticosteroids regulate brain hippocampal 5-HT receptor mRNA expression. J Neurosci 13:914–923, 1993.
  55. 55.
    Chen Y, Bender RA, Brunson KL, Pomper JK, Grigoriadis DE, Durst W, Baram TZ. Modulation of dendritic differentiation by corticotropin-releasing factor in the developing hippocampus. Proc Natl Acad Sci USA 101: 15782–15787, 2004.
  56. 56.
    Chen ZY, Jing D, Bath KG, Ieraci A, Khan T, Siao CJ, Herrera DG, Toth M, Yang C, McEwen BS, Hempstead BL, Lee FS. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314: 140–143, 2006.
  57. 58.
    Clark RA, Valente AJ. Nuclear factor kappa B activation by NADPH oxidases. Mech Ageing Dev 125: 799–810, 2004.
  58. 59.
    Cleare AJ. The neuroendocrinology of chronic fatigue syndrome. Endocr Rev 24: 236–252, 2003.
  59. 60.
    Coburn-Litvak PS, Pothakos K, Tata DA, McCloskey DP, Anderson BJ. Chronic administration of corticosterone impairs spatial reference memory before spatial working memory in rats. Neurobiol Learning Memory 80: 11–23,2003.
  60. 61.
    Coburn-Litvak PS, Tata DA, Gorby HE, McCloskey DP, Richardson G, Anderson BJ. Chronic corticosterone affects brain weight, mitochondrial, but not glial volume fraction in hippocampal area CA3. Neuroscience 124: 429–438, 2004.
  61. 62.
    Cockburn A, Lee AK. Marsupial femmes fatales. Natural History 97: 40–47, 1988.
  62. 63.
    Cohen H, Zohar J, Gidron Y, Matar MA, Belkind D, Loewenthal U, Kozlovsky N, Kaplan Z. Blunted HPA axis response to stress influences susceptibility to posttraumatic stress response in rats. Biol Psychiatr 59: 1208–1218, 2006.
  63. 64.
    Conrad CD. What is the functional significance of chronic stress-induced CA3 dendritic retraction within the hippocampus? Behav Cogn Neurosci Rev 5:41–60, 2006.
  64. 65.
    Conrad CD, Galea LAM, Kuroda Y, McEwen BS. Chronic stress impairs rat spatial memory on the Y-Maze and this effect is blocked by tianeptine pre-treatment. Behav Neurosci 110: 1321–1334, 1996.
  65. 66.
    Conrad CD, Grote KA, Hobbs RJ, Ferayorni A. Sex differences in spatial and non-spatial Y-maze performance after chronic stress. Neurobiol Learning Memory 79: 32–40, 2003.
  66. 67.
    Conrad CD, Jackson JL, Wise LS. Chronic stress enhances ibotenic acid-induced damage selectively within the hippocampal CA3 region of male, but not female rats. Neuroscience 125: 759–767, 2004.
  67. 68.
    Conrad CD, Magarinos AM, LeDoux JE, McEwen BS. Repeated restraint stress facilitates fear conditioning independently of causing hippocampal CA3 dendritic atrophy. Behav Neurosci 113: 902–913, 1999.
  68. 69.
    Convit A, Wolf OT, Tarshish C, de Leon MJ. Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. Proc Natl Acad Sci USA 100: 2019–2022, 2003.
  69. 70.
    Cook SC, Wellman CL. Chronic stress alters dendritic morphology in rat medial prefrontal cortex. J Neurobiol 60: 236–248, 2004.
  70. 71.
    Coplan JD, Smith ELP, Altemus M, Scharf BA, Owens MJ, Nemeroff CB, Gorman JM, Rosenblum LA. Variable foraging demand rearing: sustained elevations in cisternal cerebrospinal fluid corticotropin-releasing factor concentrations in adult primates. Biol Psychiat 50: 200–204, 2001.
  71. 72.
    Corodimas KP, LeDoux JE, Gold PW, Schulkin J. Corticosterone potentiation of learned fear. Ann NY Acad Sci 746: 392, 1994.
  72. 73.
    Cotman CW, Berchtold NC. Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci 25: 295–301, 2002.
  73. 74.
    Craft TKS, Zhang N, Glasper ER, Hurn PD, DeVries AC. Neonatal factors influence adult stroke outcome. Psychoneuroendocrinology 31: 601–613, 2006.
  74. 75.
    Crombag HS, Gorny G, Li Y, Kolb B, Robinson TE. Opposite effects of amphetamine self-administration experience on dendritic spines in the medial and orbital prefrontal cortex. Cerebral Cortex 15: 341–348, 2005.
  75. 76.
    Czeh B, Michaelis T, Watanabe T, Frahm J, de Biurrun G, van Kampen M, Bartolomucci A, Fuchs E. Stress-induced changes in cerebral metabolites, hippocampal volume and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci USA 98: 12796–12801, 2001.
  76. 77.
    Dachir S, Kadar T, Robinzon B, Levy A. Cognitive deficits induced in young rats by long-term corticosterone administration. Behav Neural Biol 60:103–109, 1993.
  77. 78.
    Dallman MF. Chronic stress and obesity: A new view of “comfort food.”Proc Natl Acad Sci USA 100: 11696–11701, 2003.
  78. 79.
    Davidson TL, Kanoski SE, Walls EK, Jarrard LE. Memory inhibition and energy regulation. Physiol Behav 86: 731–746, 2005.
  79. 80.
    De Leon MJ, Convit A, Wolf OT, Tarshish CY, DeSanti S, Rusinek H, Tsui W, Kandil E, Scherer AJ, Roche A, Imossi A, Thorn E, Bobinski M, Caraos C, Lesbre P, Schlyer D, Poirier J, Reisberg B, Fowler J.Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET). Proc Natl Acad Sci USA 98: 10966–10971, 2001.
  80. 81.
    De Paula HMG, Hoshino K. Correlation between the fighting rates of REM sleep-deprived rats and susceptibility to the “wild running” of audiogenic seizures. Brain Res 926: 80–85, 2002.
  81. 82.
    De Quervain DJF, Roozendaal B, Nitsch RM, McGaugh JL, Hock C.Acute cortisone administration impairs retrieval of long-term declarative memory in humans. Nature Neurosci 3: 313–314, 2000.
  82. 83.
    DelParigi A, Chen K, Salbe AD, Hill JO, Wing RR, Reiman EM, Tataranni A. Persistence of abnormal neural responses to a meal in postobese individuals. Int J Obesity 28: 370–377, 2004.
  83. 84.
    Demitrack MA. Neuroendocrine research strategies in chronic fatigue syndrome. In: Chronic Fatigue and Related Immune Deficiency Syndromes, edited by Goodnick PJ and Klimas NG. Washington, DC: American Psychiatric Press, 1996, chapt. 3, p. 45–66.
  84. 85.
    Diamond DM, Bennett MC, Fleshner M, Rose GM. Inverted-U relationship between the level of peripheral corticosterone and the magnitude of hippocampal primed burst potentiation. Hippocampus 2: 421–430, 1992.
  85. 86.
    Diano S, Farr SA, Benoit SC, McNay EC, da Silva I, Horvath B, Gaskin FS, Nonaka N, Jaeger LB, Banks WA, Morley JE, Pinto S, Sherwin RS, Xu L, Yamada KA, Sleeman MW, Tschop MH, Horvath TL. Ghrelin controls hippocampal spine synapse density and memory performance. Nature Neurosci 9: 381–388, 2006.
  86. 87.
    Diatchenko L, Nackley AG, Slade GD, Fillingim RB, Maixner W.Idiopathic pain disorders: pathways of vulnerability. Pain 123: 226–230, 2006.
  87. 88.
    Dinkel K, MacPherson A, Sapolsky RM. Novel glucocorticoid effects on acute inflammation in the CNS. J Neurochem 84: 705–716, 2003.
  88. 89.
    Donahue CP, Jensen RV, Ochiishi T, Eisenstein I, Zhao M, Shors T, Kosik KS. Transcriptional profiling reveals regulated genes in the hippocampus during memory formation. Hippocampus 12: 821–833, 2002.
  89. 90.
    Donahue CP, Kosik KS, Shors TJ. Growth hormone is produced within the hippocampus where it responds to age, sex, stress. Proc Natl Acad Sci USA103: 6031–6036, 2006.
  90. 91.
    Dore S, Kar S, Rowe W, Quirion R. Distribution and levels of [125I]IGF-I, [125I]IGF-II and [125I]insulin receptor binding sites in the hippocampus of aged memory-unimpaired and -impaired rats. Neuroscience 80: 1033–1040, 1997.
  91. 92.
    Drevets WC, Price JL, Simpson JR Jr, Todd RD, Reich T, Vannier M, Raichle ME. Subgenual prefrontal cortex abnormalities in mood disorders.Nature 386: 824–827, 1997.
  92. 93.
    Drewnowski A, Specter SE. Poverty and obesity: the role of energy density and energy costs. Am J Clin Nutr 79: 6–16, 2004.
  93. 94.
    Driessen M, Hermann J, Stahl K, Zwaan M, Meier S, Hill A, Osterheider M, Petersen D. Magnetic resonance imaging volumes of the hippocampus and the amygdala in women with borderline personality disorder and early traumatization. Arch Gen Psychiat 57: 1115–1122, 2000.
  94. 95.
    Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiat 59: 1116–1127, 2006.
  95. 96.
    Eichenbaum H, Otto T. The hippocampus: what does it do? Behav Neural Biol 57: 2–36, 1992.
  96. 97.
    Eisch AJ, Harburg GC. Opiates, psychostimulants, adult hippocampal neurogenesis: insights for addiction and stem cell biology. Hippocampus 16:271–286, 2006.
  97. 98.
    Elmquist JK, Elias CF, Saper CB. From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 22: 221–232, 1999.
  98. 99.
    Endo Y, Nishimura JI, Kimura F. Impairment of maze learning in rats following long-term glucocorticoid treatments. Neurosci Lett 203: 199–202,1996.
  99. 100.
    Epel ES, Blackburn EH, Lin J, Dhabhar FS, Adler NE, Morrow JD, Cawthon RM. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 101: 17312–17315, 2004.
  100. 101.
    Evans GW. A multimethodological analysis of cumulative risk and allostatic load among rural children. Dev Psychol 39: 924–933, 2003.
  101. 102.
    Evans GW, Gonnella C, Marcynyszyn LA, Gentile L, Salpekar N.The role of chaos in poverty and children’s socioemotional adjustment. Psychol Sci 16: 560–565, 2004.
  102. 103.
    Farrell AP. Coronary arteriosclerosis in salmon: growing old or growing fast? Comp Biochem Physiol A Comp Physiol 132: 723–735, 2002.
  103. 104.
    Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, Edwards V, Koss MP, Marks JS. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The adverse childhood experiences (ACE) study. Am J Prev Med 14: 245–258, 1998.
  104. 105.
    Fenoglio KA, Brunson KL, Baram TZ. Hippocampal neuroplasticity induced by early-life stress: functional and molecular aspects. Front Neuroendocrinol 27: 180–192, 2006.
  105. 106.
    Finfgeld-Connett D. Clarification of social support. J Nurs Scholarsh37: 4–9, 2005.
  106. 107.
    Francis D, Diorio J, Liu D, Meaney MJ. Nongenomic transmission across generations of maternal behavior and stress responses in the rat. Science286: 1155–1158, 1999.
  107. 108.
    Francis DD, Diorio J, Plotsky PM, Meaney MJ. Environmental enrichment reverses the effects of maternal separation on stress reactivity. J Neurosci 22: 7840–7843, 2002.
  108. 109.
    Frick KD, Carlson MC, Glass TA, McGill S, Rebok GW, Simpson C, Fried LP. Modeled cost-effectiveness of the experience corps Baltimore based on a pilot randomized trial. J Urban Health Bull NY Acad Med 81: 106–117,2004.
  109. 110.
    Fries E, Hesse J, Hellhammer J, Hellhammer DH. A new view on hypocortisolism. Psychoneuroendocrinology 30: 1010–1016, 2005.
  110. 111.
    Frodl T, Meisenzahl EM, Zetzsche T, Born C, Jager M, Groll C, Bottlender R, Leinsinger G, Moller HJ. Larger amygdala volumes in first depressive episode as compared to recurrent major depression and healthy control subjects. Biol Psychiat 53: 338–344, 2003.
  111. 112.
    Galea LAM, McEwen BS, Tanapat P, Deak T, Spencer RL, Dhabhar FS. Sex differences in dendritic atrophy of CA3 pyramidal neurons in response to chronic restraint stress. Neuroscience 81: 689–697, 1997.
  112. 113.
    Gangwisch JE, Malaspina D, Boden-Albala B, Heymsfield SB.Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep28: 1289–1296, 2005.
  113. 114.
    Garrosa E, Moreno-Jimenez B, Liang Y, Gonzalez JL. The relationship between socio-demographic variables, job stressors, burnout, hardly personality in nurses: a exploratory study. Int J Nursing Studies 2006.
  114. 115.
    Geinisman Y, deToledo-Morrell L, Morrell F, Heller RE.Hippocampal markers of age-related memory dysfunction: behavioral, electrophysiological and morphological perspectives. Prog Neurobiol 45: 223–252, 1995.
  115. 116.
    Gerlach J, McEwen BS. Rat brain binds adrenal steroid hormone: radioautography of hippocampus with corticosterone. Science 175: 1133–1136,1972.
  116. 117.
    Geronimus AT. The weathering hypothesis and the health of African-American women and infants: evidence and speculations. Ethnicity Disease 2:207–221, 1992.
  117. 118.
    Ghashghaei HT, Barbas H. Pathways for emotion: interactions of prefrontal and anterior temporal pathways in the amygdala of the Rhesus monkey. Neuroscience 115: 1261–1279, 2002.
  118. 119.
    Goertzel BN, Pennachin C, de Souza Coelho L, Maloney EM, Jones JF, Gurbaxani B. Allostatic load is associated with symptoms in chronic fatigue syndrome patients. Pharmacogenomics 7: 485–494, 2006.
  119. 120.
    Gotz ME, Malz CR, Dirr A, Blum D, Gsell W, Schmidt S, Burger R, Pohli S, Riederer P. Brain aging phenomena in migrating sockeye salmonOncorhynchus nerka nerka. J Neural Transm 112: 1177–1199, 2005.
  120. 121.
    Gould E, McEwen BS, Tanapat P, Galea LAM, Fuchs E. Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation. J Neurosci 17: 2492–2498, 1997.
  121. 122.
    Govindarajan A, Rao BSS, Nair D, Trinh M, Mawjee N, Tonegawa S, Chattarji S. Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects. Proc Natl Acad Sci USA 103: 13208–13213, 2006.
  122. 123.
    Graves LA, Heller EA, Pack IA, Abel T. Sleep deprivation selectively impairs memory consolidation for contextual fear conditioning. Learning Memory 10: 168–176, 2003.
  123. 124.
    Grillo CA, Piroli GG, Wood GE, Reznikov LR, McEwen BS, Reagan LP. Immunocytochemical analysis of synaptic proteins provides new insights into diabetes-mediated plasticity in the rat hippocampus. Neuroscience 136:477–486, 2005.
  124. 125.
    Guan Z, Peng X, Fang J. Sleep deprivation impairs spatial memory and decreases extracellular signal-regulated kinase phosphorylation in the hippocampus. Brain Res 1018: 38–47, 2004.
  125. 126.
    Guzman-Marin R, Suntsova N, Stewart DR, Gong H, Szymusiak R, McGinty D. Sleep deprivation reduces proliferation of cells in the dentate gyrus of the hippocampus in rats. J Physiol 549.2: 563–571, 2003.
  126. 127.
    Haan MN. Therapy insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer’s disease. Nature Clin Pract Neurol 2: 159–166, 2006.
  127. 128.
    Hairston IS, Little MTM, Scanlon MD, Barakat MT, Palmer TD, Sapolsky RM, Heller HC. Sleep restriction suppresses neurogenesis induced by hippocampus-dependent learning. J Neurophysiol 94: 4224–4233, 2005.
  128. 129.
    Hansson AC, Sommer WH, Metsis M, Stromberg I, Agnati LF, Fuxe K. Corticosterone actions on the hippocampal brain-derived neurotrophic factor expression are mediated by Exon IV promoter. J Neuroendocrinol 18: 104–114, 2006.
  129. 130.
    Hariri AR, Goldberg TE, Mattay VS, Kolachana BS, Callicott JH, Egan MF, Weinberger DR. Brain-derived neurotrophic factor val66 met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 23: 6690–6694, 2003.
  130. 131.
    Harvey J, Shanley LJ, O’Malley D, Irving AJ. Leptin: a potential cognitive enhancer? Biochem Soc Trans 33: 1029–1032, 2005.
  131. 132.
    Heim C, Nemeroff CB. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiat 49: 1023–1039, 2001.
  132. 133.
    Herman AI, Kaiss KM, Ma R, Philbeck JW, Hasan A, Dasti H, DePetrillo PB. Serotonin transporter promoter polymorphism and monoamine oxidase type A VNTR allelic variants together influence alcohol binge drinking risk in young women. Am J Med Genet B Neuropsychiat Genet 133: 74–78,2005.
  133. 134.
    Herman JP, Cullinan WE. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 20: 78–84,1997.
  134. 135.
    Houdenhove BV, Luyten P. Beyond dualism: the role of life stress in chronic pain. Pain 113: 238–247, 2005.
  135. 136.
    Huang GJ, Herbert J. Serotonin modulates the suppressive effects of corticosterone on proliferating progenitor cells in the dentate gyrus of the hippocampus in the adult rat. Neuropsychopharmacology 30: 231–241, 2005.
  136. 137.
    Huibers MJH, Beurskens AJHM, Prins JB, Kant IJ, Bazelmans E, van Schayck CP, Knottnerus JA, Bleijenberg G. Fatigue, burnout, chronic fatigue syndrome among employees on sick leave: do attributions make the difference? Occup Environ Med 60: i26–i31, 2003.
  137. 138.
    Huizenga NATM, Koper JW, De Lange P, Pols HAP, Stolk RP, Burger H, Grobbee DE, Brinkmann AO, De Jong FH, Lamberts SWJ. A polymorphism in the glucocorticoid receptor gene may be associated with an increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab 83: 144–151, 1998.
  138. 139.
    Ikegaya Y, Saito H, Abe K. Dentate gyrus field potentials evoked by stimulation of the basolateral amygdaloid nucleus in anesthetized rats. Brain Res718: 53–60, 1996.
  139. 140.
    Isgor C, Kabbaj M, Akil H, Watson SJ. Delayed effects of chronic variable stress during peripubertal-juvenile period on hippocampal morphology and on cognitive and stress axis functions in rats. Hippocampus 14: 636–648,2004.
  140. 141.
    Jacobson L, Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev 12:118–134, 1991.
  141. 142.
    Jiang X, Xu K, Hoberman J, Tian F, Marko AJ, Waheed JF, Harris CR, Marini AM, Enoch MA, Lipsky RH. BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology 30: 1353–1361,2005.
  142. 143.
    Joels M. Corticosteroid effects in the brain: U-shape it. Trends Pharmacol Sci 27: 244–250, 2006.
  143. 144.
    Joels M, Pu Z, Wiegert O, Oitzl MS, Krugers HJ. Learning under stress: how does it work? Trends Cogn Sci 10:152–158, 2006.
  144. 145.
    Johnson LR, Farb C, Morrison JH, McEwen BS, LeDoux JE.Localization of glucocorticoid receptors at postsynaptic membranes in the lateral amygdala. Neuroscience 136: 289–299, 2005.
  145. 146.
    Karssen AM, Meijer OC, Berry A, Pinol RS, de Kloet ER. Low doses of dexamethasone can produce a hypocorticosteroid state in the brain.Endocrinology 146: 5587–5595, 2005.
  146. 147.
    Karssen AM, Meijer OC, van der Sandt ICJ, Lucassen PJ, de Lange ECM, de Boer AG, De Kloet ER. Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain.Endocrinology 142: 2686–2694, 2001.
  147. 148.
    Karst H, Berger S, Turiault M, Tronche F, Schutz G, Joels M.Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. Proc Natl Acad Sci USA102: 19204–19207, 2005.
  148. 149.
    Karst H, Wadman WJ, Joels M. Corticosteroid receptor-dependent modulation of calcium currents in rat hippocampal CA1 neurons. Brain Res 649:234–242, 1994.
  149. 150.
    Karten YJG, Jones MA, Jeurling SI, Cameron HA. GABAergic signaling in young granule cells in the adult rat and mouse dentate gyrus.Hippocampus 16: 312–320, 2006.
  150. 151.
    Kastin AJ, Akerstrom V. Glucose and insulin increase the transport of leptin through the blood-brain barrier in normal mice but not in streptozotocin-diabetic mice. Neuroendocrinology 73: 237–242, 2001.
  151. 152.
    Kaufman J, Charney DS. Neurobiological correlates of child abuse. Biol Psychiat 45: 1235–1236, 1999.
  152. 153.
    Kaufman J, Plotsky PM, Nemeroff CB, Charney DS. Effects of early adverse experiences on brain structure and function: clinical implications. Biol Psychiat 48: 778–790, 2000.
  153. 154.
    Kawachi I, Kennedy BP, Lochner K, Prothrow-Stith D. Social capital, income inequality, mortality. Am J Public Health 87: 1491–1498, 1997.
  154. 155.
    Kempermann G, Gage FH. New nerve cells for the adult brain. Sci Am280: 48–53, 1999.
  155. 156.
    Kendler KS. Major depression and the environment: a psychiatric genetic perspective. Pharmacopsychiatry 31: 5–9, 1998.
  156. 157.
    Kerr D, Campbell L. Hippocampal glucocorticoid receptor activation enhances voltage-dependent calcium conductances: relevance to brain aging.Proc Natl Acad Sci USA 89: 8527–8531, 1992.
  157. 158.
    Kessler RC. The effects of stressful life events on depression. Annu Rev Psychol 48: 191–214, 1997.
  158. 159.
    Kim EY, Mahmoud GS, Grover LM. REM sleep deprivation inhibits LTP in vivo in area CA1 of rat hippocampus. Neurosci Lett 388: 163–167, 2005.
  159. 160.
    Kim JJ, Koo JW, Lee HJ, Han JS. Amygdalar inactivation blocks stress-induced impairments in hippocampal long-term potentiation and spatial memory. J Neurosci 25: 1532–1539, 2005.
  160. 161.
    Kimura D. Sex differences in the brain. Sci Am 267: 119–125, 1992.
  161. 162.
    Kirschbaum C, Prussner JC, Stone AA, Federenko I, Gaab J, Lintz D, Schommer N, Hellhammer DH. Persistent high cortisol responses to repeated psychological stress in a subpopulation of healthy men. Psychosomatic Med 57: 468–474, 1995.
  162. 163.
    Kodama M, Fujioka T, Duman RS. Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biol Psych 56: 570–580, 2004.
  163. 164.
    Kong J, Shepel PN, Holden CP, Mackiewicz M, Pack AI, Geiger JD.Brain glycogen decreases with increased periods of wakefulness: implications for homeostatic drive to sleep. J Neurosci 22: 5581–5587, 2002.
  164. 165.
    Koob GF. Corticotropin-releasing factor, norepinephrine, stress. Biol Psychiat 46: 1167–1180, 1999.
  165. 166.
    Korte-Bouws GAH, Korte SM, De Kloet ER, Bohus B. Blockade of corticosterone synthesis reduces serotonin turnover in the dorsal hippocampus of the rat as measured by microdialysis. J Neuroendocrinol 8: 877–881, 1996.
  166. 167.
    Kramer AF, Colcombe SJ, McAuley E, Eriksen KI, Scalf P, Jerome GJ, Marquez DX, Elavsky S, Webb AG. Enhancing brain and cognitive function of older adults through fitness training. J Mol Neurosci 20: 213–221,2003.
  167. 168.
    Kreibich AS, Blendy JA. cAMP response element-binding protein is required for stress but not cocaine-induced reinstatement. J Neurosci 24: 6686–6692, 2004.
  168. 169.
    Kuroda Y, McEwen BS. Effect of chronic restraint stress and tianeptine on growth factors, GAP-43 and MAP2 mRNA expression in the rat hippocampus.Mol Brain Res 59: 35–39, 1998.
  169. 170.
    Lambert KG, Buckelew SK, Staffiso-Sandoz G, Gaffga S, Carpenter W, Fisher J, Kinsley CH. Activity-stress induces atrophy of apical dendrites of hippocampal pyramidal neurons in male rats. Physiol Behav 65: 43–49, 1998.
  170. 171.
    Landfield PW, Baskin RK, Pitler TA. Brain aging correlates: Retardation by hormonal-pharmacological treatments. Science 214: 581–584,1981.
  171. 172.
    Lawal A, Kern M, Sidhu H, Hofmann C, Shaker R. Novel evidence for hypersensitivity of visceral sensory neural circuitry in irritable bowel syndrome patients. Gastroenterology 130: 26–33, 2006.
  172. 173.
    Lee J, Seroogy KB, Mattson MP. Dietary restriction enhances neurotrophin expression and neurogenesis in the hippocampus of adult mice. J Neurochem 80: 539–547, 2002.
  173. 174.
    Leproult R, Copinschi G, Buxton O, Van Cauter E. Sleep loss results in an elevation of cortisol levels the next evening. Sleep 20: 865–870,1997.
  174. 175.
    Leskela U, Rytsala H, Komulainen E, Melartin T, Sokero P, Lestela-Mielonen P, Isometsa E. The influence of adversity and perceived social support on the outcome of major depressive disorder in subjects with different levels of depressive symptoms. Psychol Med 36: 779–788, 2006.
  175. 176.
    Leuner B, Gould E, Shors TJ. Is there a link between adult neurogenesis and learning? Hippocampus 26: 216–224, 2006.
  176. 177.
    Leverenz JB, Wilkinson CW, Wamble M, Corbin S, Grabber JE, Raskind MA, Peskind ER. Effect of chronic high-dose exogenous cortisol on hippocampal neuronal number in aged nonhuman primates. J Neurosci 19:2356–2361, 1999.
  177. 178.
    Levine S, Haltmeyer G, Kara G, Denenberg V. Physiological and behavioral effects of infantile stimulation. Physiol Behav 2: 55–59, 1967.
  178. 179.
    Liposits Z, Bohn MC. Association of glucocorticoid receptor immunoreactivity with cell membrane and transport vesicles in hippocampal and hypothalamic neurons of the rat. J Neurosci Res 35: 14–19, 1993.
  179. 180.
    Lisman JE, Otmakhova NA. Storage, recall, novelty detection of sequences by the hippocampus: Elaborating on the SOCRATIC model to account for normal and aberrant effects of dopamine. Hippocampus 11: 551–568, 2001.
  180. 181.
    Liston C, Miller MM, Goldwater DS, Radley JJ, Rocher AB, Hof PR, Morrison JH, McEwen BS. Stress-induced alterations in prefrontal cortical dendritic morphology predict selective impairments in perceptual attentional set-shifting. J Neurosci 26: 7870–7874, 2006.
  181. 182.
    Lopez-Rodriguez F, Kim J, Poland RE. Total sleep deprivation decreases immobility in the forced-swim test. Neuropsychopharmacology 29:1105–1111, 2004.
  182. 183.
    Lowy MT, Gault L, Yamamoto BK. Adrenalectomy attenuates stress-induced elevations in extracellular glutamate concentrations in the hippocampus. J Neurochem 61: 1957–1960, 1993.
  183. 184.
    Lu XY, Kim CS, Frazer A, Zhang W. Leptin: a potential novel antidepressant. Proc Natl Acad Sci USA 103: 1593–1598, 2006.
  184. 185.
    Luine V, Villegas M, Martinez C, McEwen BS. Repeated stress causes reversible impairments of spatial memory performance. Brain Res 639:167–170, 1994.
  185. 186.
    Lupien SJ, de Leon M, de Santi S, Convit A, Tarshish C, Nair NPV, Thakur M, McEwen BS, Hauger RL, Meaney MJ. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nature Neurosci1: 69–73, 1998.
  186. 187.
    Lupien SJ, Fiocco A, Wan N, f. Maheu Lord C, Schramek T, Tu MT. Stress hormones and human memory function across the lifespan.Psychoneuroendocrinology 30: 225–242, 2005.
  187. 188.
    Lynch JW, Kaplan GA, Shema SJ. Cumulative impact of sustained economic hardship on physical, cognitive, psychological, social functioning. N Engl J Med 337: 1889–1895, 1997.
  188. 189.
    Maccari S, Darnaudery M, Van Reeth O. Hormonal and behavioural abnormalities induced by stress in utero: an animal model for depression. Stress4: 169–181, 2001.
  189. 190.
    MacPherson A, Dinkel K, Sapolsky R. Glucocorticoids worsen excitotoxin-induced expression of pro-inflammatory cytokines in hippocampal cultures. Exp Neurol 194: 376–383, 2005.
  190. 191.
    MacQueen GM, Campbell S, McEwen BS, Macdonald K, Amano S, Joffe RT, Nahmias C, Young LT. Course of illness, hippocampal function, hippocampal volume in major depression. Proc Natl Acad Sci USA 100: 1387–1392, 2003.
  191. 192.
    Magarinos AM, Deslandes A, McEwen BS. Effects of antidepressants and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress. Eur J Pharm 371: 113–122, 1999.
  192. 193.
    Magarinos AM, McEwen BS, Flugge G, Fuchs E. Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate tree shrews. J Neurosci 16: 3534–3540, 1996.
  193. 194.
    Magarinos AM, McEwen BS, Saboureau M, Pevet P. Rapid and reversible changes in intrahippocampal connectivity during the course of hibernation in European hamsters. Proc Natl Acad Sci USA 49: 18775–18780,2006.
  194. 195.
    Magarinos AM, Orchinik M, McEwen BS. Morphological changes in the hippocampal CA3 region induced by non-invasive glucocorticoid administration: a paradox. Brain Res 809: 314–318, 1998.
  195. 196.
    Magarinos AM, Verdugo Garcia JM, McEwen BS. Chronic restraint stress alters synaptic terminal structure in hippocampus. Proc Natl Acad Sci USA94: 14002–14008, 1997.
  196. 197.
    Makara GB, Haller J. Non-genomic effects of glucocorticoids in the neural system. Evidence, mechanisms and implications. Prog Neurobiol 65: 367–390, 2001.
  197. 198.
    Makino S, Gold PW, Schulkin J. Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus.Brain Res 640: 105–112, 1994.
  198. 199.
    Maloney EM, Gurbaxani BM, Jones JF, de Souza Coelho L, Pennachin C, Goertzel BN. Chronic fatigue syndrome and high allostatic load.Pharmacogenomics 7: 467–473, 2006.
  199. 200.
    Margineanu DG, Gower AJ, Gobert J, Wulfert E. Long-term adrenalectomy reduces hippocampal granule cell excitability in vivo. Brain Res Bull 33: 93–98, 1994.
  200. 201.
    Markowe HLJ, Marmot MG, Shipley MJ, Bulpitt CJ, Meade TW, Stirling Y, Vickers MV, Semmence A. Fibrinogen: a possible link between social class and coronary heart disease. Br Med J 291: 1312–1314, 1985.
  201. 202.
    Marmigere F, Givalois L, Rage F, Arancibia S, Tapia-Arancibia L.Rapid induction of BDNF expression in the hippocampus during immobilization stress challenge in adult rats. Hippocampus 13: 646–655, 2003.
  202. 203.
    Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS. A transgenic model of visceral obesity and the metabolic syndrome. Science 294: 2166–2170, 2001.
  203. 204.
    Matys T, Pawlak R, Matys E, Pavlides C, McEwen BS, Strickland S.Tissue plasminogen activator promotes the effects of corticotropin releasing factor on the amygdala and anxiety-like behavior. Proc Natl Acad Sci USA 101:16345–16350, 2004.
  204. 205.
    Maule AG, Tripp RA, Kaattari SL, Schreck CB. Stress alters immune function and disease resistance in chinook salmon (Oncorhynchus tshawytscha).J Endocrinol 120: 135–142, 1989.
  205. 206.
    Mayer EA. The neurobiology of stress and gastrointestinal disease. Gut47: 861–869, 2000.
  206. 207.
    Mayer EA, Berman S, Suyenobu B, Labus J, Mandelkern MA, Naliboff BD, Chang L. Differences in brain responses to visceral pain between patients with irritable bowel syndrome and ulcerative colitis. Pain 115: 398–409,2005.
  207. 208.
    McDonald AJ. Organization of amygdaloid projections to the mediodorsal thalamus and prefrontal cortex: a fluorescence retrograde transport study in the rat. J Comp Neurol 262: 46–58, 1987.
  208. 209.
    McDonald AJ, Mascagni F, Guo L. Projections of the medial and lateral prefrontal cortices to the amygdala: a Phaseolus vulgaris leucoagglutinin study in the rat. Neuroscience 71: 55–75, 1996.
  209. 210.
    McEwen B. Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology 22: 108–124, 2000.
  210. 211.
    McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med 338: 171–179, 1998.
  211. 212.
    McEwen BS. Stress and hippocampal plasticity. Annu Rev Neurosci 22:105–122, 1999.
  212. 213.
    McEwen BS, Chattarji S. Molecular mechanisms of neuroplasticity and pharmacological implications: the example of tianeptine. Eur Neuropsychopharmacol 14: S497–S502, 2004.
  213. 214.
    McEwen BS, DeKloet ER, Rostene W. Adrenal steroid receptors and actions in the nervous system. Physiol Rev 66: 1121–1188, 1986.
  214. 215.
    McEwen BS, Lasley EN. The end of sex as we know it. In: Cerebrum.The Dana Forum on Brain Science. New York: Dana Press, 2005.
  215. 216.
    McEwen BS, Stellar E. Stress and the individual: mechanisms leading to disease. Arch Int Med 153: 2093–2101, 1993.
  216. 217.
    McEwen BS, Weiss J, Schwartz L. Selective retention of corticosterone by limbic structures in rat brain. Nature 220: 911–912, 1968.
  217. 218.
    McEwen BS, Wingfield JC. The concept of allostasis in biology and biomedicine. Horm Behav 43: 2–15, 2003.
  218. 219.
    McKittrick CR, Magarinos AM, Blanchard DC, Blanchard RJ, McEwen BS, Sakai RR. Chronic social stress reduces dendritic arbors in CA3 of hippocampus and decreases binding to serotonin transporter sites. Synapse 36:85–94, 2000.
  219. 220.
    McLaughlin KJ, Baran SE, Wright RL, Conrad CD. Chronic stress enhances spatial memory in ovariectomized female rats despite CA3 dendritric retraction: possible involvement of CA1 neurons. Neuroscience 135: 1045–1054, 2005.
  220. 221.
    Mclay RN, Freeman SM, Zadina JE. Chronic corticosterone impairs memory performance in the Barnes maze. Physiol Behav 63: 933–937, 1998.
  221. 222.
    McLean SA, Williams DA, Stein PK, Harris RE, Lyden AK, Whalen G, Park KM, Liberzon I, Sen A, Gracely RH, Baraniuk JN, Clauw DJ.Cerebrospinal fluid corticotropin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia.Neuropsychopharmacology 31: 2776–2782, 2006.
  222. 223.
    Meaney MJ, Tannenbaum B, Francis D, Bhatnagar S, Shanks N, Viau V, O’Donnell D, Plotsky PM. Early environmental programming hypothalamic-pituitary-adrenal responses to stress. Semin Neurosci 6: 247–259, 1994.
  223. 224.
    Meerlo P, Overkamp GJF, Benning MA, Koolhaas JM, Van Den Hoofdakker RH. Long-term changes in open field behaviour following a single social defeat in rats can be reversed by sleep deprivation. Physiol Behav 60:115–119, 1996.
  224. 225.
    Meijer OC, de Lange ECM, Breimer DD, de Boer AG, Workel JO, De Kloet ER. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology 139: 1789–1793, 1998.
  225. 226.
    Melamed S, Shirom A, Toker S, Shapira I. Burnout and risk of type 2 diabetes: a prospective study of apparently healthy employed persons.Psychosom Med 68: 863–869, 2006.
  226. 227.
    Melchor JP, Pawlak R, Strickland S. The tissue plasminogen activator: plasminogen proteolytic cascade accelerates amyloid-β (Aβ) degradation and inhibits Aβ-induced neurodegeneration. J Neurosci 23: 8867–8871, 2003.
  227. 228.
    Mendelson S, McEwen BS. Autoradiographic analyses of the effects of adrenalectomy and corticosterone on 5-HT1A and 5-HT1B receptors in the dorsal hippocampus and cortex of the rat. Neuroendocrinology 55: 444–450,1992.
  228. 229.
    Milad MR, Quirk GJ. Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 420: 70–74, 2002.
  229. 230.
    Miracle AD, Brace MF, Huyck KD, Singler SA, Wellman CL. Chronic stress impairs recall of extinction of conditioned fear. Neurobiol Learning Memory 85: 213–218, 2006.
  230. 231.
    Mirescu C, Gould E. Stress and adult neurogenesis. Hippocampus 16:233–238, 2006.
  231. 232.
    Moghaddam B, Bolinao ML, Stein-Behrens B, Sapolsky R.Glucocorticoids mediate the stress-induced extracellular accumulation of glutamate. Brain Res 655: 251–254, 1994.
  232. 233.
    Moldofsky H. Sleep, neuroimmune and neuroendocrine functions in fibromyalgia and chronic fatigue syndrome. Adv Neuroimmunol 5: 39–56, 1995.
  233. 234.
    Mommersteeg PMC, Heijnen CJ, Kavelaars A, van Doornen LJP.Immune and endocrine function in burnout syndrome. Psychosom Med 68: 879–886, 2006.
  234. 235.
    Mommersteeg PMC, Heijnen CJ, Verbraak MJPM, van Doornen LJP. Clinical burnout is not reflected in the cortisol awakening response, the day-curve or the response to a low-dose dexamethasone suppression test.Psychoneuroendocrinology 31: 216–225, 2006.
  235. 236.
    Morgan MA, LeDoux JE. Differential contribution of dorsal and ventral medial prefrontal cortex to the acquisition and extinction of conditioned fear in rats. Behav Neurosci 109: 681–688, 1995.
  236. 237.
    Moriceau S, Sullivan R. Maternal presence serves as a switch between learning fear and attraction in infancy. Nature Neurosci 8: 1004–1006, 2006.
  237. 238.
    Moriceau S, Sullivan RM. Corticosterone influences on mammalian neonatal sensitive-period learning. Behav Neurosci 118: 274–281, 2004.
  238. 239.
    Munck A, Guyre PM. Glucocorticoids and immune function. In:Psychoneuroimmunology, edited by Ader R, Felten DL, Cohen N. San Diego, CA: Academic, 1991, p. 447–474.
  239. 240.
    Murphy BEP. Treatment of major depression with steroid suppressive drugs. J Steroid Biochem Mol Biol 39: 239–244, 1991.
  240. 241.
    Musty RE, Consroe PF. Phencyclidine produces aggressive behavior in rapid eye movement sleep-deprived rats. Life Sci 30: 1733–1738, 1982.
  241. 242.
    Nacher J, McEwen BS. The role of N-methyl-D-aspartate receptors in neurogenesis. Hippocampus 16: 267–270, 2006.
  242. 243.
    Naliboff BD, Berman S, Suyenobu B, Labus JS, Chang L, Stains J, Mandelkern MA, Mayer EA. Longitudinal change in perceptual and brain activation response to visceral stimuli in irritable bowel syndrome patients.Gastroenterology 131: 352–365, 2006.
  243. 244.
    Nelson RA. Protein and fat metabolism in hibernating bears. Federation Proc 39: 2955–2958, 1980.
  244. 245.
    Nesse R, Williams GC. Why We Get Sick: The New Science of Darwinian Medicine. New York: Times Books, 1994.
  245. 246.
    Newcomer JW, Craft S, Hershey T, Askins K, Bardgett ME.Glucocorticoid-induced impairment in declarative memory performance in adult humans. J Neurosci 14: 2047–2053, 1994.
  246. 247.
    Newcomer JW, Selke G, Melson AK, Hershey T, Craft S, Richards K, Alderson AL. Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch Gen Psychiat 56: 527–533, 1999.
  247. 248.
    Nyberg F. Growth hormone in the brain: characteristics of specific brain targets for the hormone and their functional significance. Front Neuroendocrinol21: 330–348, 2000.
  248. 249.
    Oitzl MS, De Kloet ER, Joels M, Schmid W, Cole TJ. Spatial learning deficits in mice with a targeted glucocorticoid receptor gene disruption. Eur J Neurosci 9: 2284–2296, 1997.
  249. 250.
    Okuda S, Roozendaal B, McGaugh JL. Glucocorticoid effects on object recognition memory require training-associated emotional arousal. Proc Natl Acad Sci USA 101: 853–858, 2004.
  250. 251.
    Olson AK, Eadie BD, Ernst C, Christie BR. Environmental enrichment and voluntary exercise massively increase neurogenesis in the adult hippocampus via dissociable pathways. Hippocampus 16: 250–260, 2006.
  251. 252.
    Orchinik M, Murray TF, Moore FL. A corticosteroid receptor in neuronal membranes. Science 252: 1848, 1991.
  252. 253.
    Orchinik M, Weiland NG, McEwen BS. Adrenalectomy selectively regulates GABAa receptor subunit expression in the hippocampus. Mol Cell Neurosci 5: 451–458, 1994.
  253. 254.
    Orchinik M, Weiland NG, McEwen BS. Chronic exposure to stress levels of corticosterone alters GABAA receptor subunit mRNA levels in rat hippocampus. Brain Res 34: 29–37, 1995.
  254. 255.
    Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MMB. Association of diabetes mellitus and dementia: the Rotterdam study. Diabetologia 39: 1392–1397, 1996.
  255. 256.
    Pan W, Yu Y, Cain CM, Nyberg F, Couraud PO, Kastin AJ.Permeation of growth hormone across the blood-brain barrier. Endocrinology146: 4898–4904, 2005.
  256. 257.
    Pavlides C, Kimura A, Magarinos AM, McEwen BS. Type I adrenal steroid receptors prolong hippocampal long-term potentiation. Neuroreport 5:2673–2677, 1994.
  257. 258.
    Pavlides C, Nivon LG, McEwen BS. Effects of chronic stress on hippocampal long-term potentiation. Hippocampus 12: 245–257, 2002.
  258. 259.
    Pavlides C, Watanabe Y, Magarinos AM, McEwen BS. Opposing role of adrenal steroid Type I and Type II receptors in hippocampal long-term potentiation. Neuroscience 68: 387–394, 1995.
  259. 260.
    Pawlak R, Rao BSS, Melchor JP, Chattarji S, McEwen B, Strickland S. Tissue plasminogen activator and plasminogen mediate stress-induced decline of neuronal and cognitive functions in the mouse hippocampus. Proc Natl Acad Sci USA 102: 18201–18206, 2005.
  260. 261.
    Payne JL, Quiroz JA, Zarate CA Jr, Manji HK. Timing is everything: does the robust upregulation of noradrenergically regulated plasticity genes underlie the rapid antidepressant effects of sleep deprivation? Biol Psychiat 52:921–926, 2002.
  261. 262.
    Pelletier KR. A review and analysis of the clinical- and cost-effectiveness studies of comprehensive health promotion and disease management programs at the worksite: 1998–2000 update. Am J Health Promotion 16: 107–115, 2001.
  262. 263.
    Perseghin G, Price TB, Petersen KF, Roden M, Cline GW, Gerow K, Rothman DL, Shulman GI. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects.N Engl J Med 335: 1357–1362, 1996.
  263. 264.
    Petrovich GD, Canteras NS, Swanson LW. Combinatorial amygdalar inputs to hippocampal domains and hypothalamic behavior systems. Brain Res Rev 38: 247–289, 2001.
  264. 265.
    Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, Straub RE, m. Egan F, Meyer-Lindenberg A, Weinberger DR. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 24: 10099–10102, 2004.
  265. 266.
    Pham K, Nacher J, Hof PR, McEwen BS. Repeated, but not acute, restraint stress suppresses proliferation of neural precursor cells and increases PSA-NCAM expression in the adult rat dentate gyrus. J Neurosci 17: 879–886,2003.
  266. 267.
    Pham K, Nacher J, Hof PR, McEwen BS. Repeated restraint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus. Eur J Neurosci 17: 879–886, 2003.
  267. 268.
    Phillips RG, LeDoux JE. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 106:274–285, 1992.
  268. 269.
    Piroli GG, Grillo CA, Hoskin EK, Znamensky V, Katz EB, Milner TA, McEwen BS, Charron MJ, Reagan LP. Peripheral glucose administration stimulates the translocatiom of GLUT8 glucose transporter to the endoplasmic reticulum in the rat hippocampus. J Comp Neurol 452: 103–114, 2002.
  269. 270.
    Pitman RK. Hippocampal diminution in PTSD: more (or less?) than meets the eye. Hippocampus 11: 73–74, 2001.
  270. 271.
    Plotsky PM, Thrivikraman KV, Nemeroff CB, Caldji C, Sharma S, Meaney MJ. Long-term consequences of neonatal rearing on central corticotropin-releasing factor systems in adult male rat offspring.Neuropsychopharmacology 30: 2192–2204, 2005.
  271. 272.
    Popov VI, Bocharova LS. Hibernation-induced structural changes in synaptic contacts between mossy fibres and hippocampal pyramidal neurons.Neuroscience 48: 53–62, 1992.
  272. 273.
    Popov VI, Bocharova LS, Bragin AG. Repeated changes of dendritic morphology in the hippocampus of ground squirrels in the course of hibernation. Neuroscience 48: 45–51, 1992.
  273. 274.
    Power C, Li L, Manor O, Davey Smith G. Combination of low birth weight and high adult body mass index: at what age is it established and what are its determinants? J Epidemiol Community Health 57: 969–973, 2003.
  274. 275.
    Pressman SD, Cohen S. Does positive affect influence health? Psychol Bull 131: 925–971, 2005.
  275. 276.
    Pruessner JC, Baldwin MW, Dedovic K, Renwick RMNK, Lord C, Meaney M, Lupien S. Self-esteem, locus of control, hippocampal volume, cortisol regulation in young and old adulthood. Neuroimage 28: 815–826,2005.
  276. 277.
    Pruessner JC, Hellhammer DH, Kirschbaum C. Burnout, perceived stress, cortisol responses to awakening. Psychosom Med 61: 197–204, 1999.
  277. 278.
    Pruessner JC, Hellhammer DH, Kirschbaum C. Low self-esteem, induced failure and the adrenocortical stress response. Personality Individual Differences 27: 477–489, 1999.
  278. 279.
    Pugh CR, Tremblay D, Fleshner M, Rudy JW. A selective role for corticosterone in contextual-fear conditioning. Behav Neurosci 111: 503–511,1997.
  279. 280.
    Pulford BE, Ishii DN. Uptake of circulating insulin-like growth factors (IGFs) into cerebrospinal fluid appears to be independent of the IGF receptors as well as IGF-binding proteins. Endocrinology 142: 213–220, 2001.
  280. 281.
    Quirk GJ, Likhtik E, Pelletier JG, Pare D. Stimulation of medial prefrontal cortex decreases the responsiveness of central amygdala output neurons. J Neurosci 23: 8800–8807, 2003.
  281. 282.
    Radley JJ, Rocher AB, Miller M, Janssen WGM, Liston C, Hof PR, McEwen BS, Morrison JH. Repeated stress induces dendritic spine loss in the rat medial prefrontal cortex. Cerebral Cortex 16: 313–320, 2006.
  282. 283.
    Radley JJ, Sisti HM, Hao J, Hof PR, McEwen BS, Morrison JH.Chronic behavioral stress induces apical dendritic reorganization in pyramidal neurons of the medial prefrontal cortex. Neuroscience 125: 1–6, 2004.
  283. 284.
    Radley JJ, Sisti HM, Hao J, Rocher AB, McCall T, Hof PR, McEwen BS, Morrison JH. Chronic behavioral stress induces apical dendritic reorganization in pyramidal neurons of the medial prefrontal cortex.Neuroscience 125: 1–6, 2004.
  284. 285.
    Rajeevan MS, Smith AK, Dimulescu I, Unger ER, Vernon SD, Heim C, Reeves WC. Glucocorticoid receptor polymorphisms and haplotypes associated with chronic fatigue syndrome. Genes Brain Behav 1–10, 2006.
  285. 286.
    Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiat 48: 766–777, 2000.
  286. 287.
    Rapp PR, Gallagher M. Preserved neuron number in the hippocampus of aged rats with spatial learning deficits. Proc Natl Acad Sci USA 93: 9926–9930, 1996.
  287. 288.
    Rasgon NL, Kenna HA. Insulin resistance in depressive disorders and Alzheimer’s disease: revisiting the missing link hypothesis. Neurobiol Aging26S: S103–S107, 2005.
  288. 289.
    Rasmussen T, Schliemann T, Sorensen JC, Zimmer J, West MJ.Memory impaired aged rats: no loss of principal hippocampal and subicular neurons. Neurobiol Aging 14: 143–147, 1996.
  289. 290.
    Reagan LP, Rosell DR, Wood GE, Spedding M, Munoz C, Rothstein J, McEwen BS. Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: Reversal by tianeptine. Proc Natl Acad Sci USA 101: 2179–2184, 2004.
  290. 291.
    Repetti RL, Taylor SE, Seeman TE. Risky families: family social environments and the mental and physical health of offspirng. Psychol Bull 128:330–366, 2002.
  291. 292.
    Ribeiro SC, Kennedy SE, Smith YR, Stohler CS, Zubieta JK.Interface of physical and emotional stress regulation through the endogenous opioid system and μ-opioid receptors. Prog Neuro-Psychopharm Biol Psychiat29: 1264–1280, 2005.
  292. 293.
    Richardson MP, Strange BA, Dolan RJ. Encoding of emotional memories depends on amygdala and hippocampus and their interactions. Nature Neurosci 7: 278–285, 2004.
  293. 294.
    Rizk P, Salazar J, Raisman-Vozari R, Marien M, Ruberg M, Colpaert F, Debeir T. The alpha2-adrenoceptor antagonist dexefaroxan enhances hippocampal neurogenesis by increasing the survival and differentiation of new granule cells. Neuropsychopharmacology 31: 1146–1157,2006.
  294. 295.
    Robinson TE, Kolb B. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci 17: 8491–8497, 1997.
  295. 296.
    Roman V, Van der Borght K, Leemburg SA, Van der Zee EA, Meerlo P. Sleep restriction by forced activity reduces hippocampal cell proliferation. Brain Res 1065: 53–59, 2005.
  296. 297.
    Romcy-Pereira R, Pavlides C. Distinct modulatory effects of sleep on the maintenance of hippocampal and medial prefrontal cortex LTP. Eur J Neurosci 20: 3453–3462, 2004.
  297. 298.
    Romeo RD, Bellani R, Karatsoreos IN, Chhua N, Vernov M, Conrad CD, McEwen BS. Stress history and pubertal development interact to shape hypothalamic-pituitary-adrenal axis plasticity. Endocrinology 147: 1664–1674, 2006.
  298. 299.
    Romeo RD, Lee SJ, Chhua N, McPherson CR, McEwen BS.Testosterone cannot activate an adult-like stress response in prepubertal male rats. Neuroendocrinology 79: 125–132, 2004.
  299. 300.
    Romeo RD, Lee SJ, McEwen BS. Differential stress reactivity in intact and ovariectomized prepubertal and adult female rats. Neuroendocrinology 80:387–393, 2004.
  300. 301.
    Roozendaal B, Griffith QK, Buranday J, de Quervain DJF, McGaugh JL. The hippocampus mediates glucocorticoid-induced impairment of spatial memory retrieval: dependence on the basolateral amygdala. Proc Natl Acad Sci USA 100: 1328–1333, 2003.
  301. 302.
    Rovio S, Kareholt I, Helkala EL, Viitanen M, Winblad B, Tuomilehto J, Soininen H, Nissinen A, Kivipelto M. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer’s disease. Lancet 4:705–711, 2005.
  302. 303.
    Sachar EJ, Hellman L, Roffwarg HP, Halpern FS, Fukushima DK, Gallagher TF. Disrupted 24-hour patterns of cortisol secretion in psychotic depression. Arch Gen Psychiarty 28: 19–24, 1973.
  303. 304.
    Sampson RJ, Raudenbush SW, Earls F. Neighborhoods and violent crime: a multilevel study of collective effects. Science 277: 918–924, 1997.
  304. 305.
    Sanchez MM, Young LJ, Plotsky PM, Insel TR. Distribution of corticosteroid receptors in the rhesus brain: relative absence of glucocorticoid receptors in the hippocampal formation. J Neurosci 20: 4657–4668, 2000.
  305. 306.
    Sandeep TC, Yau JLW, MacLullich AMJ, Noble J, Deary IJ, Walker BR, Seckl JR. 11β-Hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics. Proc Natl Acad Sci USA101: 6734–6739, 2004.
  306. 307.
    Sandi C. Stress, cognitive impairment and cell adhesion molecules.Nature Rev Neurosci 5: 917–930, 2004.
  307. 308.
    Sanghi S, MacLaughlin EJ, Jewell CW, Chaffer S, Naus PJ, Watson LE, Dostal DE. Cyclooxygenase-2 inhibitors: a painful lesson. Cardiovasc Hematol Disord Drug Targets 6: 85–100, 2006.
  308. 309.
    Santini E, Ge H, Ren K, Pena de Ortiz S, Quirk GJ. Consolidation of fear extinction requires protein synthesis in the medial prefrontal cortex. J Neurosci 24: 5704–5710, 2004.
  309. 310.
    Sapolsky R. Stress, the Aging Brain and the Mechanisms of Neuron Death. Cambridge, MA: MIT Press, 1992, vol. 1, p. 423.
  310. 311.
    Sapolsky R, Krey L, McEwen BS. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev 7: 284–301,1986.
  311. 312.
    Sapolsky RM. Why Zebras Don’t Get Ulcers. New York: Henry Holt,2004.
  312. 313.
    Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, preparative actions. Endocrine Rev 21: 55–89, 2000.
  313. 314.
    Sarrieau A, Vial M, McEwen BS, Broer Y, Dussaillant M, Philibert D, Moguilewsky M, Rostene W. Corticosteroid receptors in rat hippocampal sections: effect of adrenalectomy and corticosterone replacement. J Ster Biochem24: 721–724, 1986.
  314. 315.
    Saxena S, Jane-Llopis E, Hosman C. Prevention of mental and behavioural disorders: implications for policy and practice. World Psychiat 5: 5–14, 2006.
  315. 316.
    Schelling G, Briegel J, Roozendaal B, Stoll C, Rothenhausler HB, Kapfhammer HP. The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder in survivors. Biol Psychiat 50: 978–985,2001.
  316. 317.
    Schelling G, Kilger E, Roozendaal B, de Quervain DJF, Briegel J, Dagge A, Rothenhausler HB, Krauseneck T, Nollert G, Kapfhammer HP.Stress doses of hydrocortisone, traumatic memories, symptoms of posttraumatic stress disorder in patients after cardiac surgery: a randomized study. Biol Psychiat 55: 627–633, 2004.
  317. 318.
    Schelling G, Roozendaal B, De Quervain DJF. Can posttraumatic stress disorder be prevented with glucocorticoids? Ann NY Acad Sci 1032: 158–166, 2004.
  318. 319.
    Seeman TE, Singer BH, Ryff CD, Dienberg G, Levy-Storms L.Social relationships, gender, allostatic load across two age cohorts. Psychosom Med 64: 395–406, 2002.
  319. 320.
    Seri B, Garcia-Verdugo JM, McEwen BS, Alvarez-Buylla A.Astrocytes give rise to new neurons in the adult mammalian hippocampus. J Neurosci 21: 7153–7160, 2001.
  320. 321.
    Sheline YI, Gado MH, Kraemer HC. Untreated depression and hippocampal volume loss. Am J Psychiat 160: 1516–1518, 2003.
  321. 322.
    Sheline YI, Gado MH, Price JL. Amygdala core nuclei volumes are decreased in recurrent major depression. Neuroreport 9: 2023–2028, 1998.
  322. 323.
    Sheline YI, Sanghavi M, Mintun MA, Gado MH. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 19: 5034–5043, 1999.
  323. 324.
    Shors TJ, Miesegaes G. Testosterone in utero and at birth dictates how stressful experience will affect learning in adulthood. Proc Natl Acad Sci USA 99:13955–13960, 2002.
  324. 325.
    Siiteri P, Murai J, Hammond G, Nisker J, Raymoure W, Kuhn R.The serum transport of steroid hormones. Rec Prog Horm Res 38: 457–510,1982.
  325. 326.
    Silva RH, Abilio VC, Takatsu AL, Kameda SR, Grassl C, Chehin AB, Medrano WA, Calzavara MB, Registro S, Andersen ML, Machado RB, Carvalho RC, d R. Ribeiro A, Tufik S, Frussa-Filho R. Role of hippocampal oxidative stress in memory deficits induced by sleep deprivation in mice.Neuropharmacology 46: 895–903, 2004.
  326. 327.
    Silver EJ, Heneghan AM, Bauman LJ, Stein RE. The relationship of depressive symptoms to parenting competence and social support in inner-city mothers of young children. Matern Child Health J 10: 105–112, 2006.
  327. 328.
    Singh VB, Corley KC, Krieg RJ, Phan TH, Boadle-Biber MC. Sound stress activation of tryptophan hydroxylase blocked by hypophysectomy and intracranial RU 38486. Eur J Pharmacol 256: 177–184, 1994.
  328. 329.
    Singh-Manoux A, Marmot MG, Adler NE. Does subjective social status predict health and change in health status better than objective status?Psychosom Med 67: 855–861, 2005.
  329. 330.
    Smith MA, Cizza G. Stress-induced changes in brain-dervied neurotrophic factor expression are attenuated in aged Fischer 344/N rats.Neurobiol Aging 17: 859–864, 1996.
  330. 331.
    Sonnentag S. Burnout and functioning of the hypothalamus-pituitary-adrenal axis: there are no simple answers. Scand J Work Environ Health 32: 333–337, 2006.
  331. 332.
    Sousa N, Lukoyanov NV, Madeira MD, Almeida OFX, Paula-Barbosa MM. Reorganization of the morphology of hippocampal neurites and synapses after stress-induced damage correlates with behavioral improvement.Neuroscience 97: 253–266, 2000.
  332. 333.
    Sousa N, Madeira MD, Paula-Barbosa MM. Effects of corticosterone treatment and rehabilitation on the hippocampal formation of neonatal and adult rats. An unbiased stereological study. Brain Res 794: 199–210, 1998.
  333. 334.
    Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 354: 1435–1439, 1999.
  334. 335.
    Spiegel K, Tasali E, Penev P, Van Cauter E. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, increased hunger and appetite. Ann Intern Med141: 846–850, 2004.
  335. 336.
    Squire L. The hippocampus and the neuropsychology of memory. In:Neurobiology of the Hippocampus, edited by Seifert W. London: Academic, 1983, p. 491–511.
  336. 337.
    Starkman MN, Gebarski SS, Berent S, Schteingart DE. Hippocampal formation volume, memory dysfunction, cortisol levels in patients with Cushing’s syndrome. Biol Psychiatry 32: 756–765, 1992.
  337. 338.
    Starkman MN, Schteingart DE. Neuropsychiatric manifestations of patients with Cushing’s syndrome. Arch Intern Med 141: 215–219, 1981.
  338. 339.
    Stein-Behrens BA, Lin WJ, Sapolsky RM. Physiological elevations of glucocorticoids potentiate glutamate accumulation in the hippocampus. J Neurochem 63: 596–602, 1994.
  339. 340.
    Steptoe A, Owen N, Kunz-Ebrecht SR, Brydon L. Loneliness and neuroendocrine, cardiovascular, inflammatory stress responses in middle-aged men and women. Psychoneuroendocrinology 29: 593–611, 2004.
  340. 341.
    Steptoe A, Wardle J, Marmot M. Positive affect and health-related neuroendocrine, cardiovascular, inflammatory processes. Proc Natl Acad Sci USA102: 6508–6512, 2005.
  341. 342.
    Sterling P, Eyer J. Allostasis: a new paradigm to explain arousal pathology. In: Handbook of Life Stress, Cognition and Health, edited by Fisher S, Reason J. New York: Wiley, 1988, p. 629–649.
  342. 343.
    Stewart MG, Davies HA, Sandi C, Kraev IV, Rogachevsky VV, Peddie CJ, Rodriguez JJ, Cordero MI, Donohue HS, Gabbott PLA, Popov VI. Stress suppresses and learning induces plasticity in CA3 of rat hippocampus: a three-dimensional ultrastructural study of thorny excrescences and their postsynaptic densities. Neuroscience 131: 43–54, 2005.
  343. 344.
    Stockmeier CA, Mahajan GJ, Konick LC, Overholser JC, Jurjus GJ, Meltzer HY, Uylings HBM, Friedman L, Rajkowska G. Cellular changes in the postmortem hippocampus in major depression. Biol Psychiat 56: 640–650,2004.
  344. 345.
    Stranahan AM, Khalil D, Gould E. Social isolation delays the positive effects of running on adult neurogenesis. Nature Neurosci 9: 526–533, 2006.
  345. 346.
    Sullivan RM, Landers M, Yeaman B, Wilson DA. Good memories of bad events in infancy. Nature 407: 38–39, 2000.
  346. 347.
    Sunanda MSR, Raju TR. Effect of chronic restraint stress on dendritic spines and excrescences of hippocampal CA3 pyramidal neurons—a quantitative study. Brain Res 694: 312–317, 1995.
  347. 348.
    Sze P. Glucocorticoid regulation of the serotonergic system of the brain. In: Advances in Biochemical Psychopharmacology, edited by Costa E, Giacobini E, Paoletti R. New York: Raven, 1976, p. 251–265.
  348. 349.
    Szeszko PR, Lipsky R, Mentschel C, Robinson D, Gunduz-Bruce H, Sevy S, Ashtari M, Napolitano B, Bilder RM, Kane JM, Goldman D, Malhotra AK. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol Psychiat 10: 631–636, 2005.
  349. 350.
    Taishi P, Chen Z, Obal F Jr, Hansen MK, Zhang J, Fang J, Krueger JM. Sleep-associated changes in interleukin-1, mRNA in the brain. J Interferon Cytokine Res 18: 793–798, 1998.
  350. 351.
    Tang AC, Akers KG, Reeb BC, Romeo RD, McEwen BS. Programming social, cognitive, neuroendocrine development by early exposure to novelty. Proc Natl Acad Sci USA. 103: 15716–15721, 2007.
  351. 352.
    Tang J, Liu J, Zhou C, Ostanin D, Grisham MB, Granger DN, Zhang JH. Role of NADPH oxidase in the brain injury of intracerebral hemorrhage. J Neurochem 94: 1342–1350, 2005.
  352. 353.
    Tartar JL, Ward CP, McKenna JT, Thakkar M, Arrigoni E, McCarley RW, Brown RE, Strecker RE. Hippocampal synaptic plasticity and spatial learning are impaired in a rat model of sleep fragmentation. Eur J Neurosci 23:2739–2748, 2006.
  353. 354.
    Thai L, Lee PHK, Ho J, Suh H, Hong JS. Regulation of prodynorphin gene expression in the hippocampus by glucocorticoids. Mol Brain Res 16: 150–157, 1992.
  354. 355.
    Thayer JF, Lane RD. A model of neurovisceral integration in emotion regulation and dysregulation. J Affect Disorders 61: 201–216, 2000.
  355. 356.
    Trejo JL, Carro E, Torres-Aleman I. Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. J Neurosci 21: 1628–1634, 2001.
  356. 357.
    Van Praag H, Shubert T, Zhao C, Gage FH. Exercise enhances learning and hippocampal neurogenesis in aged mice. J Neurosci 25: 8680–8685, 2005.
  357. 358.
    Van Rossum EFC, Binder EB, Majer M, Koper JW, Ising M, Modell S, Salyakina D, Lamberts SWJ, Holsboer F. Polymorphisms of the glucocorticoid receptor gene and major depression. Biol Psychiat 59: 681–688,2006.
  358. 359.
    Venero C, Borrell J. Rapid glucocorticoid effects on excitatory amino acid levels in the hippocampus: a microdialysis study in freely moving rats. Eur J Neurosci 1: 2465–2473, 1999.
  359. 360.
    Vermetten E, Schmahl C, Lindner S, Loewenstein RJ, Bremner JD.Hippocampal and amygdalar volumes in dissociative identity disorder. Am J Psychiat 163: 630–636, 2006.
  360. 361.
    Vgontzas AN, Zoumakis E, Bixler EO, Lin HM, Follett H, Kales A, Chrousos GP. Adverse effects of modest sleep restriction on sleepiness, performance, inflammatory cytokines. J Clin Endocrinol Metab 89: 2119–2126,2004.
  361. 362.
    Vollmann-Honsdorf GK, Flugge G, Fuchs E. Chronic psychosocial stress does not affect the number of pyramidal neurons in tree shrew hippocampus. Neurosci Lett 233: 121–124, 1997.
  362. 363.
    Vyas A, Mitra R, Rao BSS, Chattarji S. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neurosci 22: 6810–6818, 2002.
  363. 364.
    Wadhwa PD, Sandman CA, Garite TJ. The Neurobiology of Stress in Human Pregnancy: Implications for Prematurity and Development of the Fetal Central Nervous System. New York: Elsevier Science, 2001, p. 131–142.
  364. 365.
    Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ, Kosslyn SM, rose RM, Cohen JD. Placebo-induced changes in fMRI in the anticipation and experience of pain. Science 303: 1162–1167, 2004.
  365. 366.
    Wakschlak A, Weinstock M. Neonatal handling reverses behavioral abnormalities induced in rats by prenatal stress. Physiol Behav 48: 289–292,1990.
  366. 367.
    Wang GJ, Yang J, Volkow ND, Telang F, Ma Y, Zhu W, Wong CT, Tomasi D, Thanos PK, Fowler JS. Gastric stimulation in obese subjects activates the hippocampus and other regions involved in brain reward circuitry.Proc Natl Acad Sci USA 103: 15641–15645, 2006.
  367. 368.
    Wang J, Rao H, Wetmore GS, Furlan PM, Korczykowski M, Dinges DF, Detre JA. Perfusion functional MRI reveals cerebral blood flow pattern under psychological stress. Proc Natl Acad Sci USA 102: 17804–17809, 2005.
  368. 369.
    Warner-Schmidt JL, Duman RS. Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus 16: 239–249,2006.
  369. 370.
    Watanabe Y, Gould E, Cameron HA, Daniels DC, McEwen BS.Phenytoin prevents stress- and corticosterone-induced atrophy of CA3 pyramidal neurons. Hippocampus 2: 431–436, 1992.
  370. 371.
    Weaver ICG, Cervoni N, Champagne FA, D’Alessio AC, Sharma S, Seckl JR, Dymov S, Szyf M, Meaney MJ. Epigenetic programming by maternal behavior. Nature Neurosci 7: 847–854, 2004.
  371. 372.
    Weiland NG, Orchinik M, Tanapat P. Chronic corticosterone treatment induces parallel changes in N-methyl-D-aspartate receptor subunit messenger RNA levels and antagonist binding sites in the hippocampus. Neuroscience 78:653–662, 1997.
  372. 373.
    Wellman CL. Dendritic reorganization in pyramidal neurons in medial prefrontal cortex after chronic corticosterone administration. J Neurobiol 49:245–253, 2001.
  373. 374.
    Wender R, Brown AM, Fern R, Swanson RA, Farrell K, Ransom BR.Astrocytic glycogen influences axon function and survival during glucose deprivation in central white matter. J Neurosci 20: 6804–6810, 2000.
  374. 375.
    Westenbroek C, Den Boer JA, Veenhuis M, Ter Horst GJ. Chronic stress and social housing differentially affect neurogenesis in male and female rats. Brain Res Bull 64: 303–308, 2004.
  375. 376.
    Whitmer RW, Pelletier KR, Anderson DR, Baase CM, Frost GJ. A wake-up call for corporate America. J Occup Environ Med 45: 916–925, 2003.
  376. 377.
    Wilson IA, Ikonen S, Gureviciene I, McMahan RW, Gallagher M, Eichenbaum H, Tanila H. Cognitive aging and the hippocampus: how old rats represent new environments. J Neurosci 24: 3870–3878, 2004.
  377. 378.
    Wilson TW, Kaplan GA, Kauhanen J, Cohen RD, Wu M, Salonen R, Salonen JT. Association between plasma fibrinogen concentration and five socioeconomic indices in the kuopio ischemic heart disease risk factor study.Am J Epidemiol 137: 292–300, 1993.
  378. 379.
    Wingfield JC, Romero LM. Adrenocortical responses to stress and their modulation in free-living vertebrates. In: Coping With the Environment: Neural and Endocrine Mechanisms. New York: Oxford Univ. Press, 2000, p. 211–234.
  379. 380.
    Winocur G, Greenwood CE. The effects of high fat diets and environment influences on cognitive performance in rats. Behav Brain Res 101:153–161, 1999.
  380. 381.
    Winocur G, Piroli GG, Grillo C, Reagan LP, Greenwood CE, Reznikov LR, McEwen BS. Memory impairment in obese Zucker rats: an investigation of cognitive function in an animal model of insulin resistance and obesity. Behav Neurosci 119: 1389–1395, 2005.
  381. 382.
    Wiskott L, Rasch MJ, Kempermann G. A functional hypothesis for adult hippocampal neurogenesis: avoidance of catastrophic interference in the dentate gyrus. Hippocampus 16: 329–343, 2006.
  382. 383.
    Wood GE, Shors TJ. Stress facilitates classical conditioning in males, but impairs classical conditioning in females through activational effects of ovarian hormones. Proc Natl Acad Sci USA 95: 4066–4071, 1998.
  383. 384.
    Wood GE, Young LT, Reagan LP, Chen B, McEwen BS. Stress-induced structural remodeling in hippocampus: prevention by lithium treatment.Proc Natl Acad Sci USA 101: 3973–3978, 2004.
  384. 385.
    Wood GE, Young LT, Reagan LP, McEwen BS. Acute and chronic restraint stress alter the incidence of social conflict in male rats. Horm Behav43: 205–213, 2003.
  385. 386.
    Wood PB. Fibromyalgia syndrome: a central role for the hippocampus—a theoretical construct. J Musculoskeletal Pain 12: 19–26, 2004.
  386. 387.
    Wood PB. Stress and dopamine: implications for the pathophysiology of chronic widespread pain. Medical Hypoth 62: 420–424, 2004.
  387. 388.
    Wood PB. Mesolimbic dopaminergic mechanisms and pain control. Pain120: 230–234, 2006.
  388. 389.
    Woolley CS, Gould E, McEwen BS. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res531: 225–231, 1990.
  389. 390.
    Wright CE, Steptoe A. Subjective socioeconomic position, gender and cortisol responses to waking in an elderly population.Psychoneuroendocrinology 30: 582–590, 2005.
  390. 391.
    Wright RL, Conrad CD. Chronic stress leaves novelty-seeking behavior intact while impairing spatial recognition memory in the Y-maze. Stress 8: 151–154, 2005.
  391. 392.
    Wright RL, Lightner EN, Harman JS, Meijer OC, Conrad CD.Attenuating corticosterone levels on the day of memory assessment prevents chronic stress-induced impairments in spatial memory. Eur J Neurosci 24: 595–605, 2006.
  392. 393.
    Yau JLW, Noble J, Kenyon CJ, Hibberd C, Kotelevtsev Y, Mullins JJ, Seckl JR. Lack of tissue glucocorticoid reactivation in 11β-hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments. Proc Natl Acad Sci USA 98: 4716–4721, 2001.
  393. 394.
    Young EA, Haskett RF, Grunhaus L, Pande A, Weinberg M, Watson SJ, Akil H. Increased evening activation of the hypothalamic-pituitary-adrenal axis in depressed patients. Arch Gen Psychiatry 51: 701–707,1994.
  394. 395.
    Youngblood BD, Zhou J, Smagin GN, Ryan DH, Harris RBS. Sleep deprivation by the “flower pot” technique and spatial reference memory. Physiol Behav 61: 249–256, 1997.
  395. 396.
    Yu Y, Kastin AJ, Pan W. Reciprocal interactions of insulin and insulin-like growth factor I in receptor-mediated transport across the blood-brain barrier. Endocrinology 147: 2611–2615, 2006.
  396. 397.
    Zigman JM, Jones JE, Lee CE, Saper CB, Elmquist JK. Expression of ghrelin receptor mRNA in the rat and the mouse brain. J Comp Neurol 494: 528–548, 2006.

Neuroplasticity & SPECT Imaging

30 10 2012

Today I want to suggest a very interesting interview between Dr. Joseph Mercola and Dr. Daniel Amen about the exciting technologies that may assist us to better understand, assess and address brain-related disorders (yes, including “mental disorder”, which are, as you know by now, are brain disorders). This interview highlight once again the need to develop a more scientific diagnostic system to brain disorders such as depression, OCD, Bipolar disorder, eating disorders and Psychotic disorders. I wish to thank my LinkedIn connection, Monica Azizi from Florida, for publishing this great interview.

Dr. Daniel Amen